ifosfamide has been researched along with Cancer of Lung in 737 studies
Excerpt | Relevance | Reference |
---|---|---|
"This Phase II trial of paclitaxel/ifosfamide included patients with bi-dimensionally measurable metastatic breast cancer in second or third relapse, following anthracycline-containing regimens; ECOG PS < 2, and adequate hepatic, cardiac, renal, and hematological functions." | 9.08 | Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer. ( Amorim, WC; Ferreira-Filho, AF; Guimaraes, RC; Morici, AC; Murad, AM; Schwartsmann, G, 1997) |
"This Phase I/II study investigates increasingly high doses of ifosfamide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in patients with metastatic soft tissue sarcoma (STS)." | 9.08 | A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. ( Arseniev, L; Bokemeyer, C; Franzke, A; Hartmann, JT; Kanz, L; Link, H; Metzner, B; Schmoll, HJ; Schöber, C, 1997) |
"To investigate the value of contrast-enhanced computed tomography (CECT) radiomics features in predicting the efficacy of epirubicin combined with ifosfamide in patients with pulmonary metastases from soft tissue sarcoma." | 8.12 | Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features. ( Jiang, X; Li, M; Ma, ST; Miao, L; Wang, YM; Zhang, HH, 2022) |
"This case shows us that operation on late stage cardiac angiosarcomas can alleviate a patient's symptoms; postoperative paclitaxel monotherapy was insufficient and ifosfamide and epirubicin plus recombinant human endostatin has a limited effect on late stage cardiac angiosarcoma." | 7.91 | The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report. ( Davies, H; Jiang, L; Shi, K; Xu, X, 2019) |
"The aim of this retrospective study was to evaluate the feasibility and efficacy of response to continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for patients with recurrent or refractory osteosarcoma." | 7.81 | Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study. ( He, AN; Huang, YJ; Min, DL; Shen, Z; Sun, YJ; Yao, Y, 2015) |
"To determine demographic data, prognostic factors and outcome of childhood osteosarcoma treated with a carboplatin-based chemotherapeutic protocol at Chiang Mai University." | 7.79 | Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand. ( Charoenkwan, P; Choeyprasert, W; Natesirinilkul, R; Sittipreechacharn, S, 2013) |
"This study assessed the therapeutic effect of and adverse reactions to pirarubicin (THP) chemotherapy in osteosarcoma patients with lung metastasis, and analyzed the relationship between THP therapeutic effect and expression of p-glycoprotein and topoisomerase-II." | 7.76 | Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis. ( Chen, P; Lin, F; Sun, Y; Wang, Z; Yao, Y; Zhao, H, 2010) |
"We report a patient with primary lung adenocarcinoma who had Ewing's sarcoma and was successfully treated with ifosfamide." | 7.74 | [A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide]. ( Arai, H; Fukumura, H; Kudo, M; Masuda, M; Nakajima, K; Oshiro, H; Rino, Y; Wada, N; Watanuki, Y; Yamanaka, S; Yukawa, N, 2008) |
"Cyclophosphamide (CTX) and ifosfamide (IFX) are alkylating agents used to treat osteosarcoma (OS)." | 7.73 | Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. ( Duan, X; Jia, SF; Kleinerman, ES; Koshkina, N, 2006) |
"Ifosfamide, Carboplatin and Etoposide (ICE) therapy was used to treat 4 patients, 2 with refractory osteosarcoma, and one each with relapsed brain tumor and newly diagnosed brain tumor." | 7.70 | [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. ( Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M, 1998) |
"Generalized and partial seizures with secondary generalization were observed during ifosfamide-mesna (IFO) treatment in a patient with lung epidermoid carcinoma." | 7.69 | [Epileptic seizures and treatment with ifosfamide-mesna]. ( Farisse, P; Somma-Mauvais, H; Viallat, JR, 1994) |
" A 16-year-old girl with metastatic osteosarcoma experienced recurrent bouts of symptomatic pancreatitis 24 hours after treatment with ifosfamide administered as a single agent." | 7.69 | Acute pancreatitis after ifosfamide therapy. ( Adamson, PC; Balis, FM; Blaney, SM; Izraeli, S, 1994) |
"From January 1990 to December 1995 we treated 35 patients (pts) with bone and soft tissue sarcoma with ifosfamide (IFM)." | 7.69 | [The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas]. ( Ishii, T; Kitoh, M; Satoh, T; Tatezaki, S; Umeda, T; Yonemoto, T, 1997) |
"Forty seven patients with inoperable adenocarcinoma and large cell carcinoma of the lung were treated with a combination of cisplatin (25 mg/m2), ifosfamide (1." | 7.68 | [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Mori, T; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991) |
"A 13-year-old boy with unresectable pulmonary metastatic osteosarcoma, which was refractory to high dose methotrexate, adriamycin, cisplatin and combination of bleomycin, cyclophosphamide and actinomycin D, was treated by aggressive chemotherapy including the combination of ifosfamide (1 g/m2 x day 1-4), Carboplatin (100 mg/m2 x day 1-4) and Vindesine (4 mg/m2 x day 1)." | 7.68 | [Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report]. ( Fujita, H; Ishimoto, K; Kiyokawa, N; Kyo, K; Mizuno, T; Takada, K; Yabuta, K, 1991) |
"The mesna, doxorubicin, ifosfamide, dacarbazine regimen produced a 47% response rate (including 10% complete responses) in 105 eligible adults with advanced sarcoma." | 7.68 | Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma. ( Aisner, J; Antman, KH; Elias, A; Ryan, L, 1990) |
"Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)." | 7.67 | High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989) |
"Fifty-three patients with inoperable non-small cell bronchial carcinoma were treated at four-weekly intervals with two cytostatic drugs, doxorubicin (50 mg/m2 on day 1) and ifosfamide (2000 mg/m2 on days 1-3)." | 7.66 | [Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide]. ( Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U, 1983) |
" Both have a dose-response relationship." | 6.68 | Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996) |
"Breast stromal sarcoma is very rare, accounting for less than 1% of mammary neoplasms, and the treatment strategy is not well established, especially regarding chemotherapy." | 5.37 | Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case. ( Inoue, K; Iwase, H; Kuriwaki, K; Sueta, A; Yamamoto, Y, 2011) |
"The European Organization for Research and Treatment of Cancer (EORTC) 62012 study was a Phase III trial of doxorubicin versus doxorubicin-ifosfamide chemotherapy in 455 patients with advanced soft tissue sarcoma (STS)." | 5.24 | Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study. ( Collin, F; Daugaard, S; Fisher, C; Gronchi, A; Grünwald, V; Hogendoorn, PCW; Judson, I; Lia, M; Litière, S; Mechtersheimer, G; Messiou, C; Sciot, R; van der Graaf, W; Wardelmann, E; Young, RJ, 2017) |
"Patients with high-grade soft tissue sarcomas were treated with 2 cycles of ifosfamide, mitomycin, doxorubicin, and cisplatin plus GM-CSF subcutaneous followed by 45 Gy irradiation with concurrent 2 cycles of mitomycin, doxorubicin, and cisplatin followed by surgery +/- intraoperative radiation or brachytherapy." | 5.22 | Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively. ( Haddock, M; Mahoney, M; Maples, W; Markovic, SN; O'Connor, MI; Okuno, S; Petersen, I; Shives, T; Sim, F, 2016) |
"To compare three-drug chemotherapy with cisplatin, doxorubicin, and methotrexate with four-drug chemotherapy with cisplatin, doxorubicin, methotrexate, and ifosfamide for the treatment of osteosarcoma." | 5.13 | Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. ( Bernstein, ML; Betcher, D; Ferguson, WS; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, M; Healey, JH; Kleinerman, E; Krailo, MD; Link, MP; Meyers, PA; Nadel, H; Nieder, M; Schwartz, CL; Siegal, GP; Weiner, MA; Wells, RJ; Womer, RB, 2008) |
"The outcome of patients with metastatic osteosarcoma treated in two consecutive trials from 1986 to 1997 was analyzed to evaluate the efficacy of carboplatin-based multiagent chemotherapy and to identify prognostic factors." | 5.12 | Metastatic osteosarcoma. ( Billups, CA; Cain, AM; Daw, NC; Jenkins, JJ; McCarville, MB; Meyer, WH; Neel, MD; Rao, BN; Rodriguez-Galindo, C, 2006) |
"A phase IIb trial using liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) in combination with ifosfamide (IFX) for patients with relapsed osteosarcoma was undertaken to determine (a) the tolerability of the combination therapy, (b) if L-MTP-PE increased the toxicity of IFX, and (c) whether IFX altered or suppressed the in vivo immune response to L-MTP-PE." | 5.08 | Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation. ( Gano, JB; Jaffe, N; Jia, SF; Kleinerman, ES; Meyers, PA; Raymond, AK, 1995) |
"This Phase II trial of paclitaxel/ifosfamide included patients with bi-dimensionally measurable metastatic breast cancer in second or third relapse, following anthracycline-containing regimens; ECOG PS < 2, and adequate hepatic, cardiac, renal, and hematological functions." | 5.08 | Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer. ( Amorim, WC; Ferreira-Filho, AF; Guimaraes, RC; Morici, AC; Murad, AM; Schwartsmann, G, 1997) |
"This Phase I/II study investigates increasingly high doses of ifosfamide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in patients with metastatic soft tissue sarcoma (STS)." | 5.08 | A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. ( Arseniev, L; Bokemeyer, C; Franzke, A; Hartmann, JT; Kanz, L; Link, H; Metzner, B; Schmoll, HJ; Schöber, C, 1997) |
"To estimate the duration of survival (S) of patients with metastatic osteosarcoma (MOS) at diagnosis treated with a multiagent, ifosfamide-containing chemotherapeutic and surgical regimen and to evaluate the toxicity of this regimen." | 5.08 | Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. ( Ayala, A; Ferguson, WS; Gieser, P; Goorin, AM; Harris, MB; Holbrook, T; Link, MP; Shochat, SJ, 1998) |
"43 patients with metastasizing sarcomas were treated with a combination of either vincristin, adriamycin and cis-platinum (n = 21) or ifosfamide and cis-platinum at three weeks' intervals in each case." | 5.05 | [Chemotherapy in advanced sarcomas (author's transl)]. ( Bierbaum, W; Bremer, K; Firusian, N; Higi, M; Niederle, N; Scheulen, ME; Schmidt, CG; Seeber, S, 1981) |
"A patient with a small-cell lung cancer (SCLC) developed an asymptomatic hyponatremia, with all features of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), two days after the start of his first cycle of chemotherapy with vindesine, ifosfamide and cisplatin." | 4.80 | Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review. ( Paridaens, R; Vanhees, SL; Vansteenkiste, JF, 2000) |
"The authors describe skin pigment changes in a 5-year-old patient receiving ifosfamide, MESNA, and etoposide for the treatment of relapsed Wilms tumor." | 4.78 | Ifosfamide-induced hyperpigmentation. ( Cornelius, AS; Murry, DJ; Teresi, ME, 1993) |
"The alkylating agent ifosfamide, an analog of cyclophosphamide, has demonstrated significant activity in soft tissue sarcoma and testicular carcinoma." | 4.77 | Ifosfamide. ( Baker, LH; Zalupski, M, 1988) |
"To investigate the value of contrast-enhanced computed tomography (CECT) radiomics features in predicting the efficacy of epirubicin combined with ifosfamide in patients with pulmonary metastases from soft tissue sarcoma." | 4.12 | Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features. ( Jiang, X; Li, M; Ma, ST; Miao, L; Wang, YM; Zhang, HH, 2022) |
"This case shows us that operation on late stage cardiac angiosarcomas can alleviate a patient's symptoms; postoperative paclitaxel monotherapy was insufficient and ifosfamide and epirubicin plus recombinant human endostatin has a limited effect on late stage cardiac angiosarcoma." | 3.91 | The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report. ( Davies, H; Jiang, L; Shi, K; Xu, X, 2019) |
"The aim of this retrospective study was to evaluate the feasibility and efficacy of response to continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for patients with recurrent or refractory osteosarcoma." | 3.81 | Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study. ( He, AN; Huang, YJ; Min, DL; Shen, Z; Sun, YJ; Yao, Y, 2015) |
"We reviewed the records of 50 patients with osteosarcoma who underwent marginal resection following effective preoperative chemotherapy; 18 were treated with the MMIA (high-dose methotrexate (HD-MTX), adriamycin (ADR), ifosfamide (IFO)) and cisplatin (DDP), and 32 patients were treated with the DIA (DDP, ADR and IFO)." | 3.80 | Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes. ( Xu, M; Xu, S; Yu, X, 2014) |
"To determine demographic data, prognostic factors and outcome of childhood osteosarcoma treated with a carboplatin-based chemotherapeutic protocol at Chiang Mai University." | 3.79 | Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand. ( Charoenkwan, P; Choeyprasert, W; Natesirinilkul, R; Sittipreechacharn, S, 2013) |
"This study assessed the therapeutic effect of and adverse reactions to pirarubicin (THP) chemotherapy in osteosarcoma patients with lung metastasis, and analyzed the relationship between THP therapeutic effect and expression of p-glycoprotein and topoisomerase-II." | 3.76 | Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis. ( Chen, P; Lin, F; Sun, Y; Wang, Z; Yao, Y; Zhao, H, 2010) |
"We report a patient with primary lung adenocarcinoma who had Ewing's sarcoma and was successfully treated with ifosfamide." | 3.74 | [A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide]. ( Arai, H; Fukumura, H; Kudo, M; Masuda, M; Nakajima, K; Oshiro, H; Rino, Y; Wada, N; Watanuki, Y; Yamanaka, S; Yukawa, N, 2008) |
"Cyclophosphamide (CTX) and ifosfamide (IFX) are alkylating agents used to treat osteosarcoma (OS)." | 3.73 | Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. ( Duan, X; Jia, SF; Kleinerman, ES; Koshkina, N, 2006) |
"Ifosfamide, Carboplatin and Etoposide (ICE) therapy was used to treat 4 patients, 2 with refractory osteosarcoma, and one each with relapsed brain tumor and newly diagnosed brain tumor." | 3.70 | [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. ( Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M, 1998) |
"In three new approved indications (non Hodgkin's lymphoma, Hodgkin's lymphoma and acute lymphoblastic leukaemia) and in three previously existing indications (ovarian cancer, soft tissue sarcomas and osteogenic sarcomas), non comparative trials show that ifosfamide can induce tumour regression in patients who relapse after a first course of chemotherapy (sometimes containing cyclophosphamide)." | 3.70 | Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness. ( , 1998) |
"Generalized and partial seizures with secondary generalization were observed during ifosfamide-mesna (IFO) treatment in a patient with lung epidermoid carcinoma." | 3.69 | [Epileptic seizures and treatment with ifosfamide-mesna]. ( Farisse, P; Somma-Mauvais, H; Viallat, JR, 1994) |
" A 16-year-old girl with metastatic osteosarcoma experienced recurrent bouts of symptomatic pancreatitis 24 hours after treatment with ifosfamide administered as a single agent." | 3.69 | Acute pancreatitis after ifosfamide therapy. ( Adamson, PC; Balis, FM; Blaney, SM; Izraeli, S, 1994) |
"Patients with advanced adenocarcinoma of the lung with measurable or assessable disease received chemotherapy with mesna, ifosfamide, carboplatin, and etoposide (MICE)." | 3.69 | Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study. ( Boerrigter, L; Mooi, WJ; Rodenhuis, S; Slebos, RJ; Top, B; van Zandwijk, N; van't Veer, L, 1997) |
"Patients with lung metastases originating from an osteosarcoma of the extremity received chemotherapy (high dose methotrexate, cisplatin, doxorubicin, and ifosfamide) followed by simultaneous resection of primary and metastatic lesions and additional chemotherapy." | 3.69 | Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. ( Bacci, G; Bertoni, F; Briccoli, A; Donati, D; Ferrari, S; Forni, C; Manfrini, M; Mercuri, M; Monti, C; Zanoni, A, 1997) |
"From January 1990 to December 1995 we treated 35 patients (pts) with bone and soft tissue sarcoma with ifosfamide (IFM)." | 3.69 | [The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas]. ( Ishii, T; Kitoh, M; Satoh, T; Tatezaki, S; Umeda, T; Yonemoto, T, 1997) |
"The series of 9 compounds, including 3 racemates and 6 enantiomers of bromine-substituted analogues of ifosfamide (bromo-, chlorobromo- and dibromofosfamides) have been evaluated for antitumor activity against L1210 leukemia, Lewis lung carcinoma and B16 melanoma in mice." | 3.68 | Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds. ( Glazman-Kuśnierczyk, H; Matuszyk, J; Radzikowski, C, 1992) |
"Forty seven patients with inoperable adenocarcinoma and large cell carcinoma of the lung were treated with a combination of cisplatin (25 mg/m2), ifosfamide (1." | 3.68 | [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Mori, T; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991) |
"A 13-year-old boy with unresectable pulmonary metastatic osteosarcoma, which was refractory to high dose methotrexate, adriamycin, cisplatin and combination of bleomycin, cyclophosphamide and actinomycin D, was treated by aggressive chemotherapy including the combination of ifosfamide (1 g/m2 x day 1-4), Carboplatin (100 mg/m2 x day 1-4) and Vindesine (4 mg/m2 x day 1)." | 3.68 | [Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report]. ( Fujita, H; Ishimoto, K; Kiyokawa, N; Kyo, K; Mizuno, T; Takada, K; Yabuta, K, 1991) |
"The mesna, doxorubicin, ifosfamide, dacarbazine regimen produced a 47% response rate (including 10% complete responses) in 105 eligible adults with advanced sarcoma." | 3.68 | Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma. ( Aisner, J; Antman, KH; Elias, A; Ryan, L, 1990) |
"Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)." | 3.67 | High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989) |
"Fifty-three patients with inoperable non-small cell bronchial carcinoma were treated at four-weekly intervals with two cytostatic drugs, doxorubicin (50 mg/m2 on day 1) and ifosfamide (2000 mg/m2 on days 1-3)." | 3.66 | [Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide]. ( Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U, 1983) |
" This phase II study evaluated the efficacy and safety of IFM combination with recommended current supportive therapy for recurrent SCLC in second-line and heavily treated setting." | 2.87 | A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting. ( Fukatsu, A; Hase, T; Hasegawa, Y; Hayashi, H; Kawada, K; Kondo, M; Morise, M; Nomura, F; Sokai, A; Tanaka, I, 2018) |
"Ifosfamide is a chloro-isophosphoramide prodrug activated by hepatic Cytochrome P450 enzymes." | 2.82 | Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models. ( Ahluwalia, D; Ferraro, DJ; Hart, CP; Jung, D; Liu, Q; Matteucci, MD; Sun, JD; Wang, Y, 2016) |
"The European Intergroup Cooperative Ewing's Sarcoma Study investigated whether cyclophosphamide has a similar efficacy as ifosfamide in standard-risk (SR) patients and whether the addition of etoposide improves survival in high-risk (HR) patients." | 2.73 | Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. ( Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A, 2008) |
"To investigate the prognostic value of systemic exposure to etoposide (Area Under the concentration Curve (AUC(VP16))) on overall survival (OS) in patients with small cell lung cancer (SCLC)." | 2.73 | Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study. ( Chabaud, S; Court-Fortune, I; Falandry, C; Fournel, C; Freyer, G; Girard, P; Ribba, B; Souquet, PJ; Tod, M; Tranchand, B; Trillet-Lenoir, V; You, B, 2008) |
"Paclitaxel was given at the dose of 200 mg/m iv in 3 hours, ifosfamide (with mesna) at the dose of 3 g/m and carboplatin at an area under the curve 5, on day 1, every 21 days for a total of six cycles in responding or stabilized patients." | 2.71 | Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer. ( Ardizzoni, A; Ariganello, O; Boni, C; Cafferata, MA; De Marinis, F; Meriggi, F; Neumaier, CE; Portalone, L; Rosso, R; Torri, V; Zaniboni, A, 2003) |
"Ifosfamide is an active alkylating agent used in the first-line treatment of NSCLC." | 2.71 | Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel. ( Chen, MC; Chen, YM; Lee, CS; Lin, WC; Perng, RP; Shih, JF; Tsai, CM, 2003) |
"Secondary objectives were time to disease progression, response rates, evaluation of toxicity, disease-related symptoms, World Health Organization performance status (PS), and quality of life (QoL)." | 2.71 | Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. ( Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N, 2003) |
"Ifosfamide (I) has also been approved for NSCLC treatment." | 2.71 | Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma. ( Billiart, I; Bourgeois, H; Chabrun, V; Chieze, S; Daban, A; Ferrand, V; Germain, T; Lemerre, D; Meurice, JC; Tourani, JM, 2004) |
" Haematological toxicity and dosage reductions were higher with SuperMIP, which was nevertheless associated with a significantly increased absolute dose intensity." | 2.71 | A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer. ( Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Paesmans, M; Richez, M; Sculier, JP; Thiriaux, J; Van Houtte, P; Wackenier, P, 2004) |
"Grade 3 thrombocytopenia was observed in five cases (36%)." | 2.71 | Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report. ( Kitamura, T; Kume, H; Matsumoto, S; Nishimatsu, H; Okamoto, N; Suzuki, M; Takahashi, S; Tomita, K, 2005) |
"Grade 3-4 neutropenia was the dose limiting toxicity, observed in 36% of patients." | 2.71 | Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial. ( Brunetti, C; Cassano, G; Colucci, G; Galetta, D; Gebbia, V; Germano, D; Giampaglia, M; Guida, M; Izzi, G; Lorusso, V; Nettis, G; Silvestris, N; Spada, M, 2005) |
"To find the maximum tolerated dose for ifosfamide in combination with paclitaxel and carboplatin in small-cell lung cancer patients (SCLC), who are resistant to cyclophosphamide, doxorubicin and etoposide (CDE)." | 2.70 | Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer. ( Beijnen, JH; Groen, HJ; Kerbush, T; Sleijfer, DT; Smit, EF; van Putten, JW; van Rijswijk, R, 2001) |
" Peak concentration of 47 micrograms/ml was observed after 1 h." | 2.70 | Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients. ( Gasiorek, M; Kobylińska, K; Kobylińska, M; Koralewski, P; Sobik, B, 2001) |
"Neutropenia was the dose limiting toxicity (G1=6%, G2=11%, G3=10%, G4=7%)." | 2.70 | Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer. ( Camps, C; García, R; Maestu, I; Montalar, J; Morales, S; Segura, A; Torregrosa, D; Vadell, C; Yuste, AL, 2001) |
" No toxic death was reported." | 2.70 | Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC). ( Ardizzoni, A; Baldini, E; Boni, L; Cafferata, MA; Conte, PF; Neumaier, C; Prochilo, T; Rosso, R; Tibaldi, C, 2001) |
"Paclitaxel was given after the first dose of ifosfamide on Day 1." | 2.69 | A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. ( Berkowitz, R; Bunnell, CA; Buswell, L; Muto, M; Sheets, E; Shulman, LN; Thompson, L, 1998) |
" The urinary profiles of mesna and dimesna excretion were determined on days 1, 2, and 5; pharmacokinetic parameters for blood samples were determined only on day 5." | 2.69 | Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide. ( Anthony, LB; Brade, WP; Bush, DA; Frazier, MW; Goren, MP; Hande, KR; Johnson, DH; Li, JT, 1998) |
"Gemcitabine was administered at a dose of 1,000 mg/m2 on days 1, 8, and 15, followed by a 1-week rest, while ifosfamide was given at a dose of 1,500 mg/m2 on days 8 through 12." | 2.69 | Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer. ( Blatter, J; Chomy, F; Chomy, P; Drings, P; Eberhard, W; Gatzemeier, U; Khayat, D; Manegold, C; Seeber, S; Wilke, HJ, 1998) |
"Ifosfamide 4 g/m2 was given for 4 h by intravenous infusion on day 2." | 2.69 | Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer. ( Thongprasert, S, 1998) |
"Megestrol acetate 250 mg PO was administered throughout the duration of chemotherapy." | 2.69 | A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial. ( Craffey, M; Dowlati, A; Levitan, N; MacKay, W; McKenney, J; Remick, SC; Tahsildar, H, 1998) |
" Four patients were assigned to different dosage levels, and drug toxicity was evaluated for the first 2 cycles." | 2.69 | Phase I study of a combination of irinotecan and ifosfamide in advanced primary lung cancer. ( Gohara, R; Ichiki, M; Kawayama, T; Kinoshita, M; Mitui, T; Oizumi, K; Okubo, Y; Rikimaru, T, 1999) |
"The ifosfamide dose was escalated as follows: 3000 mg/m2 (level 1), 5000 mg/m2 (level 2), 7000 mg/m2 (level 3), 9000 mg/m2 (level 4)." | 2.69 | A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer. ( Arakawa, M; Chou, D; Gejyo, F; Ito, K; Kagamu, H; Sakai, K; Shimbo, T; Suzuki, E; Takahashi, M; Tanaka, H; Tanaka, J; Wakabayashi, M; Yoshizawa, H, 2000) |
" The present retrospective analysis assessed two ways of dosing carboplatin: according to body surface area (mg/m2) or to the estimated targeted area under the concentration versus time curve (AUC)." | 2.69 | A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party. ( Alexopoulos, CG; Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Koumakis, G; Lafitte, JJ; Lecomte, J; Mommen, P; Ninane, V; Paesmans, M; Sculier, JP; Thiriaux, J; Zacharias, C, 1999) |
"The gemcitabine dose was escalated from 500 to 1200 mg/m2 on days 3 and 8 every third week." | 2.69 | Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study. ( De Filippis, S; Guerriero, G; Pompili, P; Rea, S; Recchia, F; Rosselli, M, 1999) |
"To determine the population pharmacokinetic (PK) parameters of doxorubicin (Dox), etoposide (Eto) and ifosfamide (Ifo) in small cell lung cancer (SCLC) patients, to assess the potential relationship between those parameters and to estimate the impact of individual morphological and biological covariates on patients' PK parameters." | 2.69 | Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study. ( Ardiet, C; Boissel, JP; Court-Fortune, I; Freyer, G; Girard, P; Ligneau, B; Rebattu, P; Riou, R; Souquet, PJ; Tranchand, B; Trillet-Lenoir, V, 2000) |
" Our trial failed to demonstrate a significant improvement in response or survival when patients with metastatic NSCLC were treated, in addition to ifosfamide and mitomycin, by combination of moderate dosages of cisplatin and carboplatin instead of moderate dosage of cisplatin alone." | 2.69 | Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. ( Alexopoulos, CG; Baumöhl, J; Berghmans, T; Florin, MC; Klastersky, J; Koumakis, G; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Schmerber, J; Sculier, JP; Thiriaux, J; Zacharias, C, 2000) |
"Paclitaxel dose levels were 135, 170, 200, 250, and 300 mg/m2." | 2.68 | Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. ( Bitran, JD; Drinkard, LC; Golomb, HM; Hoffman, PC; Krauss, SA; Masters, GA; Samuels, BL; Vokes, EE; Watson, S, 1995) |
" The dosage of paclitaxel was escalated from 75 to 225 mg/m2." | 2.68 | A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. ( Carey, RW; Elias, AD; Grossbard, ML; Jacobs, C; Jauss, S; Kwiatkowski, DJ; Lynch, TJ; Shulman, LN; Strauss, GM; Sugarbaker, DJ, 1995) |
"The early stages of bronchial carcinoma are still a domain of operative treatment." | 2.68 | [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study]. ( Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N, 1995) |
"Ifosfamide is a chiral pro-drug which is administered clinically in its racemic form." | 2.68 | Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma. ( Chrystyn, H; Corlett, SA; Parker, D, 1995) |
"Ifosfamide was therefore decreased to 1." | 2.68 | Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. ( Drinkard, LC; Golomb, HM; Hoffman, PC; Masters, GA; Samuels, BL; Vokes, EE; Watson, S, 1996) |
" MIP regimen was permanently suspended in 14 patients because of toxic events." | 2.68 | Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer. ( Baud, M; Bedin, A; Chouaid, C; Febvre, M; Lebeau, B; Urban, T, 1996) |
"Ifosfamide was administered at a dose of 1." | 2.68 | Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study. ( Drinkard, LC; Golomb, HM; Hoffman, PC; Krauss, SA; Masters, GA; Samuels, BL; Vokes, EE, 1996) |
"The addition of IFN-alpha to induction CT appears to confer a survival benefit to SCLC patients but optimal dosing schedule has yet to be defined." | 2.68 | Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial. ( Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E, 1996) |
"Phlebitis was observed in 15 of 30 patients (50%) who did not have central implantable venous systems." | 2.68 | Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma. ( Amato, S; Barbieri, M; Cuevas, M; Dominguez, M; Lacava, J; Langhi, M; Leone, B; Machiavelli, M; Ortiz, E; Perez, J; Rodriguez, R; Romero Acuña, J; Romero Acuña, L; Romero, A; Sabatini, C; Salvadori, M; Vallejo, C, 1996) |
" Both have a dose-response relationship." | 2.68 | Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996) |
"The ongoing phase I study reported here sought to determine the maximum tolerated doses of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) and carboplatin when given at specific times in combination with ifosfamide, mesna, and filgrastim." | 2.68 | Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results. ( Palackdharry, CS, 1997) |
"Gemcitabine was administered at a dose of 1,000 mg/m2 on days 1, 8, and 15 followed by a 1-week rest, while ifosfamide was given at a dose of 1,500 mg/m2 on day 8 and days 9 through 12." | 2.68 | A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer. ( Blatter, J; Chomy, F; Chomy, P; Drings, P; Eberhard, W; Gatzemeier, U; Khayat, D; Manegold, C; Seeber, S; Wilke, HJ, 1997) |
" The study design and dosing schedule are discussed in this report." | 2.68 | Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer. ( Golomb, HM; Hoffman, PC; Masters, G; Mauer, AM; Vokes, EE; Watson, S, 1997) |
"We have treated 26 consecutive chemotherapy-naive patients with stage IIIB/IV non-small cell lung cancer with an innovative regimen based on a 1-hour infusion of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) 125 to 250 mg/m2, ifosfamide 3 g/m2 (with mesna), and carboplatin dosed to an area under the concentration-time curve of 5, every 21 days for a total of six cycles in responding or stabilized patients." | 2.68 | Paclitaxel, ifosfamide, and carboplatin for the treatment of stages IIIB and IV non-small cell lung cancer: preliminary results. ( Alghisi, A; Bozzola, G; Marini, G; Meriggi, F; Mutti, S; Pascarella, A; Rizzi, A; Zaniboni, A, 1997) |
"Paclitaxel was escalated from 75 to 225 mg/m2 in 25-mg/m2 increments." | 2.68 | Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. ( Carey, RW; Elias, AD; Grossbard, ML; Herbst, R; Jacobs, C; Kwiatkowski, DJ; Leong, T; Lynch, C; Lynch, TJ; Skarin, AT; Strauss, GM, 1997) |
"Levels of depression were lower and showed little change." | 2.67 | A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party. ( Bleehen, NM; Girling, DJ; Machin, D; Stephens, RJ, 1993) |
"Ifosfamide was infused at the dose of 2 g/m2 over a 4-hour bolus infusion, followed by 2-g/m2 24-hour continuous infusions of ifosfamide, for a total of 14 or 18 g/m2 (6-8 days)." | 2.67 | Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. ( Eckardt, J; Eilber, F; Forscher, C; Fu, YS; Holmes, C; Lowenbraun, S; Rosen, G, 1994) |
"The etoposide dose was escalated, with six patients receiving 300 mg/m2 total dose (level 1), six receiving 600 mg/m2 (level 2), three receiving 900 mg/m2 (level 3), and five receiving 1,200 mg/m2 (level 4)." | 2.67 | Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer. ( Comis, R; Haas, N; Kilpatrick, D; Krigel, RL; Langer, C; Padavic, K; Palackdharry, CS, 1994) |
"Verapamil 480 mg day-1 was given for 3 days starting 24 h prior to chemotherapy which consisted of bolus vindesine 7 mg followed by ifosfamide/mesna 5 g m-2 over 24 h, followed by mesna alone for a further 8 h." | 2.67 | Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study. ( Cantwell, BM; Corris, PA; Harris, AL; Millward, MJ; Munro, NC; Robinson, A, 1993) |
"Ifosfamide has shown promising single-agent activity in non-small cell lung cancer." | 2.67 | Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report. ( Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M, 1992) |
"Oral etoposide was given on days 1-5, 15-19, and 29-33." | 2.67 | A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer. ( Anderson, H; Prendiville, J; Radford, JA; Swindell, R; Thatcher, N, 1991) |
"Ifosfamide was administered by intravenous drip infusion at a daily dose of 2 g/m2 for 5 consecutive days, and mesna was intravenously administered at 20% of the ifosfamide dose, three times daily for 5 consecutive days." | 2.67 | Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders. ( Fukuoka, M; Furuse, K; Ikegami, H; Kawahara, M; Kodama, N; Masuda, N; Nakamura, S; Negoro, S; Nishio, H; Ohnoshi, T, 1991) |
"Thirty six patients with advanced solid tumors (24 lung: 3 oat-cell, 14 squamous, 7 adenocarcinomas, 3 soft tissue sarcomas, 6 breast carcinomas; 1 seminoma; 2 ovarian adenocarcinomas) entered a phase II study of high-dose ifosfamide (IF) administered in combination with the uroprotective agent sodium 2-mercapto-ethane-sulfonate (Mesna)." | 2.65 | Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors. ( Brema, F; Cinquegrana, A; Nobile, MT; Rosso, R; Santi, L, 1984) |
" The major dose-limiting toxic effect of CIA was leukopenia." | 2.64 | Protection against chemotherapy toxicity by IV hyperalimentation. ( Bodey, GP; Copeland, EW; Dudrick, SJ; Freireich, EJ; Issell, BF; Valdivieso, M; Zaren, HA, 1978) |
" A daily dosage of 50 to 60 mg/kg ifosfamide on 5 consecutive days produced the best results." | 2.64 | Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide. ( Brock, N; Burkert, H; Fichtner, E; Schnitker, J, 1976) |
"Extraosseous Ewing sarcoma is a rare, poorly differentiated round-cell tumour that is part of the Ewing sarcoma family of tumours." | 2.61 | Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature. ( Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A, 2019) |
"Chemotherapy for treatment of osteosarcoma was demonstrated to be effective in eradicating primary tumor and pulmonary metastases in the mid-twentieth century." | 2.50 | Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma. ( Jaffe, N, 2014) |
" We therefore investigated the therapeutic efficacy of STI571, alone or combined with chemotherapy, in human SCLC cells or tumors xenografted into nude mice." | 2.43 | In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy. ( de Cremoux, P; Decaudin, D; Fréneaux, P; Judde, JG; Livartowski, A; Nemati, F; Pouillart, P; Poupon, MF; Sastre, X; Tran-Perennou, C, 2005) |
"Synovial sarcoma is a malignant soft-tissue neoplasm, usually arising in close association with the joints and generally carrying a poor prognosis." | 2.43 | Bilateral metastatic renal synovial sarcoma. ( Matin, SF; Pollock, RE; Stage, AC, 2005) |
"Myxoid liposarcoma has a relatively good prognosis but tends to recur locally." | 2.43 | Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review. ( Clarke, PM; Sandison, A; Tysome, JR, 2006) |
"Ifosfamide is an old drug still considered an effective cytostatic agent in the treatment of NSCLC." | 2.42 | Ifosfamide in non-small cell lung cancer. ( Boni, C; Zanelli, F, 2003) |
"Brain metastases are rare in the natural history of Wilms tumor." | 2.41 | Brain metastases in Wilms' tumor: case report and literature review. ( Grimard, L; Halton, JM; Hsu, E; MacRae, R; Nizalik, E, 2002) |
"Ifosfamide has been in use for several decades and is generally considered to be one of the most effective drugs for the treatment of non-small cell lung cancer (NSCLC)." | 2.40 | Ifosfamide and docetaxel in non-small cell lung cancer. ( Büchholz, E; Drings, P; Manegold, C, 1998) |
"Ifosfamide has been combined with gemcitabine in a phase I/II study." | 2.40 | Combination studies with gemcitabine in the treatment of non-small-cell lung cancer. ( Steward, WP, 1998) |
"Gemcitabine has a mild toxicity profile that allows it to be combined easily in triplet combinations with other doublets." | 2.40 | Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer. ( Bunn, PA, 1999) |
"Ifosfamide has been used in combination with several drugs including cisplatin, giving rise to multiple doublets and triplets including the ifosfamide-cisplatin-mitomycin regimen (Cullen's MIC regimen) that has been commonly used in Europe." | 2.40 | Ifosfamide in non-small-cell lung cancer. ( Balaña, C; Martin, C; Rosell, R, 1999) |
"Paclitaxel has been used in combination with several other nonplatinum agents for the treatment of NSCLC." | 2.40 | Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer. ( Langer, CJ; Socinski, MA, 1999) |
"Ifosfamide has been found to have antineoplastic activity in a variety of solid tumors." | 2.39 | The role of ifosfamide in germ cell tumors and small cell lung cancer. ( Nichols, CR, 1995) |
"Ifosfamide is an analogue of cyclophosphamide that is active against a variety of solid tumors, including non-small cell lung cancer." | 2.39 | Ifosfamide in non-small cell lung cancer. ( Johnson, DH, 1996) |
"Ifosfamide has the broad range of clinical activity, but its ultimate role as part of initial therapy remains to be discerned." | 2.38 | Clinical trials with ifosfamide: the Indiana University experience. ( Einhorn, LH; Loehrer, PJ; Nichols, CR; Williams, SD, 1992) |
" The stability of ifosfamide and its high bioavailability have allowed its use in chronic, 7-day ambulatory IV infusions, with decreased toxicity and hospitalization." | 2.38 | Novel approaches with ifosfamide in small cell lung cancer. ( Cerny, T; De Campos, E; Lind, M; Thatcher, N, 1992) |
"The role of chemotherapy in the treatment of myxofibrosarcoma is unclear." | 1.56 | Complete remission of a case of high-grade myxofibrosarcoma with lung metastases after modified MAID regimen chemotherapy. ( Cui, Y; Pan, Y; Shi, X, 2020) |
"NUT carcinoma is an extremely rare disease and yet extremely aggressive with 2-year survival of only approximately 19% and median survival of 6 to 9 months." | 1.56 | Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation. ( Chang, JS; Pan, M, 2020) |
"Malignant phyllodes tumors are rare breast neoplasms that are associated with a 6." | 1.51 | Complete remission of giant malignant phyllodes tumor with lung metastasis: A case report. ( Jung, JH; Kim, WW; Lee, J; Lee, JW; Lee, SJ; Moon, SH; Park, HY, 2019) |
"Ameloblastoma is generally characterized as a benign tumor originating in odontogenic epithelium." | 1.51 | MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report. ( Li, D; Liu, Y; Qiao, L; Sun, M; Wang, L; Xu, S, 2019) |
"Considering the physical condition of patient, the patient underwent surgical resection of the right lung lesion after receiving endostar combined with chemotherapy and maintained endostar alone for 47 cycles." | 1.46 | Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report. ( Dong, Y; Jiang, S; Wang, G, 2017) |
"Patients with bones or brain metastases were treated with palliative radiotherapy only or combined with Doxorubicin." | 1.43 | Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. ( Blecharz, P; Jakubowicz, J; Kulpa, J; Mituś, JW; Reinfuss, M; Walasek, T, 2016) |
" The aim of this study was to assess the efficacy and safety of ifosfamide in combination with carboplatin and etoposide (ICE) in previously untreated patients with SCLC." | 1.42 | Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer. ( Koo, DH; Lee, HS; Lee, SS; Lee, YG; Lim, SY; Nam, H; Oh, S; Song, JU, 2015) |
" A partial radiological response was achieved; dosage was reduced to 1." | 1.40 | Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases. ( Basso, U; Maruzzo, M; Montesco, MC; Rastrelli, M; Roma, A; Zanardi, E, 2014) |
"Pediatr Blood Cancer 2015;62:274-278." | 1.40 | ( Adiguzel, R; Andreana, PR; Arslan, Z; Ates, M; Bemis, T; Bercovitch, LG; Bögli, S; Boucherez, J; Boudouf, S; Briat, JF; Brown, BM; Busemann, A; Buters, J; Byers, JS; Cairo, MS; Carrier, F; Chalmers, JJ; Chang, E; Chen, J; Chen, Y; Christenson, MK; Cielecka-Piontek, J; Cole, PA; Cooper, BS; Davis, PH; De Silva, RA; Decato, S; DeFries, RS; Demir, V; Denic, A; Deserno, M; Dickey, AM; Diss, E; Eberlein, B; Eyerich, S; Faluvegi, G; Farlow, MR; Fletcher, JW; Francetic, T; Furlan, L; Garbacki, P; Gartung, A; Garvin, JH; Gates, L; Gaymard, F; Ghetti, B; Gibson, MP; Griffin, RG; Hamed, M; Hammad, LA; Hammond, GB; Han, J; Hann, R; Hao, N; Harrison, LA; Heidecke, CD; Hutchins, GD; Inlow, M; Irmer, H; Jani, P; Jara-Cavieres, A; Jawadi, H; Jiang, Q; Jiang, Y; Kameda, T; Keeler, EG; Kim, H; Kim, R; Kim, S; Kinney, PL; Krause, A; Kumar, V; Kwok, Y; Lam, T; Lanni, F; Le May, M; Lee, A; Lee, JF; Lee, MJ; Leontyev, IV; Li, Q; Li, X; Liu, J; Liu, NK; Lominadze, D; Lösche, M; Lu, QB; Lu, Y; Lu, Z; Mach, H; Madsen, E; Marletta, M; Marlier, ME; McDonald, BC; McKay, IS; Mckenzie, CL; Mecozzi, S; Menges, P; Meyers, D; Michaelis, VK; Montooth, KL; Moore, LR; Morgan, JK; Morris, E; Movahed, M; Nalabothula, N; Narayanan, S; Nguyen, D; Nho, K; Oken, B; Ong, TC; Osborne, LS; Paczkowska, M; Park, EK; Pennino, D; Peters, S; Potluri, LP; Qin, C; Radhakrishnan, K; Randerson, JT; Rantanen, J; Reyt, G; Ring, J; Risacher, SL; Rodriguez, M; Saykin, AJ; Schmidt-Weber, CB; Sengelaub, DR; Shatters, RG; Shen, L; Shen, V; Shindell, DT; Stuchebrukhov, AA; Swaminathan, S; Takahashi, K; Talaczyńska, A; Tallman, EF; Tan, C; Terry, SF; Trabbic, KR; Trease, AJ; Tretter, C; Uitto, J; Váradi, A; von Bernstorff, W; Voulgarakis, A; Wagenhofer, M; Wahbeh, H; Wang, EN; Wang, X; Wells, RJ; West, JD; Williams, PS; Wolff, JE; Wootla, B; Xu, B; Xu, XM; Yoder, KK; Zalewski, P; Zan, GH; Zborowski, M; Zhang, HH; Zhang, W; Zhao, J; Zoecklein, L, 2014) |
"Alveolar soft part sarcomas are rarely seen and highly malignant tumors, and the prognosis of stage IV ASPS is poor." | 1.38 | [Treatment and prognosis of stage IV alveolar soft part sarcoma]. ( Yang, Y; Zhao, J, 2012) |
" No significant dose-response relationship was found in terms of LRC." | 1.37 | Sequential or concomitant chemotherapy in limited stage small-cell lung cancer. ( Anchisi, S; Bieri, S; Elhfidh, M; Khanfir, K; Matzinger, O; Mirimanoff, RO; Ozsahin, M; Zouhair, A, 2011) |
"Breast stromal sarcoma is very rare, accounting for less than 1% of mammary neoplasms, and the treatment strategy is not well established, especially regarding chemotherapy." | 1.37 | Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case. ( Inoue, K; Iwase, H; Kuriwaki, K; Sueta, A; Yamamoto, Y, 2011) |
"We present a case of pleomorphic malignant fibrous histiocytoma arising from the left forearm in a 45-year-old man who had undergone resection and radiotherapy for a tumor 3 years previously." | 1.35 | Pleomorphic malignant fibrous histiocytoma: response of bone, lung, and brain metastases to chemotherapy. ( Hoshi, M; Ieguchi, M; Takami, M, 2008) |
"A 30-year-old man was diagnosed with testicular cancer, and underwent a radical orchiectomy." | 1.35 | [A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin]. ( Egawa, S; Hatano, T; Ito, H; Kishimoto, K; Tomita, M; Wada, T; Yanada, S, 2008) |
"From 1979 to 2002, 27 patients with Ewing's sarcoma (20) or PNET (7) were treated." | 1.34 | Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands. ( Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M, 2007) |
"Paclitaxel (175 mg/m(2)) was administered on day 1 and ifosfamide (2500 mg/m(2)) on day 1-2 every 3 weeks." | 1.34 | Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer. ( Ahn, JS; Ahn, MJ; Hong, YS; Hwang, IG; Kang, WK; Lee, J; Lee, SC; Lim, H; Park, BB; Park, JO; Park, K; Park, S, 2007) |
"The response of adult soft tissue sarcoma (STS) to chemotherapy is uncertain." | 1.34 | [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. ( Guan, ZZ; Huang, HQ; Jiang, WQ; Li, FH; Lin, TY; Luo, HY; Qiu, MZ; Sun, XF; Wang, F; Wang, SS; Xu, F; Xu, GC; Xu, RH, 2007) |
"Angiosarcomas are rare soft tissue malignancies." | 1.33 | Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature. ( Bearz, A; Berretta, M; Berretta, S; Brollo, A; Buonadonna, A; Canzonieri, V; Frustaci, S; Morra, A; Rupolo, M; Tirelli, U, 2006) |
" The purpose of the study was to determine the optimal dosage and the maximal tolerated dose (MTD) of a specified schedule of gemcitabine and ifosfamide." | 1.33 | Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer. ( Aschroft, L; Baka, S; Blackhall, F; Buchholz, E; Lorigan, P; Manegold, C; Nagel, S; Schott-von-Römer, K; Thatcher, N, 2006) |
"Synovial sarcoma is an extremely rare primary pulmonary tumor whose description is based on a limited number of cases." | 1.32 | [Primary pulmonary synovial sarcoma: a report and diagnosis of 2 cases]. ( Baldo Padró, X; Bernadó Turmo, L; Haro Estarriol, M; Rubio Goday, M; Sebastián Quetglas, F; Viñas Villaró, G, 2003) |
"Spinal cord compression has also been rarely reported in all age groups." | 1.32 | Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent. ( Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N, 2004) |
"The response rate in brain metastases was 50." | 1.31 | Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. ( Fujita, A; Fukuoka, S; Sekine, K; Tagaki, S; Takabatake, H, 2000) |
"The aim of this study was to develop a population pharmacokinetic model that could describe the pharmacokinetics of ifosfamide." | 1.31 | Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients. ( Beijnen, JH; Groen, HJ; Huitema, AD; Kerbusch, T; Mathĵt, RA; vanPutten, JW, 2001) |
" Similar dose-response curves were found for both metabolites." | 1.30 | Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide. ( Brüggemann, SK; Kisro, J; Wagner, T, 1997) |
"The role and value of chemotherapy for soft tissue sarcomas remain unclear." | 1.30 | [Chemotherapy for pulmonary metastases of soft tissue sarcoma]. ( Kito, M; Umeda, T, 1998) |
"But pulmonary hemorrhage and respiratory failure resulted in her death 7 months after initial diagnosis." | 1.30 | Treatment of primary pure angiosarcoma of ovary with multiple lung metastases: a case report. ( Chao, KC; Juang, CM; Lai, CZ; Lu, CJ; Twu, NF; Yeng, MS, 1999) |
" These results compare favourably with other combined modality studies, using multiple radiotherapy fractions with cisplatin-based combinations and dosage reduction for patients staged in more anatomical detail." | 1.29 | Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation. ( Burt, P; Hicks, F; Leahy, B; Lorigan, P; Prendiville, J; Stout, R; Thatcher, N, 1994) |
"Ifosfamide was administered at the daily dose of 1200 mg/m2/24 h." | 1.29 | [Peri-operative chemotherapy during resection of pulmonary metastases of sarcoma]. ( Azorin, JF; Delepine, G; Delepine, N; Destable, MD; Pocard, M; Tremblay, B, 1994) |
" The dosage of IEP in this study caused moderate toxicity." | 1.29 | Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC). ( Jiamsriponges, K; Thongprasert, S, 1993) |
"A case of malignant fibrous histiocytoma (MFH) of jejunal origin with brain and lung metastases was treated by jejunal resection." | 1.29 | [A case of malignant fibrous histiocytoma of jejunal origin with marked response to cisplatin, ifosfamide and adriamycin]. ( Fujita, A; Isai, H; Kondo, M; Minase, T; Sekine, K; Tagaki, S, 1993) |
" Moreover, a dose-response relationship was detectable: 1/6 patients without lung irradiation vs." | 1.29 | Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies. ( Dunst, J; Jürgens, H; Paulussen, M, 1993) |
" As compared with the values obtained on day 1, on day 5 the terminal half-life and AUC values determined for IF were reduced by 30% (6." | 1.29 | Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy. ( Kurowski, V; Wagner, T, 1993) |
"Ifosfamide has shown promising single-agent activity in non-small cell lung cancer (NSCLC)." | 1.28 | Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer. ( Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M, 1992) |
"The authors report a case of pulmonary squamous cell carcinoma which occurred after chemotherapy of non-Hodgkin's lymphoma (NHL)." | 1.28 | [Elderly non-Hodgkin's lymphoma presenting with pulmonary squamous cell carcinoma as a complication of chemotherapy for malignant lymphoma]. ( Annoh, S; Arai, N; Kaneko, H; Shirai, T; Tsukahara, T; Umeda, M, 1992) |
"Cerebral metastases occurred in 20% of all patients and was the apparent sole site of relapse in 11% of the CR patients." | 1.28 | Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. ( Burt, P; Prendiville, J; Radford, J; Ranson, M; Steward, W; Stout, R; Thatcher, N, 1991) |
"Ifosfamide is a newly available analog of cyclophosphamide in the oxazaphosphorine drug class." | 1.28 | Ifosfamide vs cyclophosphamide in cancer therapy. ( Weiss, RB, 1991) |
"Thirty-one patients with inoperable squamous cell carcinoma of the lung were treated with a combination of cis-platin (CDDP, 100 mg/m2 day 1), ifosfamide (IFX, 2 g/m2 day 1, 2, 3; with mesna) and vindesine (VDS, 3 mg/m2 day 1)." | 1.28 | [Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991) |
" A positive correlation was found between the elimination half-life of ifosfamide and age (r = 0." | 1.28 | The effect of age on the pharmacokinetics of ifosfamide. ( Cerny, T; Lind, MJ; Margison, JM; Thatcher, N; Wilkinson, PM, 1990) |
" Treatment was repeated every 3 weeks for a maximum of six courses and no dosage reductions were allowed." | 1.28 | Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis. ( Bronchud, MH; Kamthan, AG; Lind, MJ; Ranson, MR; Steward, WP; Stout, R; Thatcher, N, 1990) |
"The course of 72 patients (36 with squamous carcinoma, 25 with adenocarcinoma, two with alveolar-cell carcinoma and nine with large-cell carcinoma) could be evaluated." | 1.27 | [Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin]. ( Abel, U; Dirks, HP; Drings, P; Grimm, V; Heinrich, S; Kleckow, M; Manke, HG; Queisser, W; Stiefel, P, 1984) |
" The collected experience emphasizes the many individual variables encountered in clinical practice complicating the effort of correlating pharmacokinetic data with clinical results." | 1.27 | Pharmacokinetic studies in lung cancer patients. ( Cattaneo, MT; Piazza, E; Varini, M, 1984) |
"The most frequent histology was squamous cell carcinoma found in 20 patients." | 1.27 | [Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. ( Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R, 1985) |
" IFN-alpha nl alone at this dosage was shown to have some cytotoxic activity." | 1.27 | Augmentation of cytotoxicity of chemotherapy by human alpha-interferons in human non-small cell lung cancer xenografts. ( Balkwill, FR; Carmichael, J; Fergusson, RJ; Smyth, JF; Wolf, CR, 1986) |
"Ifosfamide at 5 g/m2 was given as a bolus to 48 patients with advanced progressing non-small cell lung cancer." | 1.27 | Ifosfamide by bolus as treatment for advanced non-small cell lung cancer. ( Anderson, H; Hilton, A; Rahman, A; Smith, DB; Steward, WP; Thatcher, N; Webb, K, 1986) |
"The etoposide combination was tolerated better." | 1.27 | Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer. ( Abel, U; Bülzebruck, H; Drings, P; Kleckow, M; Manke, HG; Stiefel, P, 1986) |
"Ifosfamide and mesna were administered to 77 patients with advanced malignancies." | 1.27 | Prediction of ifosfamide/mesna associated encephalopathy. ( Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA, 1986) |
" There was a proportionate increase in the AUC for the 5-g oral dose, indicating 100% bioavailability at all three dose levels." | 1.27 | Bioavailability of ifosfamide in patients with bronchial carcinoma. ( Cerny, T; Margison, JM; Thatcher, N; Wilkinson, PM, 1986) |
"Ifosfamide (Holoxan) has an effect as a single drug on testicular carcinoma and shows synergism with cisplatinum in mice." | 1.26 | The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy. ( Clemm, C; Hartenstein, R; Wilmanns, W, 1982) |
"Oral ifosfamide therapy was determined to be feasible, and further studies are justified to assess the pharmacokinetics of the optimum dosage and scheduling regimens." | 1.26 | The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma. ( McNiel, NO; Morgan, LR, 1981) |
"Ifosfamide was administered to 21 patients with recurrent or disseminated lung cancer at a dose of 4." | 1.26 | Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules. ( Costanzi, JJ; Gagliano, R; Hokanson, JA; Loukas, D; Panettiere, FJ, 1978) |
"153 patients with inoperable malignant tumors were treated by the so-called synchronization therapy with vincristine and ifosfamide." | 1.26 | [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)]. ( Hartwich, G; Lutz, H; Neidhardt, B, 1978) |
"12 patients with extensive metastases of malignant testicular tumors and 5 other patients with other rapidly growing metastasizing tumors were treated." | 1.25 | [Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)]. ( Jonas, U; Körner, F; Lund, S, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 120 (16.28) | 18.7374 |
1990's | 312 (42.33) | 18.2507 |
2000's | 216 (29.31) | 29.6817 |
2010's | 80 (10.85) | 24.3611 |
2020's | 9 (1.22) | 2.80 |
Authors | Studies |
---|---|
Miao, L | 1 |
Ma, ST | 1 |
Jiang, X | 1 |
Zhang, HH | 2 |
Wang, YM | 1 |
Li, M | 1 |
Conforti, F | 1 |
Pala, L | 1 |
Vivanet, G | 1 |
Corti, C | 1 |
Catania, C | 1 |
Maiettini, D | 1 |
Varano, G | 1 |
Di Venosa, B | 1 |
Curigliano, G | 2 |
Salvini, P | 1 |
Berardi, R | 1 |
Ballatore, Z | 1 |
De Pas, TM | 1 |
Miyoshi, AI | 1 |
Ueda, Y | 1 |
Kurita, T | 1 |
Kimura, T | 1 |
Yoshino, K | 1 |
Hosomi, T | 1 |
Shibasaki, N | 1 |
Otsuka, H | 1 |
Uketa, S | 1 |
Makino, Y | 1 |
Shichiri, Y | 1 |
Maroun, CA | 1 |
Khalifeh, I | 1 |
Tfayli, A | 1 |
Moukarbel, RV | 1 |
Cui, Y | 1 |
Pan, Y | 1 |
Shi, X | 1 |
Inoue, S | 1 |
Hirai, S | 2 |
Katayama, T | 1 |
Benkhaled, S | 1 |
Mané, M | 1 |
Jungels, C | 1 |
Shumelinsky, F | 1 |
Aubain, NS | 1 |
Van Gestel, D | 1 |
Pan, M | 1 |
Chang, JS | 1 |
Hui, C | 1 |
Shin, DH | 1 |
Wakeling, A | 1 |
Donaldson, SS | 1 |
Hazard, FK | 1 |
Rangaswami, A | 1 |
Hiniker, SM | 1 |
Pannu, AK | 1 |
Sharma, N | 1 |
Young, RJ | 1 |
Litière, S | 1 |
Lia, M | 1 |
Hogendoorn, PCW | 1 |
Fisher, C | 1 |
Mechtersheimer, G | 1 |
Daugaard, S | 1 |
Sciot, R | 1 |
Collin, F | 1 |
Messiou, C | 1 |
Grünwald, V | 1 |
Gronchi, A | 1 |
van der Graaf, W | 1 |
Wardelmann, E | 1 |
Judson, I | 1 |
Meazza, C | 2 |
Cefalo, G | 1 |
Massimino, M | 1 |
Daolio, P | 2 |
Pastorino, U | 2 |
Scanagatta, P | 2 |
Morosi, C | 1 |
Podda, M | 3 |
Ferrari, A | 3 |
Terenziani, M | 1 |
Spreafico, F | 1 |
Casanova, M | 2 |
Parafioriti, A | 1 |
Collini, P | 2 |
Gandola, L | 2 |
Bastoni, S | 1 |
Biassoni, V | 1 |
Schiavello, E | 1 |
Chiaravalli, S | 1 |
Puma, N | 1 |
Bergamaschi, L | 1 |
Luksch, R | 2 |
Tanaka, I | 1 |
Kawada, K | 1 |
Morise, M | 1 |
Hase, T | 1 |
Hayashi, H | 2 |
Sokai, A | 1 |
Fukatsu, A | 1 |
Kondo, M | 2 |
Nomura, F | 1 |
Hasegawa, Y | 1 |
Jiang, S | 1 |
Wang, G | 1 |
Dong, Y | 1 |
Carden, MA | 1 |
Perdahl-Wallace, E | 1 |
Greenberg, J | 3 |
McCarty, JM | 1 |
Lee, J | 3 |
Jung, HA | 1 |
Kim, Y | 2 |
Choi, S | 1 |
Han, J | 2 |
Choi, YL | 1 |
Lee, SH | 1 |
Ahn, JS | 2 |
Park, K | 4 |
Sun, JM | 1 |
Tatenuma, T | 1 |
Mizuno, N | 1 |
Jikuya, R | 1 |
Hashizume, A | 1 |
Yasui, M | 1 |
Umemoto, S | 1 |
Kawai, M | 1 |
Hiruma, T | 1 |
Kishida, T | 1 |
Jiang, L | 1 |
Xu, X | 1 |
Davies, H | 1 |
Shi, K | 1 |
Moon, SH | 1 |
Jung, JH | 1 |
Kim, WW | 1 |
Park, HY | 1 |
Lee, JW | 1 |
Lee, SJ | 1 |
Li, D | 1 |
Xu, S | 3 |
Sun, M | 1 |
Qiao, L | 1 |
Wang, L | 1 |
Liu, Y | 1 |
Yamamoto, Y | 3 |
Tsukiyama, I | 1 |
Nii, S | 1 |
Harada, R | 1 |
Watanabe, K | 2 |
Yabushita, H | 1 |
Wakatsuki, A | 1 |
Saito, H | 4 |
Hasegawa, T | 1 |
Tiseo, M | 2 |
Bordi, P | 1 |
Bortesi, B | 1 |
Boni, L | 4 |
Boni, C | 7 |
Baldini, E | 9 |
Grossi, F | 2 |
Recchia, F | 4 |
Zanelli, F | 4 |
Fontanini, G | 1 |
Naldi, N | 1 |
Campanini, N | 1 |
Azzoni, C | 1 |
Bordi, C | 1 |
Ardizzoni, A | 10 |
Choeyprasert, W | 1 |
Natesirinilkul, R | 1 |
Charoenkwan, P | 1 |
Sittipreechacharn, S | 1 |
Johnson, K | 1 |
Notrica, DM | 1 |
Carpentieri, D | 1 |
Jaroszewski, D | 1 |
Henry, MM | 1 |
Al-Hader, AA | 1 |
Jain, A | 1 |
Al-Nasrallah, N | 1 |
Einhorn, LH | 9 |
Koufos, N | 1 |
Michailidou, D | 1 |
Xynos, ID | 1 |
Tomos, P | 1 |
Athanasiadou, K | 1 |
Kosmas, C | 6 |
Tsavaris, N | 3 |
Ozdemir, O | 1 |
Ozdemir, P | 1 |
Veral, A | 1 |
Uluer, H | 1 |
Ozhan, MH | 1 |
Berghmans, T | 13 |
Lafitte, JJ | 14 |
Scherpereel, A | 5 |
Paesmans, M | 14 |
Lecomte, J | 11 |
Marco, VG | 1 |
Meert, AP | 6 |
Leclercq, N | 4 |
Sculier, JP | 19 |
Okuno, S | 1 |
Petersen, I | 1 |
Shives, T | 1 |
Mahoney, M | 1 |
Haddock, M | 1 |
Sim, F | 1 |
O'Connor, MI | 1 |
Markovic, SN | 1 |
Maples, W | 1 |
Dutour, A | 1 |
Josserand, V | 1 |
Jury, D | 1 |
Guillermet, S | 1 |
Decouvelaere, AV | 1 |
Chotel, F | 1 |
Pointecouteau, T | 1 |
Rizo, P | 1 |
Coll, JL | 1 |
Blay, JY | 1 |
Jaffe, N | 2 |
Zanardi, E | 1 |
Maruzzo, M | 1 |
Montesco, MC | 1 |
Roma, A | 1 |
Rastrelli, M | 1 |
Basso, U | 2 |
Raciborska, A | 1 |
Bilska, K | 1 |
Drabko, K | 1 |
Chaber, R | 1 |
Sobol, G | 1 |
Pogorzała, M | 1 |
Wyrobek, E | 1 |
Połczyńska, K | 1 |
Rogowska, E | 1 |
Rodriguez-Galindo, C | 2 |
Wożniak, W | 1 |
Hung, GY | 1 |
Yen, HJ | 1 |
Yen, CC | 1 |
Chen, WM | 1 |
Chen, PC | 1 |
Wu, HT | 1 |
Chiou, HJ | 1 |
Chang, WH | 1 |
Hsu, HE | 1 |
Kameda, T | 1 |
Takahashi, K | 1 |
Kim, R | 1 |
Jiang, Y | 1 |
Movahed, M | 1 |
Park, EK | 1 |
Rantanen, J | 1 |
Marlier, ME | 1 |
DeFries, RS | 1 |
Voulgarakis, A | 1 |
Kinney, PL | 1 |
Randerson, JT | 1 |
Shindell, DT | 1 |
Chen, Y | 2 |
Faluvegi, G | 1 |
Diss, E | 1 |
Nalabothula, N | 1 |
Nguyen, D | 1 |
Chang, E | 1 |
Kwok, Y | 1 |
Carrier, F | 1 |
Radhakrishnan, K | 1 |
Lee, A | 1 |
Harrison, LA | 1 |
Morris, E | 1 |
Shen, V | 1 |
Gates, L | 1 |
Wells, RJ | 2 |
Wolff, JE | 1 |
Garvin, JH | 1 |
Cairo, MS | 1 |
Eberlein, B | 1 |
Hann, R | 1 |
Eyerich, S | 1 |
Pennino, D | 1 |
Ring, J | 1 |
Schmidt-Weber, CB | 1 |
Buters, J | 1 |
Dickey, AM | 1 |
Trease, AJ | 1 |
Jara-Cavieres, A | 1 |
Kumar, V | 1 |
Christenson, MK | 1 |
Potluri, LP | 1 |
Morgan, JK | 1 |
Shatters, RG | 1 |
Mckenzie, CL | 1 |
Davis, PH | 1 |
Osborne, LS | 1 |
Francetic, T | 1 |
Le May, M | 1 |
Hamed, M | 1 |
Mach, H | 1 |
Meyers, D | 1 |
Cole, PA | 1 |
Chen, J | 1 |
Li, Q | 1 |
Zborowski, M | 1 |
Moore, LR | 1 |
Williams, PS | 1 |
Chalmers, JJ | 1 |
Cooper, BS | 1 |
Hammad, LA | 1 |
Montooth, KL | 1 |
Bögli, S | 1 |
Brown, BM | 1 |
Marletta, M | 1 |
Tretter, C | 1 |
Wagenhofer, M | 1 |
Leontyev, IV | 1 |
Stuchebrukhov, AA | 1 |
Ates, M | 1 |
Demir, V | 1 |
Adiguzel, R | 1 |
Arslan, Z | 1 |
Zan, GH | 1 |
Tan, C | 1 |
Deserno, M | 1 |
Lanni, F | 1 |
Lösche, M | 1 |
Decato, S | 1 |
Bemis, T | 1 |
Madsen, E | 1 |
Mecozzi, S | 1 |
Trabbic, KR | 1 |
De Silva, RA | 1 |
Andreana, PR | 1 |
Wahbeh, H | 1 |
Oken, B | 1 |
Uitto, J | 1 |
Jiang, Q | 1 |
Váradi, A | 1 |
Bercovitch, LG | 1 |
Terry, SF | 1 |
Liu, J | 1 |
Zhao, J | 3 |
Lee, JF | 1 |
Gartung, A | 1 |
Jawadi, H | 1 |
Zhang, W | 1 |
Lominadze, D | 1 |
Lee, MJ | 1 |
Denic, A | 1 |
Wootla, B | 1 |
Zoecklein, L | 1 |
Rodriguez, M | 1 |
Kim, S | 1 |
Nho, K | 1 |
Risacher, SL | 1 |
Inlow, M | 1 |
Swaminathan, S | 1 |
Yoder, KK | 1 |
Shen, L | 1 |
West, JD | 1 |
McDonald, BC | 1 |
Tallman, EF | 1 |
Hutchins, GD | 1 |
Fletcher, JW | 1 |
Farlow, MR | 1 |
Ghetti, B | 1 |
Saykin, AJ | 1 |
Reyt, G | 1 |
Boudouf, S | 1 |
Boucherez, J | 1 |
Gaymard, F | 1 |
Briat, JF | 1 |
Hao, N | 1 |
Gibson, MP | 1 |
Jani, P | 1 |
Wang, X | 1 |
Lu, Y | 1 |
Qin, C | 1 |
Lu, Z | 1 |
Hammond, GB | 1 |
Xu, B | 1 |
Liu, NK | 1 |
Byers, JS | 1 |
Lam, T | 1 |
Lu, QB | 1 |
Sengelaub, DR | 1 |
Xu, XM | 1 |
von Bernstorff, W | 1 |
Irmer, H | 1 |
Menges, P | 1 |
Peters, S | 2 |
Heidecke, CD | 1 |
Busemann, A | 1 |
Li, X | 1 |
Narayanan, S | 1 |
Michaelis, VK | 1 |
Ong, TC | 1 |
Keeler, EG | 1 |
Kim, H | 1 |
McKay, IS | 1 |
Griffin, RG | 1 |
Wang, EN | 1 |
Furlan, L | 1 |
Paczkowska, M | 1 |
Zalewski, P | 1 |
Garbacki, P | 1 |
Talaczyńska, A | 1 |
Krause, A | 1 |
Cielecka-Piontek, J | 1 |
Xu, M | 2 |
Yu, X | 2 |
Ibrahim, ZA | 1 |
Chan, WH | 1 |
Wong, SL | 1 |
Ong, EJ | 1 |
Narihan, MZ | 1 |
Huang, YJ | 1 |
He, AN | 1 |
Sun, YJ | 1 |
Shen, Z | 1 |
Min, DL | 1 |
Yao, Y | 2 |
Pagano, M | 1 |
Baldi, L | 1 |
Gnoni, R | 1 |
Braglia, L | 1 |
Savoldi, L | 2 |
Liu, YP | 1 |
Jin, J | 1 |
Wang, WH | 1 |
Wang, SL | 1 |
Song, YW | 1 |
Fang, H | 1 |
Ren, H | 1 |
Liu, XF | 1 |
Yu, ZH | 1 |
Li, YX | 1 |
Grignani, G | 2 |
Martín-Broto, J | 1 |
Schuler, M | 1 |
Reichardt, P | 1 |
Schönknecht, C | 1 |
Hadjamu, M | 1 |
Oechsner, M | 1 |
Andratschke, N | 1 |
Duma, MN | 1 |
Zhou, Y | 1 |
Xu, Y | 1 |
Zhong, W | 1 |
Wang, M | 1 |
Lee, HS | 1 |
Lee, YG | 1 |
Koo, DH | 1 |
Oh, S | 1 |
Nam, H | 1 |
Song, JU | 1 |
Lim, SY | 2 |
Lee, SS | 1 |
Mituś, JW | 1 |
Blecharz, P | 1 |
Walasek, T | 1 |
Reinfuss, M | 1 |
Jakubowicz, J | 1 |
Kulpa, J | 1 |
Gallo, K | 1 |
Brickman, A | 1 |
Warren, WH | 1 |
Gattuso, P | 1 |
Seder, CW | 1 |
Sun, JD | 1 |
Liu, Q | 1 |
Ahluwalia, D | 1 |
Ferraro, DJ | 1 |
Wang, Y | 1 |
Jung, D | 1 |
Matteucci, MD | 1 |
Hart, CP | 1 |
Wang, B | 1 |
Saha, D | 1 |
Basu, A | 1 |
Maiti, A | 1 |
Rodriguez, E | 1 |
Lee, AC | 1 |
Nodomi, S | 1 |
Umeda, K | 1 |
Okamoto, T | 1 |
Saida, S | 1 |
Hiramatsu, H | 1 |
Adachi, S | 1 |
Heike, T | 1 |
Ranganath, P | 1 |
Kesler, KA | 1 |
Pagliaro, LC | 1 |
Zschäbitz, S | 1 |
Lasitschka, F | 1 |
Hadaschik, B | 1 |
Hofheinz, RD | 1 |
Jentsch-Ullrich, K | 1 |
Grüner, M | 1 |
Jäger, D | 1 |
Grüllich, C | 1 |
Thornton, K | 1 |
Pesce, CE | 1 |
Choti, MA | 1 |
Paulussen, M | 2 |
Craft, AW | 1 |
Lewis, I | 1 |
Hackshaw, A | 1 |
Douglas, C | 1 |
Dunst, J | 2 |
Schuck, A | 1 |
Winkelmann, W | 1 |
Köhler, G | 1 |
Poremba, C | 1 |
Zoubek, A | 1 |
Ladenstein, R | 1 |
van den Berg, H | 1 |
Hunold, A | 1 |
Cassoni, A | 1 |
Spooner, D | 2 |
Grimer, R | 1 |
Whelan, J | 1 |
McTiernan, A | 2 |
Jürgens, H | 2 |
Azim, HA | 1 |
Elattar, I | 1 |
Loberiza, FR | 1 |
Azim, H | 1 |
Mok, T | 1 |
Ganti, AK | 1 |
Hoshi, M | 1 |
Takami, M | 1 |
Ieguchi, M | 1 |
Girard, N | 1 |
Cottin, V | 1 |
Lapalus, MG | 1 |
Tronc, F | 1 |
Cordier, JF | 3 |
Bregni, M | 1 |
Pedrazzoli, P | 1 |
Shibuya, T | 1 |
Osada, T | 1 |
Kodani, T | 3 |
Hojo, M | 1 |
Ueyama, H | 1 |
Kato, J | 1 |
Nagahara, A | 1 |
Otaka, M | 1 |
Ogihara, T | 1 |
Nagao, K | 1 |
Fujime, M | 1 |
Watanabe, S | 1 |
Pintoffl, J | 1 |
Meisinger, I | 1 |
Mayer, F | 1 |
Horger, M | 1 |
von Weyhern, C | 1 |
Kanz, L | 8 |
Hartmann, JT | 2 |
Berretta, M | 2 |
Zanet, E | 1 |
Taibi, R | 1 |
Martellotta, F | 1 |
Pavone, P | 1 |
Bearz, A | 2 |
Gobitti, C | 1 |
Ciancia, EM | 1 |
Canzonieri, V | 2 |
Tirelli, U | 2 |
Grushka, JR | 1 |
Ryckman, J | 1 |
Mueller, C | 1 |
Roessingh, Ade B | 1 |
Walton, JM | 1 |
St Vil, D | 1 |
Laberge, JM | 1 |
Bernard, C | 1 |
Nguyen, VH | 1 |
Puligandla, PS | 1 |
Al Balushi, Z | 1 |
Bulduc, S | 1 |
Mulleur, C | 1 |
Lallier, M | 1 |
Loriot, Y | 1 |
Mordant, P | 1 |
Deutsch, E | 1 |
Olaussen, KA | 1 |
Soria, JC | 2 |
Némati, F | 3 |
Daniel, C | 1 |
Arvelo, F | 2 |
Legrier, ME | 1 |
Froget, B | 1 |
Livartowski, A | 3 |
Assayag, F | 1 |
Bourgeois, Y | 2 |
Poupon, MF | 4 |
Decaudin, D | 3 |
Zhao, H | 1 |
Wang, Z | 1 |
Lin, F | 1 |
Sun, Y | 2 |
Chen, P | 1 |
Barnoud, R | 1 |
Collardeau-Frachon, S | 1 |
de la Roche, E | 1 |
Vasiljevic, A | 1 |
Thomson, V | 1 |
Ranchère, D | 1 |
Devouassoux, G | 1 |
Devouassoux-Shisheboran, M | 1 |
Pavageau, AH | 1 |
Croué, A | 1 |
Reguerre, Y | 1 |
Rialland, X | 2 |
Rousselet, MC | 1 |
Sugihara, T | 1 |
Fujimura, T | 1 |
Kume, H | 3 |
Homma, Y | 1 |
Machak, GN | 1 |
Polotskiĭ, BE | 1 |
Meluzova, OM | 1 |
Chernov, IS | 1 |
Aliev, MD | 1 |
Buchbinder, D | 1 |
Steinberg, G | 1 |
Linetsky, M | 1 |
Casillas, J | 1 |
Lindet, C | 1 |
Vanhuyse, M | 1 |
Thebaud, E | 1 |
Robin, YM | 1 |
Penel, N | 1 |
Lee, KW | 1 |
Kim, YJ | 1 |
Kim, JH | 2 |
Bang, SM | 1 |
Chung, JH | 1 |
Lee, JS | 7 |
Ushijima, M | 1 |
Yamakawa, Y | 1 |
Sakabe, E | 1 |
Waki, H | 1 |
Katou, K | 1 |
Contreras Ibáñez, JA | 1 |
Navas García, N | 1 |
Díaz Gómez, L | 1 |
Xu, C | 1 |
Nishi, H | 1 |
Isaka, K | 1 |
Vello Román, A | 1 |
Samprón Rodríguez, M | 1 |
Pazos Arias, B | 1 |
Romero Reinoso, C | 1 |
Peteiro Cancelo, A | 1 |
Khanfir, K | 1 |
Elhfidh, M | 1 |
Anchisi, S | 1 |
Matzinger, O | 1 |
Bieri, S | 1 |
Mirimanoff, RO | 1 |
Ozsahin, M | 1 |
Zouhair, A | 1 |
Yamagishi, A | 1 |
Sakurai, T | 1 |
Naito, S | 1 |
Tsukigi, M | 1 |
Kato, T | 1 |
Nagaoka, A | 1 |
Tomita, Y | 1 |
Iwaba, A | 1 |
Yamakawa, M | 1 |
Hong, S | 1 |
Shin, SJ | 1 |
Jung, M | 1 |
Jeong, J | 1 |
Lee, YJ | 1 |
Shin, KH | 2 |
Roh, JK | 1 |
Rha, SY | 1 |
Sueta, A | 1 |
Inoue, K | 2 |
Kuriwaki, K | 1 |
Iwase, H | 1 |
Schwitter, M | 1 |
Potocnik, P | 1 |
von Moos, R | 1 |
Frick, H | 1 |
Furrer, M | 1 |
Cathomas, R | 1 |
Jacot, W | 1 |
Pujol, JL | 8 |
Chakra, M | 1 |
Molinier, O | 2 |
Bozonnat, MC | 1 |
Gervais, R | 1 |
Quantin, X | 4 |
Ahn, JH | 1 |
Mirza, T | 1 |
Ameerally, P | 1 |
Fernandez-Pineda, I | 1 |
Bahrami, A | 1 |
Green, JF | 1 |
McGregor, LM | 1 |
Davidoff, AM | 1 |
Sandoval, JA | 1 |
Barone, C | 2 |
Germano, D | 2 |
Matano, E | 1 |
Marini, G | 4 |
Labianca, R | 1 |
Di Costanzo, F | 4 |
Bagnulo, A | 1 |
Pennucci, C | 1 |
Caroti, C | 1 |
Mencoboni, M | 2 |
Prochilo, T | 3 |
Cafferata, MA | 4 |
Ouadnouni, Y | 1 |
Smahi, M | 1 |
Bouchikh, M | 1 |
Achir, A | 1 |
Msougar, Y | 1 |
Lakranbi, M | 1 |
Benosman, A | 1 |
Onesti, E | 1 |
Fabi, A | 1 |
Mingoia, M | 1 |
Savarese, A | 1 |
Anelli, V | 1 |
Koudriavtseva, T | 1 |
Abedallaa, N | 1 |
Tremblay, L | 1 |
Baey, C | 1 |
Fabre, D | 1 |
Planchard, D | 2 |
Pignon, JP | 1 |
Guigay, J | 2 |
Pechoux, CL | 1 |
de Montpreville, VT | 1 |
Besse, B | 1 |
Giner, V | 12 |
Berchier, MC | 11 |
Lewin, D | 1 |
Bosschaerts, T | 2 |
Mouillet, G | 1 |
Monnet, E | 1 |
Milleron, B | 5 |
Puyraveau, M | 2 |
Quoix, E | 7 |
David, P | 1 |
Ducoloné, A | 1 |
Zalcman, G | 1 |
Depierre, A | 6 |
Westeel, V | 4 |
Tienghi, A | 1 |
Hall, KS | 1 |
Fagioli, F | 2 |
Picci, P | 1 |
Barbieri, E | 1 |
Eriksson, M | 1 |
Ruggieri, P | 1 |
Lindholm, P | 1 |
Prete, A | 1 |
Bisogno, G | 2 |
Tamburini, A | 1 |
Abate, ME | 1 |
Smeland, S | 1 |
Ferrari, S | 4 |
Punanov, IuA | 1 |
Gafton, GI | 1 |
Gudz', IuV | 1 |
Nabokov, VV | 1 |
Ivanova, TV | 1 |
Safonova, SA | 1 |
Levchenko, EV | 1 |
Kupatadze, DD | 1 |
Novik, VI | 1 |
Lazareva, IuR | 1 |
Krzhivitskiĭ, PI | 1 |
Petrov, VG | 1 |
Teixeira, A | 1 |
Vieira, C | 1 |
Sousa, N | 1 |
Begonha, R | 1 |
Afonso, M | 1 |
Amaro, T | 1 |
Maurício, J | 1 |
Cuneo, KC | 1 |
Riedel, RF | 1 |
Dodd, LG | 1 |
Harpole, DH | 1 |
Kirsch, DG | 1 |
Dede, DS | 1 |
Aksoy, S | 1 |
Cengiz, M | 1 |
Gullu, I | 1 |
Altundag, K | 1 |
Luo, J | 1 |
Wu, FY | 1 |
Li, AW | 1 |
Zheng, D | 1 |
Liu, JM | 6 |
Yang, Y | 1 |
Mazza, EA | 1 |
Thiriaux, J | 10 |
Florin, MC | 3 |
Efremidis, A | 7 |
Alexopoulos, CG | 7 |
Recloux, P | 3 |
Ninane, V | 13 |
Mommen, P | 11 |
Klastersky, J | 8 |
Billingham, LJ | 3 |
Bathers, S | 1 |
Burton, A | 1 |
Bryan, S | 1 |
Cullen, MH | 7 |
Lam, KC | 1 |
Yeo, W | 1 |
De Ruysscher, D | 2 |
Lievens, Y | 2 |
Van den Brande, P | 2 |
Nackaerts, K | 2 |
Vansteenkiste, J | 5 |
Ettinger, DS | 6 |
Finkelstein, DM | 1 |
Ritch, PS | 2 |
Lincoln, ST | 1 |
Blum, RH | 1 |
Oelmann, E | 1 |
Thomas, M | 3 |
Serve, H | 1 |
Kienast, J | 1 |
Zühlsdorf, M | 1 |
Mohr, M | 1 |
Klinke, F | 3 |
Dölken, G | 1 |
Macha, H | 1 |
Schmidt, EW | 1 |
Berdel, WE | 1 |
Saint-Georges, F | 1 |
Terrier, P | 1 |
Sabourin, JC | 1 |
Bonvalot, S | 1 |
De Montpreville, V | 1 |
Ruffie, P | 3 |
Li, DX | 1 |
Chen, XB | 1 |
Souquet, PJ | 5 |
Tan, EH | 4 |
Rodrigues Pereira, J | 1 |
Van Klaveren, R | 1 |
Price, A | 1 |
Gatzemeier, U | 7 |
Jaworski, M | 1 |
Burillon, JP | 1 |
Aubert, D | 2 |
Janinis, J | 1 |
Driver, D | 1 |
Mitchell, C | 1 |
Cassoni, AM | 1 |
Pringle, J | 1 |
Kilby, A | 1 |
Whelan, JS | 1 |
Crinò, L | 7 |
Kremens, B | 1 |
Gruhn, B | 1 |
Klingebiel, T | 1 |
Hasan, C | 1 |
Laws, HJ | 1 |
Koscielniak, E | 1 |
Hero, B | 1 |
Selle, B | 1 |
Niemeyer, C | 1 |
Finckenstein, FG | 1 |
Schulz, A | 1 |
Wawer, A | 1 |
Zintl, F | 1 |
Graf, N | 1 |
Lin, YC | 1 |
Lin, Y | 1 |
Lin, W | 1 |
Du, CW | 1 |
Wu, MY | 1 |
Li, DR | 1 |
Wodowski, K | 1 |
Hill, DA | 1 |
Pappo, AS | 2 |
Shochat, SJ | 2 |
Kun, LE | 2 |
Spunt, SL | 2 |
Hand, S | 1 |
Baker, J | 1 |
Smith, AP | 2 |
Macbeth, FR | 1 |
Zaniboni, A | 4 |
De Marinis, F | 5 |
Portalone, L | 4 |
Meriggi, F | 3 |
Ariganello, O | 1 |
Torri, V | 1 |
Neumaier, CE | 1 |
Rosso, R | 5 |
Veronesi, G | 2 |
Spaggiari, L | 2 |
De Pas, T | 3 |
Solli, PG | 1 |
De Braud, F | 2 |
Catalano, GP | 1 |
Leo, F | 2 |
Gebbia, V | 4 |
Galetta, D | 4 |
Caruso, M | 1 |
Verderame, F | 1 |
Pezzella, G | 1 |
Valdesi, M | 1 |
Borsellino, N | 1 |
Pandolfo, G | 1 |
Durini, E | 1 |
Rinaldi, M | 3 |
Loizzi, M | 1 |
Gebbia, N | 3 |
Valenza, R | 2 |
Tirrito, ML | 1 |
Varvara, F | 1 |
Colucci, G | 4 |
Chen, YM | 7 |
Shih, JF | 2 |
Lee, CS | 1 |
Chen, MC | 1 |
Lin, WC | 6 |
Tsai, CM | 7 |
Perng, RP | 9 |
Haro Estarriol, M | 1 |
Baldo Padró, X | 1 |
Rubio Goday, M | 1 |
Sebastián Quetglas, F | 1 |
Viñas Villaró, G | 1 |
Bernadó Turmo, L | 1 |
Socinski, MA | 2 |
Neubauer, MA | 1 |
Olivares, J | 1 |
Ketchel, S | 1 |
Tynan, M | 1 |
Moore, M | 2 |
Lee, JH | 1 |
Davis, K | 1 |
Schell, M | 1 |
Garfield, D | 1 |
Mauer, AM | 4 |
Ansari, RH | 1 |
Hoffman, PC | 12 |
Krauss, SA | 6 |
Taber, D | 1 |
Tembe, SA | 1 |
Gabrys, GT | 1 |
Cotter, T | 1 |
Schumm, LP | 1 |
Szeto, L | 1 |
Vokes, EE | 13 |
Ichiki, M | 3 |
Rikimaru, T | 4 |
Gohara, R | 3 |
Koga, T | 1 |
Kawayama, T | 2 |
Matunami, M | 1 |
Oshita, Y | 1 |
Kamimura, T | 1 |
Aizawa, H | 2 |
Snee, MP | 1 |
Unsal, M | 1 |
Erturk, D | 1 |
Danson, S | 1 |
Middleton, MR | 1 |
O'Byrne, KJ | 1 |
Clemons, M | 1 |
Ranson, M | 2 |
Hassan, J | 1 |
Anderson, H | 9 |
Burt, PA | 3 |
Fairve-Finn, C | 1 |
Stout, R | 10 |
Dowd, I | 1 |
Ashcroft, L | 6 |
Beresford, C | 1 |
Thatcher, N | 37 |
Kitajima, T | 1 |
Fujiki, R | 1 |
Shimada, A | 1 |
Mohedano Mohedano, N | 1 |
Sánchez Rovira, P | 1 |
Lozano Barriuso, A | 1 |
Fernandez Morales, M | 1 |
Medina Magan, B | 1 |
Jaen Morago, A | 1 |
Porras Quintela, I | 1 |
Dueñas Garcia, R | 1 |
Fernandez Flores, E | 1 |
Moreno Moreno, MA | 1 |
Alberola, V | 2 |
Camps, C | 5 |
Provencio, M | 1 |
Isla, D | 1 |
Rosell, R | 9 |
Vadell, C | 2 |
Bover, I | 1 |
Ruiz-Casado, A | 1 |
Azagra, P | 1 |
Jiménez, U | 1 |
González-Larriba, JL | 1 |
Diz, P | 1 |
Cardenal, F | 2 |
Artal, A | 3 |
Carrato, A | 1 |
Morales, S | 2 |
Sanchez, JJ | 2 |
de las Peñas, R | 1 |
Felip, E | 1 |
López-Vivanco, G | 1 |
Fujita, A | 17 |
Ohkubo, T | 1 |
Hoshino, H | 1 |
Takabatake, H | 12 |
Tagaki, S | 13 |
Sekine, K | 16 |
Abe, S | 1 |
Margery, J | 2 |
Le Moulec, S | 1 |
Grassin, F | 1 |
Vaylet, F | 2 |
L'her, P | 1 |
Agra, Y | 1 |
Pelayo, M | 1 |
Sacristan, M | 1 |
Sacristán, A | 1 |
Serra, C | 1 |
Bonfill, X | 1 |
Marangolo, M | 6 |
Giovanis, P | 1 |
Silvestris, N | 2 |
Piscitelli, D | 1 |
Crucitta, E | 1 |
Fiore, M | 1 |
De Lena, M | 1 |
Lorusso, V | 2 |
Song, SY | 1 |
Kim, WS | 2 |
Kim, K | 1 |
Jung, CW | 1 |
Im, YH | 1 |
Kim, HJ | 2 |
Kang, WK | 2 |
Lee, HG | 1 |
Kwon, OJ | 1 |
Rhee, CH | 1 |
Park, CH | 2 |
Kita, M | 1 |
Sasaki, Y | 2 |
Okuyama, M | 1 |
Saga, Y | 1 |
Hashimoto, H | 1 |
Kaneko, S | 1 |
Yachiku, S | 1 |
Tokumitsu, M | 1 |
Inada, F | 1 |
Ishida, H | 1 |
Merimsky, O | 1 |
Kollender, Y | 1 |
Inbar, M | 1 |
Meller, I | 1 |
Bickels, J | 1 |
Bourgeois, H | 2 |
Billiart, I | 1 |
Chabrun, V | 1 |
Chieze, S | 1 |
Lemerre, D | 1 |
Germain, T | 1 |
Ferrand, V | 1 |
Meurice, JC | 2 |
Daban, A | 1 |
Tourani, JM | 3 |
Ishizuka, O | 1 |
Satoh, T | 3 |
Mizuno, H | 1 |
Mizusawa, H | 1 |
Seki, S | 1 |
Nishizawa, O | 1 |
Van Houtte, P | 3 |
Koumakis, G | 6 |
Richez, M | 2 |
Corhay, JL | 2 |
Wackenier, P | 2 |
Lothaire, P | 2 |
Giaccone, G | 4 |
Smit, EF | 5 |
de Jonge, M | 1 |
Dansin, E | 1 |
Briasoulis, E | 1 |
Douillard, JY | 2 |
Spaeth, D | 1 |
Lacombe, D | 1 |
Baron, B | 1 |
Bachmann, P | 2 |
Fumoleau, P | 1 |
Park, SJ | 1 |
Kim, HK | 2 |
Kim, CK | 1 |
Park, SK | 1 |
Go, ES | 1 |
Kim, ME | 1 |
Hong, DS | 1 |
Hernández, R | 1 |
Juan, O | 1 |
Chrystal, K | 1 |
Cheong, K | 1 |
Harper, P | 1 |
Junker, K | 2 |
Müller, KM | 1 |
Abker, S | 1 |
Bosse, U | 1 |
Takahashi, S | 2 |
Okada, K | 1 |
Nagasawa, H | 1 |
Shimada, Y | 1 |
Sakamoto, H | 1 |
Itoi, E | 1 |
VanHoutte, P | 1 |
Chuman, H | 1 |
Corapcioglu, F | 1 |
Dillioğlugil, O | 1 |
Sarper, N | 1 |
Akansel, G | 1 |
Calişkan, M | 1 |
Arisoy, AE | 1 |
de Cremoux, P | 3 |
Sastre, X | 1 |
Judde, JG | 1 |
Tran-Perennou, C | 1 |
Fréneaux, P | 1 |
Pouillart, P | 2 |
Rawlins, JM | 1 |
Batchelor, AG | 1 |
Liddington, MI | 1 |
Towns, G | 1 |
Lorent, N | 1 |
De Leyn, P | 2 |
Verbeken, E | 1 |
Dooms, C | 1 |
Van Raemdonck, D | 2 |
Anrys, B | 1 |
Rudd, RM | 2 |
Gower, NH | 2 |
Spiro, SG | 5 |
Eisen, TG | 1 |
Harper, PG | 4 |
Littler, JA | 1 |
Hatton, M | 1 |
Johnson, PW | 2 |
Martin, WM | 1 |
Rankin, EM | 1 |
James, LE | 1 |
Gregory, WM | 1 |
Qian, W | 2 |
Lee, SM | 3 |
del Prever, AB | 1 |
Berta, M | 1 |
Bertoni, F | 3 |
Mercuri, M | 3 |
Stage, AC | 1 |
Pollock, RE | 1 |
Matin, SF | 1 |
Suzuki, M | 2 |
Matsumoto, S | 1 |
Okamoto, N | 1 |
Nishimatsu, H | 1 |
Tomita, K | 2 |
Kitamura, T | 2 |
Moro-Sibilot, D | 3 |
Mercier, M | 1 |
Breton, JL | 2 |
Debieuvre, D | 1 |
Richard, P | 1 |
Haller, MA | 1 |
Herman, D | 1 |
Level, MC | 2 |
Lebas, FX | 2 |
Lorigan, P | 5 |
Woll, PJ | 4 |
O'Brien, ME | 1 |
Ashcroft, LF | 1 |
Sampson, MR | 1 |
Stephens, RJ | 4 |
Girling, DJ | 4 |
Hopwood, P | 4 |
Dillman, RO | 1 |
Barth, NM | 1 |
VanderMolen, LA | 1 |
Allen, K | 1 |
Beutel, LD | 1 |
Chico, S | 1 |
Braun, D | 2 |
Lebeau, B | 5 |
Zak, D | 1 |
Styler, MJ | 1 |
Rosenbluth, JZ | 1 |
Brodsky, I | 1 |
Boutemy, M | 1 |
Mispelaere, D | 1 |
Krzisch, C | 1 |
Jounieaux, V | 1 |
Iwasaki, Y | 1 |
Nagata, K | 1 |
Nakanishi, M | 1 |
Natuhara, A | 1 |
Kubota, Y | 1 |
Ueda, M | 1 |
Arimoto, T | 3 |
Hara, H | 1 |
Govindan, R | 1 |
Tho, LM | 1 |
Ferry, DR | 2 |
Spada, M | 1 |
Guida, M | 1 |
Cassano, G | 1 |
Brunetti, C | 1 |
Nettis, G | 1 |
Izzi, G | 1 |
Giampaglia, M | 1 |
Kawabe, M | 1 |
Sasaki, K | 1 |
Shinoda, T | 1 |
Tanabe, S | 1 |
Handa, M | 1 |
Yamada, N | 1 |
Uesaka, T | 1 |
Morioka, K | 1 |
Ihaya, A | 1 |
Tanaka, K | 1 |
Imamura, Y | 1 |
Koutras, A | 1 |
Makatsoris, T | 2 |
Mylonakis, N | 3 |
Tzelepis, G | 1 |
Dimitrakopoulos, A | 1 |
Spyropoulos, K | 1 |
Polyzos, A | 2 |
Karabelis, A | 2 |
Kalofonos, HP | 4 |
Gordon, N | 1 |
Arndt, CA | 1 |
Hawkins, DS | 1 |
Doherty, DK | 1 |
Inwards, CY | 1 |
Munsell, MF | 1 |
Stewart, J | 1 |
Koshkina, NV | 1 |
Kleinerman, ES | 4 |
Clark, PI | 1 |
Sambrook, RJ | 1 |
Owens, R | 1 |
Daw, NC | 1 |
Billups, CA | 1 |
McCarville, MB | 2 |
Rao, BN | 2 |
Cain, AM | 2 |
Jenkins, JJ | 2 |
Neel, MD | 1 |
Meyer, WH | 3 |
Lee, HW | 1 |
Choi, JH | 1 |
Lim, HY | 1 |
Park, JS | 1 |
Kim, HC | 1 |
Kang, S | 1 |
Oh, YT | 1 |
Chun, M | 1 |
Sheen, SS | 1 |
Oh, YJ | 1 |
Park, KJ | 1 |
Hwang, SC | 1 |
Duan, X | 1 |
Jia, SF | 2 |
Koshkina, N | 1 |
Barlesi, F | 1 |
Daurès, JP | 2 |
Petrilli, AS | 1 |
de Camargo, B | 1 |
Filho, VO | 1 |
Bruniera, P | 1 |
Brunetto, AL | 1 |
Jesus-Garcia, R | 1 |
Camargo, OP | 1 |
Pena, W | 1 |
Péricles, P | 1 |
Davi, A | 1 |
Prospero, JD | 1 |
Alves, MT | 1 |
Oliveira, CR | 1 |
Macedo, CR | 1 |
Mendes, WL | 1 |
Almeida, MT | 1 |
Borsato, ML | 1 |
dos Santos, TM | 1 |
Ortega, J | 1 |
Consentino, E | 1 |
Tysome, JR | 1 |
Sandison, A | 1 |
Clarke, PM | 1 |
Booton, R | 3 |
Baka, S | 2 |
Nicolson, M | 1 |
O'Brien, M | 1 |
Dunlop, D | 1 |
O'Byrne, K | 1 |
Laurence, V | 1 |
Snee, M | 1 |
Dark, G | 1 |
Indolfi, P | 1 |
Casale, F | 1 |
Cecchetto, G | 1 |
De Salvo, G | 1 |
Donfrancesco, A | 1 |
Donofrio, V | 1 |
Martone, A | 1 |
Di Martino, M | 1 |
Di Tullio, MT | 1 |
Ferigo, N | 1 |
Cottalorda, J | 1 |
Allard, D | 1 |
Gentil-Perret, A | 1 |
Fessy, M | 1 |
Berger, C | 1 |
Stéphan, JL | 1 |
Hayakawa, T | 1 |
Sato, M | 1 |
Konaka, M | 1 |
Makino, A | 1 |
Hirohata, T | 1 |
Totsu, S | 1 |
Wada, Y | 1 |
Sato, H | 1 |
Inotsume, N | 1 |
Bendell, JC | 1 |
Lauwers, GY | 1 |
Willett, C | 1 |
Clark, JW | 1 |
Warshaw, AL | 1 |
Wain, JC | 1 |
Ryan, DP | 1 |
Rupolo, M | 1 |
Buonadonna, A | 1 |
Brollo, A | 1 |
Morra, A | 1 |
Berretta, S | 1 |
Frustaci, S | 1 |
Moreno Antón, F | 1 |
Casado Herraez, A | 1 |
Puente Vázquez, J | 1 |
Gómez Díaz, R | 1 |
Aragoncillo, P | 1 |
Díaz-Rubio García, E | 1 |
Manegold, C | 8 |
Buchholz, E | 3 |
Schott-von-Römer, K | 1 |
Nagel, S | 1 |
Blackhall, F | 1 |
Aschroft, L | 1 |
Adoun, M | 1 |
Paitel, JF | 1 |
Blanc, P | 1 |
Genet, D | 1 |
Ferru, A | 1 |
Deletage, C | 1 |
Cok, G | 1 |
Göksel, T | 1 |
Soyer, S | 1 |
Atil, H | 1 |
Güzelant, A | 1 |
Aysan, T | 1 |
Pohl, G | 1 |
Krajnik, G | 1 |
Malayeri, R | 1 |
Müller, RM | 1 |
Klepetko, W | 1 |
Eckersberger, F | 2 |
Schäfer-Prokop, C | 1 |
Pokrajac, B | 1 |
Schmeikal, S | 1 |
Maier, A | 1 |
Ambrosch, G | 1 |
Woltsche, M | 1 |
Minar, W | 1 |
Pirker, R | 2 |
Antonelli, A | 1 |
Simeone, C | 1 |
Ferrari, V | 1 |
Tardanico, R | 1 |
Cunico, SC | 1 |
Kawai, K | 1 |
Takaoka, E | 1 |
Naoi, M | 1 |
Mori, K | 1 |
Minami, M | 1 |
Shimazui, T | 1 |
Akaza, H | 1 |
Li, EX | 1 |
Zhang, YT | 1 |
Shang, JT | 1 |
Xu, Z | 1 |
Geng, Y | 1 |
Li, SM | 1 |
Shi, F | 1 |
Wu, YY | 1 |
Harada, A | 1 |
Taue, R | 1 |
Kishimoto, T | 1 |
Tanimoto, S | 1 |
Izaki, H | 1 |
Takahashi, M | 2 |
Fukumori, T | 1 |
Nishitani, MA | 1 |
Kanayama, HO | 1 |
Banna, GL | 1 |
De Giorgi, U | 1 |
Ferrari, B | 1 |
Castagna, L | 1 |
Alloisio, M | 1 |
Rosti, G | 5 |
Santoro, A | 3 |
Su, Y | 1 |
Mardynskiĭ, IuS | 1 |
Zolotkov, AG | 1 |
Kudriavtsev, DV | 1 |
Nogi, H | 1 |
Kobayashi, T | 1 |
Kawase, K | 1 |
Tabei, I | 1 |
Toriumi, Y | 1 |
Kawakami, M | 1 |
Morikawa, T | 1 |
Uchida, K | 1 |
Skubitz, KM | 1 |
Manivel, JC | 1 |
Van Cutsem, O | 8 |
Collon, T | 4 |
Whang-Peng, J | 7 |
Booten, R | 1 |
Ward, T | 2 |
Heighway, J | 2 |
Morris, J | 2 |
Pilz, L | 1 |
Drings, P | 19 |
Pelosi, G | 1 |
Catalano, G | 1 |
Gandini, S | 1 |
Burke, MJ | 1 |
Walterhouse, DO | 1 |
Jacobsohn, DA | 1 |
Duerst, RE | 1 |
Kletzel, M | 1 |
Smorenburg, CH | 1 |
van Groeningen, CJ | 1 |
Meijer, OW | 1 |
Visser, M | 1 |
Boven, E | 1 |
Saint-Blancard, P | 1 |
Hardy, K | 1 |
Bonnichon, A | 1 |
Jancovici, R | 1 |
Park, S | 1 |
Ahn, MJ | 1 |
Hong, YS | 2 |
Park, BB | 1 |
Lee, SC | 1 |
Hwang, IG | 1 |
Park, JO | 2 |
Lim, H | 1 |
Piantedosi, FV | 1 |
Caputo, F | 1 |
Mazzarella, G | 1 |
Gilli, M | 1 |
Pontillo, A | 1 |
D'Agostino, D | 1 |
Campbell, S | 1 |
Marsico, SA | 1 |
Bianco, A | 1 |
Vaslamatzis, MM | 1 |
Brunello, A | 1 |
Rossi, E | 1 |
Stefani, M | 1 |
Ghiotto, C | 2 |
Marino, D | 1 |
Crivellari, G | 1 |
Monfardini, S | 1 |
Rezaï, K | 1 |
Lokiec, F | 1 |
Grandjean, I | 1 |
Weill, S | 1 |
Bordier, V | 1 |
Ekue, R | 1 |
Garcia, M | 1 |
Han, JQ | 1 |
Han, CY | 1 |
Bi, YH | 1 |
Qiu, MZ | 1 |
Xu, F | 1 |
Wang, SS | 1 |
Luo, HY | 1 |
Wang, F | 1 |
Li, FH | 1 |
Sun, XF | 1 |
Xu, GC | 1 |
Lin, TY | 1 |
Huang, HQ | 1 |
Jiang, WQ | 1 |
Guan, ZZ | 2 |
Xu, RH | 1 |
Grosshans, DR | 1 |
Meyers, CA | 1 |
Allen, PK | 1 |
Davenport, SD | 1 |
Komaki, R | 3 |
Meyers, PA | 2 |
Schwartz, CL | 1 |
Krailo, MD | 1 |
Healey, JH | 1 |
Bernstein, ML | 1 |
Betcher, D | 1 |
Ferguson, WS | 2 |
Gebhardt, MC | 1 |
Goorin, AM | 2 |
Harris, M | 1 |
Kleinerman, E | 1 |
Link, MP | 2 |
Nadel, H | 1 |
Nieder, M | 1 |
Siegal, GP | 1 |
Weiner, MA | 1 |
Womer, RB | 1 |
Grier, HE | 1 |
Kakutani, S | 1 |
Yanada, S | 1 |
Ito, H | 1 |
Tomita, M | 1 |
Wada, T | 1 |
Hatano, T | 1 |
Kishimoto, K | 1 |
Egawa, S | 1 |
Mok, TS | 1 |
Crowley, J | 1 |
Gottfried, M | 1 |
Ramlau, R | 1 |
Krzakowski, M | 1 |
Ziolo, G | 1 |
Olechnowicz, H | 1 |
Koubkova, L | 1 |
Dahabreh, J | 1 |
Szczesna, A | 1 |
Vivanco, GL | 1 |
Carpagnano, F | 1 |
Leong, SS | 3 |
Fittipaldo, A | 1 |
De Almeida, C | 1 |
Grunenwald, D | 1 |
Leyvraz, S | 4 |
Pampallona, S | 3 |
Martinelli, G | 1 |
Ploner, F | 1 |
Perey, L | 4 |
Aversa, S | 1 |
Brunsvig, P | 1 |
Montes, A | 1 |
Lange, A | 3 |
Yilmaz, U | 1 |
Bunn, PA | 4 |
You, B | 1 |
Tranchand, B | 2 |
Girard, P | 2 |
Falandry, C | 1 |
Ribba, B | 1 |
Chabaud, S | 1 |
Court-Fortune, I | 3 |
Trillet-Lenoir, V | 4 |
Fournel, C | 1 |
Tod, M | 1 |
Freyer, G | 2 |
Arai, H | 1 |
Rino, Y | 1 |
Yamanaka, S | 2 |
Yukawa, N | 1 |
Wada, N | 1 |
Kudo, M | 1 |
Watanuki, Y | 1 |
Fukumura, H | 1 |
Nakajima, K | 1 |
Oshiro, H | 1 |
Masuda, M | 1 |
Stiefel, P | 3 |
Dirks, HP | 1 |
Grimm, V | 1 |
Kleckow, M | 2 |
Manke, HG | 5 |
Queisser, W | 2 |
Abel, U | 2 |
Heinrich, S | 1 |
Liesenfeld, A | 1 |
Havemann, K | 9 |
Gropp, C | 5 |
Seifert, W | 1 |
Thomas, C | 1 |
Mahnke, HG | 1 |
Westerhausen, M | 1 |
Wellens, W | 1 |
Konrad, RM | 1 |
Bryant, BM | 1 |
Jarman, M | 1 |
Ford, HT | 2 |
Smith, IE | 4 |
Steinke, B | 1 |
Heidemann, E | 1 |
Ostendorf, P | 1 |
Wilms, K | 1 |
Waller, HD | 1 |
Valdivieso, M | 10 |
Tenczynski, TF | 1 |
Rodriguez, V | 1 |
Burgess, MA | 2 |
Mountain, CF | 2 |
Barkley, HT | 4 |
Hersh, EM | 2 |
Bodey, GP | 7 |
Saiers, JH | 2 |
Slavik, M | 2 |
Kokron, O | 3 |
Micksche, M | 1 |
Titscher, R | 2 |
Wrba, H | 1 |
Karrer, K | 1 |
Denck, H | 1 |
Pridun, N | 1 |
Zwintz, E | 1 |
Serrou, B | 1 |
Cupissol, D | 2 |
Plagne, R | 1 |
Boutin, P | 1 |
Carcassone, Y | 1 |
Michel, FB | 6 |
Nakhosteen, JA | 1 |
Niederle, N | 4 |
Harrison, EF | 5 |
Hawke, JE | 2 |
Hunter, HL | 5 |
Costanzi, JJ | 5 |
Morgan, LR | 8 |
Plotkin, D | 2 |
Tucker, WG | 2 |
Worrall, PM | 2 |
Hokanson, J | 1 |
Holoye, PY | 3 |
Anderson, T | 1 |
Duelge, J | 1 |
Hansen, RM | 1 |
Kehl, A | 1 |
Bergholz, M | 1 |
von Heyden, HW | 1 |
Nagel, GA | 1 |
Mukouda, K | 1 |
Morikawa, E | 1 |
Hasegawa, K | 1 |
Noumi, K | 1 |
Ohmura, T | 1 |
Mishima, Y | 1 |
Kawamoto, M | 1 |
Inagaki, A | 1 |
Kamitsuna, A | 1 |
Yamakido, M | 1 |
Nishimoto, Y | 1 |
Koyama, T | 1 |
Katsuta, S | 1 |
Bakowski, MT | 1 |
Crouch, JC | 1 |
Cabanillas, F | 1 |
Keating, M | 1 |
Murphy, WK | 6 |
Frazier, H | 1 |
Chen, T | 1 |
Focan, C | 1 |
Le Hung, S | 1 |
Bays-Gallaix, R | 1 |
Frere, MH | 1 |
Demonceau, G | 1 |
Mbuyamba, P | 1 |
Claessens, JJ | 1 |
Piazza, E | 1 |
Cattaneo, MT | 1 |
Varini, M | 2 |
Joss, RA | 1 |
Cavalli, F | 1 |
Goldhirsch, A | 1 |
Mermillod, B | 1 |
Brunner, KW | 1 |
Araujo, CE | 1 |
Tessler, J | 1 |
Matthiessen, W | 2 |
Stempinski, E | 2 |
Göbel, D | 2 |
Thalmann, U | 2 |
Nobile, MT | 1 |
Brema, F | 1 |
Cinquegrana, A | 1 |
Santi, L | 1 |
Holdiness, MR | 2 |
Retsas, S | 1 |
Goldin, A | 1 |
Burkert, H | 2 |
Benjamin, RS | 2 |
Freeman, MB | 1 |
Ertel, M | 1 |
Smith, TL | 1 |
Gillen, LE | 1 |
Satomi, Y | 1 |
Clemm, C | 1 |
Hartenstein, R | 1 |
Wilmanns, W | 1 |
Donley, PJ | 2 |
Bierbaum, W | 1 |
Bremer, K | 1 |
Firusian, N | 1 |
Higi, M | 1 |
Scheulen, ME | 1 |
Schmidt, CG | 2 |
Seeber, S | 3 |
Issell, BF | 3 |
MacFadyen, BV | 1 |
Gum, ET | 1 |
Dudrick, SJ | 2 |
McNiel, NO | 1 |
König, HJ | 1 |
Hartwich, G | 2 |
Bleehen, NM | 2 |
Machin, D | 2 |
Dieckmann, KP | 1 |
Loy, V | 1 |
Küpfer, A | 1 |
Aeschlimann, C | 1 |
Wermuth, B | 1 |
Cerny, T | 7 |
Brugger, W | 6 |
Henschler, R | 1 |
Heimfeld, S | 1 |
Berenson, RJ | 1 |
Mertelsmann, R | 6 |
Carles, J | 3 |
Ariza, A | 1 |
Pellicer, I | 1 |
Fernandez-Vasalo, G | 1 |
Abad, A | 2 |
Barnadas, A | 3 |
Pettengell, R | 2 |
Dexter, TM | 2 |
Testa, NG | 2 |
Addamo, GF | 1 |
Borghini, U | 2 |
Lionetto, R | 1 |
Conte, PF | 4 |
Bruzzi, P | 1 |
Pennucci, MC | 3 |
Frommhold, H | 5 |
Pressler, K | 1 |
Hodgetts, J | 2 |
Lomax, L | 2 |
Bildet, F | 1 |
Cour-Chabernaud, V | 1 |
Carpentier, AF | 1 |
Chantelard, JV | 1 |
Henin, D | 1 |
Poisson, M | 1 |
Drinkard, LC | 8 |
Samuels, BL | 8 |
Watson, S | 6 |
Bitran, JD | 2 |
Golomb, HM | 10 |
Simmonds, PD | 1 |
Mead, GM | 1 |
Whitehouse, JM | 1 |
Crawford, J | 3 |
George, M | 1 |
Masters, GA | 9 |
Strauss, GM | 2 |
Lynch, TJ | 3 |
Elias, AD | 2 |
Jacobs, C | 2 |
Kwiatkowski, DJ | 2 |
Shulman, LN | 2 |
Carey, RW | 2 |
Grossbard, ML | 3 |
Jauss, S | 1 |
Sugarbaker, DJ | 1 |
Vicente, P | 1 |
Garciá del Muro, X | 1 |
Clerici, M | 2 |
Figoli, F | 3 |
Barduagni, M | 1 |
Carlini, P | 2 |
Ceci, G | 2 |
Cortesi, E | 2 |
Carpi, A | 2 |
Santini, A | 2 |
Molina, F | 2 |
Moreno, I | 4 |
Martínez, E | 1 |
Pifarré, A | 1 |
Font, A | 2 |
Li, S | 1 |
Skacel, Z | 2 |
Gómez-Codina, J | 3 |
Postmus, PE | 9 |
Milroy, R | 2 |
Macbeth, F | 1 |
Loehrer, PJ | 8 |
Ansari, R | 4 |
Gonin, R | 2 |
Monaco, F | 1 |
Fisher, W | 1 |
Sandler, A | 2 |
Brewster, AE | 1 |
Wolff, AC | 1 |
Neuberg, D | 1 |
Comis, RL | 1 |
Ruckdeschel, JC | 1 |
Bonomi, PD | 1 |
Johnson, DH | 4 |
de Campos, E | 2 |
Radford, J | 2 |
Steward, W | 2 |
Dougal, M | 1 |
Swindell, R | 4 |
Testa, N | 1 |
Nichols, CR | 2 |
Betticher, D | 1 |
Woodhead, M | 1 |
Weir, D | 1 |
Hanley, S | 1 |
Hardy, C | 1 |
Boros, L | 3 |
Garrow, GC | 2 |
Asbury, RF | 2 |
Chang, AY | 3 |
Hsieh, S | 1 |
Raymond, AK | 1 |
Gano, JB | 1 |
Miller, VA | 1 |
Rigas, JR | 2 |
Pisters, KM | 1 |
Grant, SC | 1 |
Pfister, DG | 1 |
Heelan, RT | 1 |
Kris, MG | 1 |
Wagner, W | 1 |
von Eiff, M | 3 |
Micke, O | 1 |
Rübe, C | 2 |
Willich, N | 1 |
Corlett, SA | 1 |
Parker, D | 2 |
Chrystyn, H | 1 |
Hatton, MQ | 1 |
Cassidy, J | 1 |
Bicknell, S | 1 |
Semple, P | 1 |
Stack, B | 1 |
Steward, WP | 5 |
Shinozaki, T | 1 |
Matsushita, M | 1 |
Kusawake, H | 1 |
Watanabe, H | 1 |
Arita, S | 1 |
Chigira, M | 1 |
Udagawa, E | 1 |
Pein, F | 1 |
Saint-Andre, JP | 1 |
Flamant, F | 1 |
Faylona, EA | 1 |
Sandler, AB | 2 |
Cumin, I | 1 |
Lacroix, H | 1 |
Mahé, M | 1 |
Dutin, JP | 1 |
Dabouis, G | 2 |
Kattan, J | 1 |
Culine, S | 1 |
Theodore, C | 1 |
Droz, JP | 2 |
Watanabe, Y | 1 |
Tanaka, H | 2 |
Ogawa, M | 2 |
Tanaka, T | 1 |
Tanizawa, M | 1 |
Cargill, RI | 1 |
Boyter, AC | 1 |
Lipworth, BJ | 1 |
Elisson, LO | 1 |
Ekberg, L | 1 |
Bureau, G | 6 |
Michel, J | 3 |
Küstner, U | 2 |
Kroll, F | 2 |
Prendiville, J | 4 |
Hicks, F | 1 |
Leahy, B | 1 |
Burt, P | 3 |
Somma-Mauvais, H | 1 |
Farisse, P | 1 |
Viallat, JR | 2 |
Pocard, M | 1 |
Azorin, JF | 1 |
Delepine, N | 1 |
Delepine, G | 1 |
Tremblay, B | 1 |
Destable, MD | 1 |
Thongprasert, S | 5 |
Phromwas, N | 1 |
Atikachi, B | 1 |
Jiemsripong, K | 1 |
Moro, D | 2 |
Orfeuvre, H | 1 |
Nagy-Mignotte, H | 1 |
Mousseau, M | 1 |
Blanc-Jouvan, F | 1 |
Schaerer, R | 1 |
Brambilla, C | 1 |
Hayot, M | 1 |
Rouanet, P | 2 |
Le Chevalier, T | 5 |
Hsieh, RK | 1 |
Asbury, R | 1 |
Perez, EA | 2 |
Sowray, PC | 1 |
Gardner, SL | 1 |
Gandara, DR | 2 |
Lorrigan, P | 1 |
Izraeli, S | 1 |
Adamson, PC | 1 |
Blaney, SM | 1 |
Balis, FM | 1 |
Mornex, F | 1 |
Chauvin, F | 2 |
Fournel, P | 2 |
Voloch, A | 1 |
Perol, M | 2 |
Laennec, E | 1 |
Piperno, D | 1 |
Boyer, J | 1 |
Ardiet, JM | 1 |
Jiamsriponges, K | 1 |
González Barón, M | 3 |
Feliu, J | 3 |
Espinosa, E | 1 |
García Girón, C | 3 |
Blanco, E | 1 |
Garrido, P | 3 |
Colmenarejo, A | 1 |
Ordóñez, A | 4 |
Moyano, A | 1 |
de la Gándara, I | 1 |
van der Graaf, WT | 1 |
Haaxma-Reiche, H | 2 |
Burghouts, JT | 3 |
Pratt, CB | 2 |
Parham, DM | 1 |
Fleming, ID | 1 |
Rosen, G | 1 |
Forscher, C | 1 |
Lowenbraun, S | 1 |
Eilber, F | 1 |
Eckardt, J | 1 |
Holmes, C | 1 |
Fu, YS | 1 |
Kosmidis, P | 2 |
Skarlos, DV | 2 |
Samantas, E | 3 |
Beer, M | 1 |
Theocharis, D | 1 |
Zachariadis, E | 1 |
Gioti, A | 1 |
Papadakis, E | 1 |
Poulakis, N | 2 |
Krigel, RL | 2 |
Palackdharry, CS | 3 |
Padavic, K | 1 |
Haas, N | 1 |
Kilpatrick, D | 1 |
Langer, C | 1 |
Comis, R | 1 |
Evans, WK | 4 |
Stewart, DJ | 1 |
Shepherd, FA | 7 |
Logan, D | 4 |
Goss, G | 2 |
Maroun, JA | 1 |
Wierzbicki, R | 1 |
Warner, E | 4 |
Latreille, J | 6 |
Dahrouge, S | 2 |
Tibaldi, C | 6 |
Chella, A | 2 |
Angeletti, CA | 2 |
Romanini, A | 1 |
Andrei, A | 2 |
Algeri, R | 2 |
Silvano, G | 3 |
Chastang, C | 2 |
Jacoulet, P | 1 |
Paillot, N | 2 |
Janicot, H | 2 |
Lombard, JN | 1 |
Maestre, J | 3 |
Milla, A | 1 |
Wolf, M | 8 |
Hans, K | 8 |
Becker, H | 5 |
Hässler, R | 1 |
von Bültzingslöwen, F | 2 |
Goerg, R | 2 |
Klaasen, HA | 1 |
Dannhäuser, J | 1 |
Holle, R | 6 |
Pfab, R | 2 |
Isai, H | 1 |
Minase, T | 2 |
Arcangeli, G | 1 |
Milano, S | 2 |
Simoncini, E | 1 |
Marpicati, P | 1 |
Kurowski, V | 2 |
Wagner, T | 3 |
Hibi, S | 1 |
Naya, M | 1 |
Takaya, K | 1 |
Morimoto, M | 1 |
Kataoka, Y | 1 |
Todo, S | 1 |
Imashuku, S | 1 |
Otsuka, T | 1 |
Matsui, N | 1 |
Ohta, H | 1 |
Hattori, M | 1 |
Nakamura, T | 1 |
Kirkpatrick, A | 3 |
Splinter, TA | 4 |
Cameron, JC | 1 |
Johnson, BE | 1 |
Teresi, ME | 1 |
Murry, DJ | 1 |
Cornelius, AS | 1 |
Millward, MJ | 1 |
Cantwell, BM | 5 |
Munro, NC | 1 |
Robinson, A | 1 |
Corris, PA | 1 |
Harris, AL | 6 |
Graziano, SL | 2 |
Herndon, JE | 3 |
Richards, F | 2 |
DiFino, S | 1 |
Modeas, C | 1 |
Duggan, DB | 1 |
Green, MR | 3 |
Radford, JA | 2 |
Berrocal, A | 1 |
Barón, JM | 1 |
Meyer, T | 1 |
Herrmann, C | 1 |
Hiddemann, W | 1 |
Schauer, A | 1 |
Köpf-Maier, P | 1 |
Sass, G | 1 |
Lobo-Sanahuja, F | 1 |
García, I | 1 |
Santamaría, S | 1 |
Barrantes, JC | 1 |
Bohas, CH | 1 |
Fortune, IC | 1 |
Chatte, G | 1 |
Gridelli, C | 2 |
Rossi, A | 1 |
Incoronato, P | 1 |
Bruni, GS | 1 |
Scognamiglio, F | 1 |
Ruffolo, P | 1 |
Rinaldi, L | 1 |
Bianco, AR | 1 |
Satoh, H | 2 |
Yano, H | 2 |
Ishikawa, H | 1 |
Hasegawa, S | 2 |
Majello, E | 1 |
Sohda, T | 1 |
Wahid, NA | 1 |
Neugut, AI | 1 |
Hibshoosh, H | 1 |
Brunetti, JC | 1 |
Fountain, KS | 1 |
Rubin, M | 1 |
Urban, T | 2 |
Bedin, A | 1 |
Baud, M | 2 |
Chouaid, C | 1 |
Febvre, M | 2 |
Sergysels, R | 1 |
Koch, P | 1 |
Johnson, N | 1 |
van Schaik, J | 1 |
Andersen, S | 1 |
Blatter, J | 3 |
Bosanquet, N | 1 |
Copley-Merriman, K | 1 |
Vandebroek, J | 1 |
Mariën, S | 1 |
Roex, L | 1 |
Bertrand, P | 1 |
Bockaert, J | 1 |
De Beukelaar, T | 1 |
Deman, R | 1 |
De Muynck, P | 1 |
Ulrichts, H | 1 |
Crump, M | 1 |
Stewart, D | 4 |
Tomiak, E | 1 |
Eisenhauer, E | 3 |
Fisher, B | 1 |
Lokich, J | 1 |
Anderson, N | 1 |
Moore, C | 1 |
Bern, M | 1 |
Coco, F | 1 |
Dow, E | 1 |
Soler, P | 1 |
Arpin, D | 1 |
Bohas, C | 1 |
Riou, R | 2 |
Ecochard, D | 1 |
Gautier, V | 1 |
Zinaï, A | 1 |
Valone, FH | 1 |
Rege, VB | 1 |
Clamon, G | 1 |
Scagliotti, GV | 3 |
Ricardi, U | 1 |
Maranzano, E | 1 |
Morandi, MG | 1 |
Meacci, L | 1 |
Emiliani, E | 1 |
Bolzicco, G | 1 |
Masiero, P | 1 |
Gentile, A | 1 |
Tonato, M | 4 |
Fountzilas, G | 2 |
Pavlidis, N | 2 |
Kattis, K | 1 |
Skarlos, D | 1 |
Pawinski, A | 1 |
Lentz, MA | 1 |
van Glabbeke, M | 1 |
van Zandwijk, N | 4 |
Schnaars, Y | 1 |
Zatloukal, P | 1 |
Dolensky, J | 1 |
Jackevicius, A | 1 |
Petruzelka, L | 1 |
Zorzi, F | 1 |
Ottoni, DB | 1 |
Di Fabio, D | 1 |
Mombelloni, G | 1 |
Zarogoulidis, K | 2 |
Ziogas, E | 2 |
Papagiannis, A | 2 |
Charitopoulos, K | 1 |
Dimitriadis, K | 1 |
Economides, D | 1 |
Maglaveras, N | 1 |
Vamvalis, C | 2 |
Bosquée, L | 3 |
Pasini, F | 2 |
Humblet, Y | 3 |
Hamdan, O | 1 |
Cetto, GL | 1 |
Palmer, AJ | 1 |
Brandt, A | 1 |
Scagliotti, G | 1 |
Groen, HJ | 3 |
Gozzelino, F | 2 |
Curran, D | 1 |
Sahmoud, T | 1 |
Vallejo, C | 1 |
Romero, A | 1 |
Perez, J | 1 |
Cuevas, M | 1 |
Lacava, J | 1 |
Sabatini, C | 1 |
Dominguez, M | 1 |
Rodriguez, R | 1 |
Barbieri, M | 1 |
Romero Acuña, L | 1 |
Romero Acuña, J | 1 |
Langhi, M | 1 |
Amato, S | 1 |
Salvadori, M | 1 |
Ortiz, E | 1 |
Machiavelli, M | 1 |
Leone, B | 1 |
Rodenhuis, S | 1 |
Boerrigter, L | 1 |
Top, B | 1 |
Slebos, RJ | 1 |
Mooi, WJ | 2 |
van't Veer, L | 1 |
Paul, K | 2 |
Bacci, G | 2 |
Briccoli, A | 2 |
Donati, D | 1 |
Monti, C | 1 |
Zanoni, A | 1 |
Forni, C | 2 |
Manfrini, M | 1 |
Salomaa, ER | 1 |
Liippo, K | 1 |
Ellmen, J | 1 |
Komi, J | 1 |
Planting, AS | 3 |
de Wit, R | 2 |
van der Burg, ME | 2 |
Stoter, G | 2 |
Verweij, J | 3 |
Hsieh, A | 1 |
Mick, R | 1 |
Guaspari, A | 1 |
Witschi, H | 1 |
Espiritu, I | 1 |
Peake, JL | 1 |
Wu, K | 1 |
Maronpot, RR | 1 |
Pinkerton, KE | 1 |
Fetscher, S | 4 |
Engelhardt, R | 4 |
Hasse, J | 4 |
Wenger, M | 2 |
Lange, W | 4 |
Hastürk, S | 1 |
Kurt, B | 1 |
Kocabas, A | 2 |
Orüç, O | 1 |
Burgut, R | 2 |
Katschinski, DM | 1 |
Wiedemann, GJ | 1 |
Mentzel, M | 1 |
Mulkerin, DL | 1 |
Touhidi, R | 1 |
Robins, HI | 1 |
Wu, MF | 4 |
Chou, CM | 1 |
Yang, KY | 3 |
Brüggemann, SK | 1 |
Kisro, J | 1 |
Eberhard, W | 2 |
Wilke, HJ | 2 |
Chomy, F | 2 |
Chomy, P | 2 |
Khayat, D | 2 |
Mosconi, AM | 2 |
Celik, I | 1 |
Başçil, N | 1 |
Yalçin, S | 1 |
Güllü, IH | 1 |
Kars, A | 1 |
Barişta, I | 1 |
Tekuzman, G | 1 |
Morere, JF | 1 |
Piperno-neumann, S | 1 |
Brunet, A | 1 |
Boaziz, C | 1 |
Kohn, M | 1 |
Bouillet, T | 1 |
Breau, JL | 1 |
Murad, AM | 1 |
Guimaraes, RC | 1 |
Amorim, WC | 1 |
Morici, AC | 1 |
Ferreira-Filho, AF | 1 |
Schwartsmann, G | 1 |
Corgna, E | 1 |
Porrozzi, S | 1 |
Palladino, MA | 1 |
Darwish, S | 1 |
Minotti, V | 1 |
Semik, M | 1 |
Bokemeyer, C | 1 |
Franzke, A | 1 |
Schöber, C | 1 |
Arseniev, L | 1 |
Metzner, B | 1 |
Link, H | 1 |
Schmoll, HJ | 1 |
Masters, G | 1 |
Rizzi, A | 1 |
Alghisi, A | 1 |
Pascarella, A | 1 |
Bozzola, G | 1 |
Mutti, S | 1 |
Herbst, R | 1 |
Leong, T | 1 |
Lynch, C | 1 |
Skarin, AT | 1 |
Chap, LI | 1 |
Mirra, J | 1 |
Ippolito, V | 1 |
Rentschler, R | 1 |
Rosen, P | 1 |
Paris, A | 1 |
Reme-Saumon, M | 3 |
Khial, F | 3 |
Godard, P | 2 |
Yang, SL | 1 |
Ishii, T | 1 |
Tatezaki, S | 1 |
Yonemoto, T | 1 |
Umeda, T | 2 |
Kitoh, M | 1 |
Chou, CW | 1 |
Li, AF | 1 |
Tie, CM | 1 |
Chi, KH | 1 |
Riccardi, F | 1 |
Cariello, S | 1 |
Masutani, M | 1 |
Akusawa, H | 1 |
Kadota, A | 1 |
Ohchi, Y | 1 |
Takahashi, N | 2 |
Tanigawa, S | 1 |
Koya, Y | 1 |
Horie, T | 1 |
Glisson, B | 3 |
Palmer, J | 1 |
Fossella, F | 3 |
Shin, DM | 2 |
Perez-Soler, R | 2 |
Hong, WK | 4 |
Bunnell, CA | 1 |
Thompson, L | 1 |
Buswell, L | 1 |
Berkowitz, R | 1 |
Muto, M | 1 |
Sheets, E | 1 |
Kurie, J | 1 |
Schea, R | 1 |
Vadhan-Raj, S | 1 |
Maurer, K | 1 |
Heitger, A | 1 |
Schwaighofer, H | 1 |
Fink, FM | 1 |
Niederweiser, D | 1 |
Goren, MP | 1 |
Anthony, LB | 1 |
Hande, KR | 1 |
Brade, WP | 2 |
Frazier, MW | 1 |
Bush, DA | 1 |
Li, JT | 1 |
von Pawel, J | 2 |
Woll, P | 1 |
Koschel, G | 3 |
Clancy, L | 1 |
Pfeifer, W | 1 |
Fennelly, J | 1 |
Frisch, J | 1 |
Hirota, T | 1 |
Takeuchi, M | 1 |
Iwata, A | 1 |
Kitagawa, S | 1 |
Sato, T | 1 |
Konno, K | 1 |
Sawada, K | 1 |
Kobayashi, S | 1 |
Hamaguchi, N | 1 |
Agata, H | 1 |
Katano, N | 1 |
Fujimoto, T | 1 |
Gasbarrini, A | 1 |
Fabbri, N | 1 |
Cesari, M | 1 |
Campanacci, M | 1 |
Zacharias, C | 5 |
Vansteenkiste, JF | 2 |
De Leyn, PR | 1 |
Deneffe, GJ | 1 |
Lievens, YN | 1 |
Nackaerts, KL | 1 |
Van Raemdonck, DE | 1 |
van der Schueren, E | 1 |
Lerut, TE | 1 |
Demedts, MG | 1 |
Fahantidou, E | 1 |
Dermitzakis, G | 1 |
Gioulekas, D | 1 |
Salvati, F | 1 |
Antilli, A | 1 |
Barbera, S | 1 |
Romano, F | 1 |
Migliorino, MR | 1 |
Noseda, MA | 1 |
Crippa, M | 1 |
Ferrara, G | 2 |
Raimondi, M | 1 |
Fioretti, M | 1 |
Bandera, M | 1 |
Galeasso, G | 1 |
Cacciani, GC | 1 |
Lepidini, G | 1 |
Sunseri, G | 1 |
Lanfranco, C | 1 |
Wyka, D | 1 |
Golomb, H | 1 |
Pannacciulli, I | 1 |
Castello, G | 1 |
Lerza, R | 1 |
Botta, M | 1 |
Arboscello, E | 1 |
Bogliolo, G | 1 |
Wu, HW | 4 |
Inserra, A | 1 |
Zangari, A | 1 |
Ciprandi, G | 1 |
Boldrini, R | 1 |
Boglino, C | 1 |
Donnellan, P | 1 |
Armstrong, J | 1 |
Rowan, S | 1 |
Fennelly, D | 1 |
Lynch, V | 1 |
McDonnell, T | 1 |
McNicholas, W | 1 |
Crown, J | 1 |
Tjan-Heijnen, VC | 1 |
Biesma, B | 1 |
Festen, J | 3 |
Cox, A | 1 |
Wagener, DJ | 1 |
Tsang, KW | 1 |
Lam, WK | 1 |
Ip, M | 1 |
Kito, M | 1 |
Rey, F | 1 |
Astoul, P | 1 |
Marqueste, L | 1 |
Petite, JM | 1 |
Boutin, C | 1 |
Harris, MB | 1 |
Gieser, P | 1 |
Ayala, A | 1 |
Holbrook, T | 1 |
Shevlin, PM | 2 |
Muers, MF | 3 |
Peake, MD | 4 |
Hosker, HS | 2 |
Stead, ML | 2 |
Poulter, KM | 3 |
Brown, JM | 3 |
Soh, LT | 1 |
Ang, PT | 3 |
Spaas, P | 1 |
Specenier, P | 1 |
Demedts, M | 1 |
Ali, MA | 2 |
Kraut, MJ | 2 |
Herskovic, AM | 1 |
Du, W | 1 |
Kalemkerian, GP | 2 |
Preti, P | 2 |
Poggi, G | 1 |
Cuomo, AM | 2 |
Robustelli della Cuna, FS | 2 |
Zambelli, A | 1 |
Pavesi, L | 1 |
Han, JY | 1 |
Choi, BG | 1 |
Moon, H | 1 |
Lee, KS | 2 |
Lafontaine, T | 1 |
Maeda, Y | 1 |
Oyama, H | 1 |
Shishido, T | 1 |
Kin, T | 1 |
Izutani, T | 1 |
Yonese, J | 1 |
Fukui, I | 1 |
Nakagawa, K | 2 |
Okumura, S | 1 |
Hiratsuka, H | 1 |
Lococo, A | 1 |
Campisi, C | 1 |
Lalli, A | 1 |
Di Lullo, L | 1 |
De Filippis, S | 2 |
Vaccarili, M | 1 |
Zappalà, A | 1 |
Corrao, G | 1 |
Rea, S | 2 |
Pectasides, D | 1 |
Kalofonos, C | 1 |
Klouvas, G | 1 |
Panoussaki, E | 1 |
Tsiakopoulos, E | 1 |
Baumöhl, J | 3 |
Levitan, N | 1 |
Dowlati, A | 1 |
Craffey, M | 1 |
Tahsildar, H | 1 |
MacKay, W | 1 |
McKenney, J | 1 |
Remick, SC | 1 |
Wasserfallen, JB | 1 |
Rollier, P | 1 |
Kandioler-Eckersberger, D | 1 |
Kappel, S | 1 |
Mittlböck, M | 1 |
Dekan, G | 1 |
Ludwig, C | 1 |
Janschek, E | 1 |
Wolner, E | 1 |
Czyzewski, EA | 1 |
Goldman, S | 1 |
Mundt, AJ | 1 |
Nachman, J | 1 |
Rubin, C | 1 |
Hallahan, DE | 1 |
Philip, PA | 1 |
Rea, D | 1 |
Mitchell, K | 1 |
Carmichael, J | 2 |
Talbot, DC | 1 |
Deneffe, G | 1 |
Coosemans, W | 1 |
Lerut, T | 1 |
Igami, Y | 1 |
Yamamoto, R | 1 |
Okubo, Y | 1 |
Mitui, T | 1 |
Kinoshita, M | 1 |
Oizumi, K | 2 |
Wee, J | 2 |
Fong, KW | 2 |
Khoo, KS | 2 |
Fossella, FV | 3 |
Rigas, J | 1 |
Tognoni, A | 2 |
Cadenotti, L | 1 |
Pensa, F | 2 |
Vaira, F | 2 |
Vigani, A | 2 |
Bancalari, L | 2 |
Cordani, S | 1 |
Maggiani, R | 2 |
Canessa, PA | 1 |
Pronzato, P | 3 |
Victoria, L | 1 |
McCulloch, TM | 1 |
Callaghan, EJ | 1 |
Bauman, NM | 1 |
Woodroffe, CM | 3 |
Chetiyawardana, AD | 3 |
Joshi, R | 2 |
Cook, JE | 1 |
Trask, C | 1 |
Bessell, E | 1 |
Connolly, CK | 1 |
Tobias, J | 1 |
Souhami, RL | 4 |
Ricci, S | 1 |
Ceribelli, A | 1 |
Bianco, R | 1 |
Sassi, M | 2 |
Barni, S | 1 |
Ravaioli, A | 1 |
Adamo, V | 1 |
Cruciani, G | 1 |
Masotti, A | 1 |
Peters, R | 1 |
van de Velde, H | 1 |
Weynants, P | 1 |
Canon, JL | 1 |
Rosier, JF | 1 |
Javier Sánchez, J | 1 |
Padilla, J | 1 |
Cantó, A | 1 |
Roig, J | 1 |
Scinto, AF | 1 |
Ferraresi, V | 1 |
Milella, M | 1 |
Tucci, E | 1 |
Santomaggio, C | 1 |
Pasquali-Lasagni, R | 1 |
Del Vecchio, MR | 1 |
Campioni, N | 1 |
Nardi, M | 1 |
Cognetti, F | 1 |
Martin, C | 1 |
Balaña, C | 1 |
Langer, CJ | 1 |
Twu, NF | 1 |
Juang, CM | 1 |
Yeng, MS | 1 |
Lu, CJ | 1 |
Lai, CZ | 1 |
Chao, KC | 1 |
Belani, CP | 1 |
Corsi, DC | 1 |
Pozzo, C | 1 |
Cassano, A | 1 |
Alvaro, G | 1 |
Colloca, G | 1 |
Landriscina, M | 1 |
Astone, A | 1 |
Yoshizawa, H | 1 |
Tanaka, J | 1 |
Kagamu, H | 1 |
Ito, K | 1 |
Shimbo, T | 1 |
Chou, D | 1 |
Wakabayashi, M | 1 |
Suzuki, E | 1 |
Sakai, K | 1 |
Arakawa, M | 1 |
Gejyo, F | 1 |
Vergnenègre, A | 1 |
Thomas, P | 1 |
Robinet, G | 1 |
Pibarot, M | 1 |
Paillotin, D | 1 |
Vernejoux, JM | 1 |
Thiberville, L | 2 |
Lena, H | 1 |
Kleisbauer, JP | 1 |
Gimonet, JF | 1 |
Tan, T | 1 |
Eng, P | 1 |
Hsu, A | 1 |
Tan, YK | 1 |
Chua, EJ | 1 |
Ong, YY | 1 |
Rosselli, M | 1 |
Pompili, P | 1 |
Guerriero, G | 1 |
Campoccia, S | 1 |
Cionini, L | 1 |
Conte, P | 1 |
Perry, MC | 1 |
Ihde, DC | 3 |
Grethein, SJ | 1 |
Atkins, JN | 1 |
Vadell-Nadal, C | 1 |
Nogué-Aliguer, M | 1 |
Fabregat-Mayol, X | 1 |
Saigí-Grau, E | 1 |
Gallén-Castillo, M | 1 |
Ruotsalainen, T | 1 |
Halme, M | 1 |
Isokangas, OP | 1 |
Pyrhönen, S | 1 |
Mäntylä, M | 1 |
Pekonen, M | 1 |
Sarna, S | 1 |
Joensuu, H | 1 |
Mattson, K | 1 |
DeVore, R | 1 |
Kerr, RN | 1 |
Natale, RR | 1 |
Dunphy, F | 1 |
Kalman, L | 1 |
Miller, V | 1 |
Gandara, D | 1 |
Karp, D | 1 |
Vokes, E | 1 |
Kris, M | 1 |
Gamza, F | 1 |
Hammershaimb, L | 1 |
Takigawa, N | 2 |
Segawa, Y | 3 |
Kishino, D | 1 |
Fujiwara, K | 1 |
Ida, M | 1 |
Eguchi, K | 2 |
Takamori, S | 1 |
Hayashi, A | 1 |
Tayama, K | 1 |
Mitsuoka, M | 1 |
Fujimoto, K | 1 |
Horiuchi, M | 1 |
Hayabuchi, N | 1 |
Shirouzu, K | 1 |
Bisagni, G | 1 |
Moretti, G | 1 |
Rondini, E | 1 |
Zadro, A | 1 |
Franciosi, V | 1 |
Pazzola, A | 1 |
Vignoli, R | 1 |
Banzi, MC | 1 |
Pajetta, V | 1 |
Scott, C | 1 |
Movsas, B | 1 |
Wagner, H | 1 |
Tsavaris, NB | 3 |
Sepsas, E | 2 |
Malamos, NA | 2 |
Vadiaka, M | 4 |
Dosios, T | 1 |
Antonopoulos, MJ | 1 |
Ligneau, B | 1 |
Ardiet, C | 1 |
Rebattu, P | 1 |
Boissel, JP | 1 |
Schmerber, J | 1 |
Vanhees, SL | 1 |
Paridaens, R | 1 |
Jaillon-Abraham, C | 1 |
Coscas, Y | 1 |
Andrieu, JM | 1 |
Sayit, E | 1 |
Aktoğu, S | 1 |
Ertay, T | 1 |
Capa, G | 1 |
Erkmen, G | 1 |
Ozbilek, E | 1 |
Büyükşirin, M | 1 |
Durak, H | 1 |
Fukuoka, S | 1 |
Koufos, C | 1 |
Gurney, EM | 1 |
Napp, VV | 1 |
Hepburn, PM | 1 |
Gérinière, L | 1 |
Takita, H | 2 |
Pitoniak, RF | 1 |
Simms, T | 1 |
Davies, R | 1 |
Ahn, JB | 1 |
Ko, WK | 1 |
Lee, JG | 1 |
Shim, KY | 1 |
Jeung, HC | 1 |
Yoo, NC | 1 |
Kim, BS | 1 |
Kim, SK | 2 |
Woo, IS | 1 |
Park, YS | 1 |
Kwon, SH | 1 |
Park, YL | 1 |
Lee, JA | 1 |
Park, MJ | 1 |
Hyun, IG | 1 |
Jung, KS | 1 |
Bae, HS | 1 |
Oh, DH | 1 |
Ahn, YC | 1 |
Poquette, CA | 1 |
Brandao, L | 1 |
Czownicki, Z | 1 |
Pasz, P | 1 |
Michałek, A | 1 |
Zientek, J | 1 |
Zientek, A | 1 |
Koźlik, H | 1 |
Dingemans, AC | 1 |
van Ark-Otte, J | 1 |
Span, S | 1 |
van der Valk, P | 1 |
Fiasella, L | 1 |
Canessa, P | 1 |
Arnau Obrer, A | 2 |
Martín Díaz, E | 2 |
Pérez Alonso, D | 2 |
Regueiro Mira, F | 2 |
Cervera Juan, A | 2 |
Granell Gil, M | 2 |
Roch Pendería, S | 1 |
Cantó Armengod, A | 2 |
Panopoulos, C | 1 |
Stavroyianni, N | 2 |
Kourelis, T | 1 |
Malamos, N | 1 |
Antonopoulos, M | 1 |
Luthra, K | 1 |
Wozniak, AJ | 1 |
Behera, D | 1 |
Aggarwal, AN | 1 |
Sharma, SC | 1 |
Gupta, D | 1 |
Jindal, SK | 1 |
Cañizares Carretero, M | 1 |
Roch Tejerina, S | 1 |
Szopiński, J | 1 |
Ponarska, A | 1 |
Rogińska, E | 1 |
Rogala, E | 1 |
Rowińska-Zakrzewska, E | 1 |
van Putten, JW | 1 |
Kerbush, T | 1 |
van Rijswijk, R | 1 |
Beijnen, JH | 2 |
Sleijfer, DT | 1 |
Kerbusch, T | 1 |
vanPutten, JW | 1 |
Huitema, AD | 1 |
Mathĵt, RA | 1 |
Kobylińska, K | 1 |
Koralewski, P | 1 |
Sobik, B | 1 |
Gasiorek, M | 1 |
Kobylińska, M | 1 |
Rixe, O | 1 |
Le Guen, Y | 1 |
Touboul, E | 1 |
Granata, C | 1 |
Gambini, C | 1 |
Carlini, C | 1 |
Repetto, P | 1 |
Torre, M | 1 |
Mazzola, C | 1 |
Mattioli, G | 1 |
Jasonni, V | 1 |
Baiardi, P | 1 |
Torazzo, R | 1 |
Robustelli della Cuna, G | 1 |
Montalar, J | 1 |
Maestu, I | 1 |
García, R | 1 |
Yuste, AL | 1 |
Torregrosa, D | 1 |
Segura, A | 1 |
Hosomi, Y | 2 |
Shibuya, M | 2 |
Erkisi, M | 1 |
Erkurt, E | 1 |
Zeren, H | 1 |
Tunali, C | 1 |
Neumaier, C | 1 |
Tumolo, S | 1 |
Toffoli, G | 1 |
Saracchini, S | 1 |
Lo Re, G | 1 |
Bruschi, G | 1 |
Boccieri, MG | 1 |
Chevret, S | 1 |
Lemarié, E | 1 |
Gouva, S | 1 |
Bréchot, JM | 1 |
Terrioux, P | 1 |
Clavier, J | 1 |
Foucher, P | 1 |
Monchâtre, M | 1 |
Coëtmeur, D | 1 |
Leclerc, P | 1 |
Blanchon, F | 1 |
Rodier, JM | 1 |
Villeneuve, A | 1 |
Postovsky, S | 1 |
Beck, D | 1 |
Ben-Izhak, O | 1 |
Arush, MW | 1 |
Onyenadum, A | 1 |
Dimitropoulos, D | 1 |
Rokana, S | 1 |
Hanna, NH | 1 |
Sandier, AB | 1 |
Jung, SH | 1 |
Lane, K | 1 |
Chu, DT | 1 |
Zhang, XR | 1 |
Li, JL | 1 |
Qu, FL | 1 |
Ito, T | 1 |
Mochida, A | 1 |
Saito, K | 1 |
Nishi, K | 1 |
Sasaki, S | 1 |
Hisada, T | 1 |
Morinari, H | 1 |
Nakahara, K | 1 |
Tahara, M | 1 |
Masuda, S | 1 |
Yakumaru, K | 1 |
MacRae, R | 1 |
Grimard, L | 1 |
Hsu, E | 1 |
Nizalik, E | 1 |
Halton, JM | 1 |
Ueoka, H | 5 |
Kiura, K | 3 |
Tabata, M | 2 |
Moritaka, T | 3 |
Hiraki, S | 3 |
Harada, M | 1 |
Tanimoto, M | 1 |
Calderoni, A | 1 |
von Briel, C | 1 |
Aebi, S | 1 |
Solenthaler, M | 1 |
Betticher, DC | 1 |
Körner, F | 2 |
Lund, S | 1 |
Jonas, U | 1 |
Zaren, HA | 1 |
Freireich, EJ | 1 |
Copeland, EW | 1 |
Gagliano, R | 1 |
Loukas, D | 1 |
Panettiere, FJ | 2 |
Hokanson, JA | 1 |
Cohen, MH | 2 |
Chretien, PB | 1 |
Fossieck, BE | 2 |
Makuch, R | 2 |
Johnston, AV | 1 |
Shackney, SE | 2 |
Matthews, MJ | 2 |
Lipson, SD | 1 |
Kenady, DE | 1 |
Minna, JD | 2 |
Johnston-Early, A | 1 |
Richman, S | 1 |
Gutterman, JU | 1 |
Constanzi, JJ | 1 |
Greco, C | 2 |
Corsi, A | 2 |
Caputo, M | 1 |
Cavallari, A | 1 |
Calabresi, F | 2 |
Neidhardt, B | 1 |
Lutz, H | 1 |
Schnitker, J | 1 |
Brock, N | 2 |
Fichtner, E | 1 |
Glazman-Kuśnierczyk, H | 1 |
Matuszyk, J | 2 |
Radzikowski, C | 4 |
Nakabayashi, T | 3 |
Miyamoto, H | 3 |
Fujikane, T | 3 |
Shimizu, T | 3 |
Yasuda, S | 2 |
Akita, H | 2 |
Sakai, E | 1 |
Onodera, S | 2 |
Ohsaki, Y | 1 |
Kawakami, Y | 3 |
Rynard, S | 1 |
Songer, J | 1 |
Pennington, K | 1 |
Einhorn, L | 1 |
Zamora, P | 1 |
Garcia de Paredes, ML | 1 |
Chacon, JI | 1 |
Palmen, FM | 1 |
Carney, DN | 2 |
Vendrik, C | 2 |
Roozendaal, K | 2 |
Williams, SD | 1 |
Eberhardt, W | 1 |
Shirinian, M | 2 |
Dhingra, HH | 2 |
Goss, PE | 2 |
Maroun, J | 3 |
Lind, M | 4 |
Berendsen, HH | 1 |
Jassem, E | 1 |
Bonfrer, JM | 1 |
van Tinteren, H | 2 |
Bischoff, H | 1 |
Fischer, JR | 1 |
Löchner, S | 1 |
Peukert, M | 1 |
Schmähl, A | 1 |
García Gómez, R | 1 |
García Arroyo, R | 1 |
Meana García, A | 1 |
Martínez del Prado, P | 1 |
González del Val, R | 1 |
Pérez Manga, G | 1 |
Isobe, H | 1 |
Asakawa, M | 5 |
Suzuki, A | 5 |
Monnet, I | 1 |
Chariot, P | 1 |
Voisin, S | 1 |
Saltiel, JC | 1 |
de Cremoux, H | 1 |
Estrada-Aguilar, J | 1 |
Greenberg, H | 1 |
Walling, A | 1 |
Schroer, K | 1 |
Black, T | 1 |
Morse, S | 1 |
Hvizdala, E | 1 |
Hojo, K | 1 |
Kumasaka, Y | 1 |
Nishiyama, S | 1 |
Higashihara, T | 1 |
Oku, Y | 1 |
Okada, M | 1 |
Kajiyama, K | 1 |
Arai, N | 1 |
Annoh, S | 1 |
Kaneko, H | 1 |
Umeda, M | 1 |
Tsukahara, T | 1 |
Shirai, T | 1 |
Thomas, F | 1 |
Subirana, R | 1 |
Baldeyrou, P | 2 |
Arriagada, R | 3 |
Chazard, M | 1 |
Tursz, T | 1 |
Gurney, H | 2 |
de Campos, ES | 1 |
Dodwell, D | 1 |
Kamthan, A | 2 |
Lind, MJ | 6 |
Gomm, S | 1 |
Simmonds, AP | 1 |
Twelves, CJ | 1 |
Goldman, J | 1 |
Ash, CM | 2 |
Geddes, D | 1 |
Tobias, JS | 3 |
Pritsch, M | 1 |
Schroeder, M | 6 |
Flechtner, H | 2 |
Heim, M | 4 |
Hruska, D | 1 |
Mende, S | 2 |
Avery, L | 1 |
McKay, CP | 1 |
Wyatt, RJ | 1 |
Hancock, ML | 1 |
Hoskin, PJ | 1 |
Parton, D | 1 |
Yarnold, JR | 2 |
Cherryman, G | 1 |
Weiss, RB | 2 |
Heckmayr, M | 2 |
Hossfeld, DK | 3 |
Kaukel, E | 2 |
Neuhauss, R | 2 |
von Rohr, A | 1 |
McIntosh, R | 1 |
Ohnoshi, T | 5 |
Ueda, N | 1 |
Fujii, M | 2 |
Machida, K | 1 |
Kawahara, S | 3 |
Kozuka, A | 1 |
Maasberg, M | 2 |
Mariani, GL | 1 |
Addamo, G | 1 |
Venturini, M | 1 |
Kamei, H | 1 |
Kimura, I | 1 |
Kumar, L | 1 |
Bhargava, VL | 1 |
Sasaki, H | 2 |
Mori, T | 1 |
Nakajima, S | 2 |
Inoue, Y | 3 |
Honda, R | 3 |
Miles, DW | 2 |
Earl, HM | 2 |
Rudd, R | 2 |
James, L | 1 |
Trask, CW | 1 |
Gomm, SA | 1 |
Cuthbert, A | 1 |
Chang, J | 1 |
Burmester, H | 1 |
Hall, P | 1 |
Carroll, KB | 3 |
Fujita, H | 1 |
Kiyokawa, N | 1 |
Takada, K | 1 |
Kyo, K | 1 |
Ishimoto, K | 1 |
Yabuta, K | 1 |
Mizuno, T | 1 |
Fukuoka, M | 1 |
Negoro, S | 1 |
Masuda, N | 1 |
Furuse, K | 1 |
Kawahara, M | 1 |
Kodama, N | 1 |
Ikegami, H | 1 |
Nakamura, S | 1 |
Nishio, H | 1 |
Anderson, NR | 1 |
Tandon, DS | 1 |
Elias, A | 1 |
Ryan, L | 1 |
Aisner, J | 1 |
Antman, KH | 1 |
Baker, WJ | 1 |
Fistel, SJ | 1 |
Jones, RV | 1 |
Dorr, RT | 1 |
ten Bokkel Huinink, WW | 1 |
Wanders, J | 1 |
Simonetti, G | 1 |
Dubbelman, R | 1 |
Franklin, H | 1 |
McVie, JG | 1 |
Currie, DC | 1 |
Drake, JS | 1 |
Glisson, BS | 1 |
Dhingra, HM | 2 |
Umsawasdi, T | 2 |
Levy, JK | 1 |
Jeffries, D | 1 |
Raber, MN | 1 |
Abad-Esteve, A | 2 |
Fernandez, C | 1 |
Ribelles, N | 2 |
Culubret, M | 1 |
Woodcock, A | 1 |
Perren, TJ | 1 |
Ashley, SA | 1 |
Woodiwiss, J | 1 |
Forgeson, GV | 1 |
Matsutomo, S | 1 |
Genba, K | 1 |
Itami, S | 1 |
Horikoshi, N | 1 |
Mukaiyama, T | 1 |
Fukutani, H | 1 |
Hirano, A | 1 |
Mizunuma, N | 1 |
Trillet, V | 1 |
Champel, F | 1 |
Bernard, JP | 1 |
Brune, J | 1 |
Clavel, M | 1 |
Emonot, A | 1 |
Guérin, JC | 1 |
Kalb, JC | 1 |
Paccagnella, A | 1 |
Favaretto, A | 1 |
Brandes, A | 1 |
Fornasiero, A | 1 |
Volpi, A | 1 |
Pappagallo, G | 1 |
Festi, G | 1 |
Cipriani, A | 1 |
Vinante, O | 1 |
Laumen, R | 1 |
Jungbluth, H | 1 |
Häussinger, K | 1 |
Otto, M | 1 |
Krieger, H | 1 |
Falkson, G | 1 |
Chasen, MR | 1 |
Falkson, HC | 1 |
Margison, JM | 3 |
Wilkinson, PM | 3 |
Kamthan, AG | 1 |
Bronchud, MH | 1 |
Ranson, MR | 1 |
Olazabal, A | 1 |
Canela, M | 1 |
Bidoli, P | 2 |
Spinazzè, S | 2 |
Casali, P | 1 |
Bedini, AV | 2 |
Guzzon, A | 1 |
Rossi, JF | 1 |
Dubois, JB | 1 |
Mary, H | 1 |
Shimokata, K | 1 |
Yamamoto, M | 1 |
Saka, H | 1 |
Sakai, S | 1 |
Kawachi, H | 1 |
Eschenbach, C | 1 |
Maroske, D | 1 |
Winkler, K | 1 |
Harms, V | 1 |
Dombrowski, H | 1 |
Victor, N | 2 |
Bronchud, M | 1 |
Scarffe, JH | 1 |
Crowther, D | 1 |
Souza, LM | 1 |
Alton, NK | 1 |
Numata, T | 1 |
Nishii, K | 1 |
Yonei, T | 2 |
Yamashita, H | 2 |
Ishii, J | 2 |
Nourissat, C | 1 |
Patricot, LM | 1 |
Brunat-Mentigny, M | 1 |
Tachon, G | 1 |
Manoukian, A | 1 |
Kuśnierczyk, H | 2 |
Cataldo, I | 1 |
Bonadonna, G | 1 |
Chetiyawardana, SD | 1 |
Joshi, RC | 1 |
Payne, C | 1 |
Campbell, C | 1 |
Moussalli, H | 1 |
Hardman, PD | 1 |
Green, JA | 1 |
Errington, RD | 1 |
Myint, S | 1 |
Warenius, HM | 1 |
Thatcher, D | 1 |
Morgenstern, G | 1 |
Carr, T | 1 |
Chadwick, G | 1 |
Jones, R | 1 |
Craig, P | 1 |
Barber, PV | 1 |
Wolstenholme, RJ | 1 |
Barnes, P | 1 |
Deiraniya, A | 1 |
Dommes, M | 1 |
Fusco, V | 1 |
Gulisano, M | 1 |
Baracco, F | 1 |
Capaccio, A | 1 |
Pastorino, G | 1 |
Nosenzo, M | 1 |
Felletti, R | 1 |
Fabiano, F | 1 |
Tamura, T | 2 |
Tamai, M | 1 |
Egawa, T | 1 |
Bozzino, JM | 2 |
Corris, P | 1 |
Tsujii, H | 1 |
Irie, G | 1 |
Dalesio, O | 1 |
Palmen, FJ | 1 |
Burghouts, J | 1 |
Planting, A | 1 |
Pastran, Z | 1 |
Spielmann, M | 1 |
Rouesse, J | 1 |
Stalleicken, D | 1 |
Klasen, H | 1 |
Bülzebruck, H | 2 |
Djawid, N | 1 |
Ruchalla, E | 1 |
Tessen, HW | 1 |
Paschke, R | 1 |
Worst, P | 1 |
Brust, J | 1 |
Lange, OF | 1 |
Banks, J | 1 |
Anderson, EG | 1 |
Hoff, AM | 1 |
Naitoh, T | 1 |
Suyama, T | 1 |
Kameyama, M | 1 |
Ohtsuka, M | 1 |
Yoshizawa, Y | 1 |
Radenbach, D | 1 |
Zschaber, R | 1 |
Birch, R | 1 |
Kramer, BS | 1 |
Greco, FA | 1 |
Fergusson, RJ | 1 |
Wolf, CR | 1 |
Balkwill, FR | 1 |
Smyth, JF | 1 |
Höfeler, H | 1 |
Höffken, K | 1 |
Schoetensack, B | 1 |
Wandl, U | 1 |
Kath, R | 1 |
Müller, M | 1 |
Tsukagoshi, S | 1 |
Frankmann, C | 1 |
McMurtrey, MJ | 1 |
Jeffries, DG | 1 |
Welch, SR | 1 |
Smith, DB | 2 |
Webb, K | 1 |
Hilton, A | 1 |
Rahman, A | 1 |
Klapsing, J | 1 |
Viktor, N | 1 |
Girón, CG | 1 |
Jalón, JI | 1 |
Barón, MG | 1 |
Pooley, J | 1 |
Meanwell, CA | 2 |
Mould, JJ | 1 |
Blackledge, G | 2 |
Lawton, FG | 1 |
Stuart, NS | 1 |
Kavanagh, J | 1 |
Latief, TN | 1 |
Sakurai, M | 1 |
Saijo, N | 1 |
Shinkai, T | 1 |
Sano, T | 1 |
Suemasu, K | 1 |
Jett, JR | 1 |
Blake, AE | 1 |
Kelly, KA | 1 |
Honigsberger, L | 1 |
Li, GC | 1 |
Li, JQ | 1 |
He, YJ | 1 |
Zalupski, M | 1 |
Baker, LH | 1 |
Barclay, J | 1 |
Chopra, MP | 1 |
Fitzgerald, MD | 1 |
Zamboglou, N | 1 |
Fürst, G | 1 |
Pape, H | 1 |
Bannach, B | 1 |
Molls, M | 1 |
Schmitt, G | 1 |
Spitzer, G | 1 |
Farha, P | 1 |
Dicke, K | 1 |
Zander, A | 1 |
Vellekoop, L | 1 |
Chiuten, D | 1 |
Paprocka, M | 2 |
Budzyński, W | 1 |
Rak, J | 1 |
Kinas, R | 1 |
Misiura, K | 1 |
Stec, W | 1 |
Herdrich, K | 1 |
Hoefer, H | 1 |
Scheef, W | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
PEI REGIMEN: A THERAPEUTIC OPTION IN SMALL CELL LUNG CANCER? A MONOINSTITUTIONAL EXPERIENCE OF 46 CONSECUTIVE CASES[NCT02324296] | 46 participants (Actual) | Observational | 1998-12-31 | Completed | |||
Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment[NCT00824083] | 950 participants (Actual) | Observational | 2009-07-31 | Completed | |||
Chemotherapy-induced Necrosis in Ewing Sarcoma: Which is the Best Scoring Tool[NCT03968471] | 474 participants (Actual) | Observational | 2019-05-13 | Completed | |||
EUROPEAN INTERGROUP COOPERATIVE EWING'S SARCOMA STUDY [EICESS 92][NCT00002516] | Phase 3 | 0 participants | Interventional | 1992-07-31 | Active, not recruiting | ||
A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes Derived From Patients With Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen[NCT02133196] | Phase 2 | 85 participants (Anticipated) | Interventional | 2014-10-23 | Recruiting | ||
Phase III Trial Comparing 2 Chemotherapy Schedules (Preoperative vs Pre and Postoperative) in Stage I and II NSCLC[NCT00198354] | Phase 3 | 530 participants (Actual) | Interventional | 2001-05-31 | Completed | ||
Observational Study on Treatment of Skeletal Ewing Sarcoma at Diagnosis[NCT04845893] | 100 participants (Anticipated) | Observational | 2021-06-01 | Recruiting | |||
A Phase Ⅱ Single-arm Clinical Trial to Investigate the Efficacy and Safety of Vinorelbine-ifosfamide Regimen as Third-line Treatment in Refractory or Recurrent Extensive Small Cell Lung Cancer Patients[NCT01752517] | 60 participants (Anticipated) | Observational | 2012-12-31 | Recruiting | |||
A Phase 1, Open-Label, Dose Escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Combined Oral C-Met/ALK Inhibitor (PF-02341066) and Pan-Her Inhibitor (PF-0299804) in Patients With Advanced Non-Small Cell Lung Cancer[NCT01441128] | Phase 1 | 20 participants (Actual) | Interventional | 2011-09-01 | Terminated | ||
Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Non Small Cell Lung Cancer[NCT00005055] | Phase 2 | 39 participants (Actual) | Interventional | 2000-01-31 | Completed | ||
RANDOMISED CLINICAL TRIAL OF IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITH MID-CYCLE VINCRISTINE (VICE) VERSUS STANDARD PRACTICE CHEMOTHERAPY IN PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER (SCLC) AND GOOD PERFORMANCE STATUS[NCT00002822] | Phase 3 | 400 participants (Anticipated) | Interventional | 1996-03-31 | Completed | ||
A Phase I Trial and Pharmacokinetic Study of the Oral Platinum Analog Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors[NCT01259479] | Phase 1 | 9 participants (Actual) | Interventional | 2010-12-03 | Completed | ||
MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Osteosarcoma After Resection Of Pulmonary Metastases[NCT05726383] | Phase 2 | 32 participants (Anticipated) | Interventional | 2023-12-15 | Not yet recruiting | ||
Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma[NCT04890067] | 120 participants (Anticipated) | Observational | 2021-07-30 | Recruiting | |||
Phase II Multicenter Study Evaluating the Efficacy of Carboplatin-Etoposide Combination in Hormone-resistant Prostate Cancers With Neuroendocrine Differentiation.[NCT00973882] | Phase 2 | 60 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
A Phase Ⅱ Randomized Clinical Trial Comparing Vinorelbine-ifosfamide With Gefitinib as Third-line Treatment in Advanced EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients[NCT01749072] | Phase 2 | 120 participants (Anticipated) | Interventional | 2012-12-31 | Recruiting | ||
Efficacy and Tolerance Adjuvant High-Dose Thiotepa With Peripheral Stem Cell Rescue Associated With Conventional Chemotherapy in Children and Adults With Relapsed Osteosarcoma[NCT00978471] | Phase 2 | 44 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)[NCT02734069] | 132 participants (Anticipated) | Observational | 2016-02-29 | Recruiting | |||
(PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older[NCT01453088] | Phase 2 | 63 participants (Actual) | Interventional | 2010-06-24 | Terminated (stopped due to Lack of Accrual) | ||
Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma[NCT01241708] | Phase 3 | 146 participants (Actual) | Interventional | 2010-04-08 | Completed | ||
A Phase II Trial of Pemetrexed (Alimta [Registered Trademark]) Combined With Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects With Relapsed or Refractory NSCLC[NCT00923273] | Phase 1/Phase 2 | 42 participants (Actual) | Interventional | 2008-02-29 | Terminated (stopped due to Premature closure - investigator left the National Institutes of Health.) | ||
A Study on the Efficacy and Safety of Anlotinib Combined With Docetaxel in the Treatment of Wild-type Advanced Non-squamous Non Small Cell Lung Cancer Patients With Progress After Immunotherapy Plus Chemotherapy as First-line Treatment[NCT04619537] | Phase 2 | 42 participants (Anticipated) | Interventional | 2020-10-08 | Recruiting | ||
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies[NCT00703625] | Phase 1 | 26 participants (Actual) | Interventional | 2008-03-08 | Completed | ||
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodg[NCT00479167] | Phase 2 | 1 participants (Actual) | Interventional | 2007-05-31 | Terminated (stopped due to Lack of accrual and interest in study) | ||
A Phase Ⅱ Randomized Controlled Trial to Compare Gefitinib With Docetaxel as Second-line Therapy for Advanced or Metastatic Non-squamous NSCLC Patients With Wild-type EGFR[NCT01755923] | Phase 2 | 60 participants (Anticipated) | Interventional | 2012-12-31 | Recruiting | ||
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.[NCT02259621] | Phase 2 | 45 participants (Anticipated) | Interventional | 2014-09-30 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT01453088)
Timeframe: 1 year
Intervention | Participants (Count of Participants) |
---|---|
Auto Transplant High Dose Melphalan | 27 |
Auto Transplant High Dose Melphalan+Bortezomib | 27 |
Progression free survival of elderly patients with multiple myeloma treated with either high-dose melphalan versus high-dose melphalan and bortezomib at 3 years (NCT01453088)
Timeframe: Participants will be followed post transplant for a minimum of 3 years, and after that may be monitored as part of the study indefinitely
Intervention | Participants (Count of Participants) |
---|---|
Auto Transplant High Dose Melphalan | 13 |
Auto Transplant High Dose Melphalan+Bortezomib | 11 |
The phase I component of the study are to determine the safety and tolerability of pemetrexed in human subjects with non small cell lung cancer (NSCLC), and to determine the maximum tolerated dose. (NCT00923273)
Timeframe: 5 weeks
Intervention | mg/m^2 (Number) |
---|---|
Treatment Level 1: 3mg Load | 500 |
Treatment Level 2: 6mg Load | 500 |
Treatment Level 3: 6mg Load | 500 |
Treatment Level 4: 10mg Load | 500 |
Treatment Level 5: 15mg Load | 500 |
The phase I component of the study are to determine the safety and tolerability of sirolimus in human subjects with non small cell lung cancer (NSCLC), and to determine the maximum tolerated dose. (NCT00923273)
Timeframe: 5 weeks
Intervention | mg/m^2 (Number) |
---|---|
Treatment Level 1: 3mg Load | 10 |
Treatment Level 2: 6mg Load | 10 |
Treatment Level 3: 6mg Load | 10 |
Treatment Level 4: 10mg Load | 10 |
Treatment Level 5: 15mg Load | 10 |
Here is the count of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria for Adverse Events (CTCAE v3.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life-threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT00923273)
Timeframe: Date treatment consent signed to date off study, approximately 45 months
Intervention | Participants (Count of Participants) | |
---|---|---|
Subjects from phase I | 8subjects prior peme & 12 subjects peme naive | |
Treatment Level 1: 3mg Load | 4 | 0 |
Treatment Level 2: 6mg Load | 3 | 0 |
Treatment Level 3: 6mg Load | 3 | 0 |
Treatment Level 4: 10 mg Load | 7 | 20 |
Treatment Level 5: 15mg Load | 5 | 0 |
Clinical response is assessed by the Response Evaluation Criteria in Solid Tumors (RECIST). Complete response (CR) is disappearance of all target lesions. Partial response (PR) at least a 30% decrease in the sum of the longest diameter (LD) of target lesions, taking as reference the baseline sum LD. Stable disease (SD) is neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD, taking as reference the smallest sum LD since the treatment started. Progressive disease (PD) is at least a 20% increase in the sum of the LD of target lesions, taking as reference the smallest sum LD recorded since the treatment started or the appearance of one or more new lesions. (NCT00923273)
Timeframe: 21 weeks
Intervention | Participants (Count of Participants) | ||||
---|---|---|---|---|---|
Complete response | Partial response | Stable disease | Progressive disease | Not evaluable | |
Treatment Level 4: 10mg Load | 0 | 5 | 13 | 2 | 7 |
92 reviews available for ifosfamide and Cancer of Lung
Article | Year |
---|---|
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Ce | 2023 |
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; | 2019 |
Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Resistance, Neoplasm; Female; Huma | 2021 |
Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; C | 2014 |
Long-term survival in metastasized leiomyosarcoma: a case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Disease-Fre | 2015 |
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality | 2017 |
Multidisciplinary management of metastatic sarcoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 2008 |
Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 2009 |
Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biomar | 2009 |
Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature.
Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Celecoxib; Ch | 2009 |
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 2009 |
Leiomyosarcoma of the tongue with multiple metastases: a case report and review of literature.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy | 2012 |
Isolated subcutaneous metastasis of osteosarcoma 5 years after initial diagnosis.
Topics: Abdominal Wall; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2011 |
Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Fatal O | 2012 |
A chemosensitive pediatric extraosseous osteosarcoma: case report and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Female; Human | 2003 |
Chemotherapy versus best supportive care for extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Lomustine | 2003 |
Ifosfamide in small cell lung cancer.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Small Cell; Humans; Ifosfamide; Lung Neoplasms; Surviv | 2003 |
Ifosfamide in non-small cell lung cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 2003 |
[Pulmonary rhabdomyosarcoma generated during treatment of testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Combined Mod | 2003 |
Palliative treatment for advanced or metastatic osteosarcoma.
Topics: Amputation, Surgical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic A | 2004 |
Chemotherapy of small cell lung cancer: state of the art.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Smal | 2004 |
Osteosarcoma occurring in osteogenesis imperfecta.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality | 2004 |
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; | 2004 |
In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carcinoma, Small Cel | 2005 |
Bilateral metastatic renal synovial sarcoma.
Topics: Amputation, Surgical; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Female; Forearm; | 2005 |
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Mo | 2005 |
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma, Non- | 2006 |
Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Da | 2006 |
Giant cell tumor of the uterus: case report and response to chemotherapy.
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal | 2007 |
[Clinical features of patients with metastasis in phalanges as first symptom of primary lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcino | 2007 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Anti | 1984 |
Ifosfamide in experimental tumor systems.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Ifosfamide; Lethal Dose | 1982 |
Ifosfamide: European perspective.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administrat | 1982 |
The anticancer spectrum of ifosfamide.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Mal | 1982 |
Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Chemoth | 1995 |
Response of metastasized sex cord gonadal stromal tumor of the testis to cisplatin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifos | 1994 |
The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinica | 1995 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
Oral therapy for small cell lung cancer.
Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 1995 |
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
The role of ifosfamide in germ cell tumors and small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Ger | 1995 |
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials | 1995 |
Translocation t(11;19) (q23;p13) in a child with myelomonocytic leukemia following 2 years after chemotherapy for pneumoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Chrom | 1993 |
[A case of small cell lung cancer associated with fulminant hepatitis B].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; E | 1994 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clini | 1995 |
[Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Fem | 1994 |
Intensive combined-modality therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Ad | 1994 |
Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
Topics: Amputation, Surgical; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Th | 1993 |
Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 1994 |
Ifosfamide-induced hyperpigmentation.
Topics: Child, Preschool; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Mesna; Pigm | 1993 |
Ifosfamide in the treatment of small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 1996 |
Ifosfamide in non-small cell lung cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 1996 |
The role of ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Lung Neop | 1996 |
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 1996 |
Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinica | 1998 |
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as T | 1998 |
Ifosfamide and docetaxel in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Pha | 1998 |
Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as | 1998 |
Combination studies with gemcitabine in the treatment of non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1998 |
Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Docetaxel (Taxotere) in non-small cell lung cancer: ongoing studies in Heidelberg and future plans.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as T | 1999 |
Malignant triton tumor of the head and neck: A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Cisplatin; Combined Modality | 1999 |
Ifosfamide in non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycy | 1999 |
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 1999 |
New options in the treatment of non-small cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 1999 |
Chemotherapy in metastatic non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell | 2000 |
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Humans; Hyponatrem | 2000 |
Second-line chemotherapy for non-small-cell lung cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung | 2000 |
[Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineopl | 2000 |
Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non--small cell lung cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung | 2001 |
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 2001 |
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Ca | 2001 |
Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; | 2001 |
The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 2002 |
Brain metastases in Wilms' tumor: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Ther | 2002 |
Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy | 2002 |
[ Early anti-cancer drugs].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 2002 |
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 1992 |
Clinical trials with ifosfamide: the Indiana University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Indiana; | 1992 |
Ifosfamide in non-small cell lung cancer: a review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Th | 1992 |
Overview of ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Protocols; Humans; I | 1992 |
Novel approaches with ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Protocols; Humans; I | 1992 |
Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Humans; Ifosfamide; Lung N | 1990 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
Overview of ifosfamide in small cell and non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1990 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modal | 1990 |
Ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; | 1989 |
Ifosfamide in the treatment of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Th | 1989 |
Ifosfamide.
Topics: Breast Neoplasms; Drug Evaluation, Preclinical; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphoma | 1988 |
Ifosfamide--pharmacology, safety and therapeutic potential.
Topics: Animals; Biotransformation; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evalu | 1985 |
325 trials available for ifosfamide and Cancer of Lung
Article | Year |
---|---|
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Female; Follow-U | 2017 |
Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; | 2017 |
A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting.
Topics: Aged; Amylases; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; E | 2018 |
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; | 2013 |
Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2013 |
An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2013 |
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
Topics: Administration, Inhalation; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2016 |
Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; | 2015 |
[Combined Chemotherapy with Vinorelbine and Ifosfamide as Third-line Treatment and Beyond of Advanced Non-small Cell Lung Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease | 2015 |
Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Humans; Ifosfamide; Lung Neoplasms; Mice; Nitroimidazoles; | 2016 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
[Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chem | 2010 |
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2012 |
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2012 |
Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 2012 |
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Belg | 2002 |
Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cos | 2002 |
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo | 2002 |
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinom | 2002 |
[Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2002 |
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2002 |
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel | 2002 |
Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small | 2002 |
Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2003 |
Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospe
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; | 2003 |
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy | 2003 |
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Femal | 2003 |
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2003 |
Phase II study of irinotecan and ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 2003 |
Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug | 2003 |
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; C | 2003 |
Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 2003 |
Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2003 |
Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2003 |
Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2003 |
Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2004 |
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 2004 |
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Child; Child, Presch | 2004 |
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2004 |
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antine | 2005 |
Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bo | 2005 |
Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carc | 2005 |
Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dos | 2005 |
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2005 |
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carbo | 2005 |
Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 2005 |
Chemotherapy for metastatic NSCLC: current status and future direction.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2005 |
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small- | 2005 |
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, No | 2005 |
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter ran
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2005 |
Metastatic osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chil | 2006 |
Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Non-Sm | 2005 |
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.
Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Br | 2006 |
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2006 |
Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2006 |
Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Carcinoma, Non-Small-Cell Lung | 2006 |
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2006 |
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2007 |
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2006 |
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 2007 |
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2007 |
Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy | 2008 |
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; | 2007 |
Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cogni | 2008 |
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2008 |
Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 2008 |
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 2008 |
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Ca | 2008 |
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
Topics: Acrolein; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Hematuria; Hu | 1980 |
[Chemotherapy of nonseminomatous testicular tumors. The results of a pilot study with reduced cis-platin dosage].
Topics: Bleomycin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; | 1983 |
Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and Corynebacterium parvum.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Vaccines; Brain; Carcinoma, Small Cell; Clinical Trial | 1981 |
[Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study].
Topics: Adult; Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combin | 1982 |
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marr | 1981 |
Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cl | 1982 |
Use and safety of high-dose ifosfamide.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyc | 1982 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
Randomised trial comparing sequential methotrexate (or 5-FU), vinblastine and ifosfamide to vincristine, adriamycin and ifosfamide in advanced lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Do | 1983 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Anti | 1984 |
Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combina | 1983 |
Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Ifosfa | 1984 |
Ifosfamide: European perspective.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administrat | 1982 |
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bon | 1981 |
New drug found active against lung cancers.
Topics: Clinical Trials as Topic; Cyclophosphamide; Humans; Ifosfamide; Lung Neoplasms | 1982 |
[Chemotherapy in advanced sarcomas (author's transl)].
Topics: Cisplatin; Doxorubicin; Drug Therapy, Combination; Humans; Ifosfamide; Lung Neoplasms; Sarcoma; Vinc | 1981 |
Protective effect of N-acetylcysteine on the urotoxicity produced by oxazaphosphorine without interference with anticancer activity.
Topics: Acetylcysteine; Antineoplastic Agents; Cyclophosphamide; Hematuria; Humans; Ifosfamide; Lung Neoplas | 1982 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Small Cel | 1993 |
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Ble | 1994 |
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion, Autologous; Carboplatin; C | 1995 |
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1995 |
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1995 |
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 1995 |
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Ad | 1995 |
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-C | 1995 |
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, No | 1995 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto | 1995 |
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined | 1995 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; | 1995 |
Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; | 1995 |
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 1995 |
Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small C | 1995 |
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinom | 1995 |
Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1995 |
Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Adolescent; Adult; Aged; Antineoplastic C | 1995 |
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto | 1995 |
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Resp | 1995 |
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronc | 1995 |
Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma.
Topics: Aged; Carcinoma, Small Cell; Female; Half-Life; Humans; Ifosfamide; Infusions, Intravenous; Lung Neo | 1995 |
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Topics: Administration, Oral; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcino | 1995 |
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms | 1995 |
Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1995 |
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Epi | 1995 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clini | 1995 |
Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1995 |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female | 1994 |
Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 1994 |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1994 |
Phase I study of high-dose cisplatin, ifosfamide, and etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru | 1994 |
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1993 |
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1994 |
Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
Topics: Amputation, Surgical; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Th | 1993 |
Synovial sarcoma. Uniform response of metastases to high dose ifosfamide.
Topics: Adolescent; Adult; Female; Humans; Ifosfamide; Infusions, Parenteral; Lung Neoplasms; Male; Mesna; N | 1994 |
A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1994 |
Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1994 |
Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1994 |
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1994 |
A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 1994 |
Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1994 |
Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dr | 1994 |
MICE: a new active combination for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1993 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Wor
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cause of Death; | 1993 |
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyc | 1993 |
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell | 1993 |
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 1993 |
A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1993 |
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1993 |
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-C | 1993 |
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 1996 |
Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti | 1996 |
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dose-Response | 1996 |
Treatment of stage III-IV non-small-cell lung carcinoma with vinorelbine in combination with ifosfamide plus MESNA: a study by the Southern Italy Oncology Group (GOIM).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Humans; Ifosfa | 1996 |
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 1996 |
[Evaluation of chemotherapy for stage IV non-small cell lung cancer employing a regression tree type method for quality-adjusted survival analysis to determine prognostic factors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1996 |
Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 1996 |
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Sur | 1996 |
Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; | 1996 |
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; | 1995 |
Intensified VICE regimen may improve SCLC survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Sur | 1996 |
Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; | 1996 |
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Th | 1996 |
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Che | 1996 |
The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, D | 1996 |
r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru | 1996 |
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Admi | 1996 |
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 1996 |
[Phase I study of cisplatin, ifosfamide and CPT11 with granulocyte colony-stimulating factor support in advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 1996 |
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytog | 1996 |
Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 1996 |
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1996 |
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined | 1996 |
Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytog | 1996 |
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carbopl | 1996 |
Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 1996 |
Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 1996 |
Ifosfamide combined with toremifene in the treatment of non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administr | 1996 |
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1996 |
Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carci | 1997 |
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Carcinoma, Bronchoge | 1997 |
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Ad | 1997 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carc | 1997 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; C | 1997 |
Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1997 |
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Car | 1997 |
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Drug Admin | 1997 |
A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Comb | 1997 |
Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No | 1997 |
Vinorelbine and ifosfamide for unresectable non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administr | 1997 |
Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; F | 1997 |
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1997 |
[Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 1997 |
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Granu | 1997 |
Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Ad | 1997 |
Paclitaxel, ifosfamide, and carboplatin for the treatment of stages IIIB and IV non-small cell lung cancer: preliminary results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1997 |
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1997 |
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1997 |
A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 1996 |
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineo | 1998 |
A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Fe | 1998 |
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cohor | 1998 |
Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Cross-Over Studies; Humans; If | 1998 |
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dou | 1998 |
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chem | 1998 |
Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Granulo | 1998 |
Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Femal | 1998 |
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1998 |
Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1998 |
Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; | 1998 |
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1998 |
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic | 1998 |
Cisplatin inhibits erythroid committed progenitor (BFU-E) mobilization in peripheral blood.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot | 1998 |
Ifosfamide-based chemotherapy for previously treated lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 1998 |
New chemotherapy combinations with docetaxel in the treatment of patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1998 |
Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1998 |
Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Mo | 1998 |
Modified ice study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combi | 1998 |
Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru | 1998 |
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophospha | 1998 |
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1998 |
Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1998 |
Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1999 |
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cra | 1999 |
A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Ca | 1998 |
Phase I study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 1999 |
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Workin
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 1999 |
A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemot | 1999 |
Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combine | 1999 |
[Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 1999 |
Phase I study of a combination of irinotecan and ifosfamide in advanced primary lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Humans; Ifosfamid | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Ifosfamide; Lung Neoplasms | 1999 |
A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Modifying the ICE regimen for better prognosis small cell lung cancer--an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; | 1999 |
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1999 |
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose- | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined M | 1999 |
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1999 |
Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 2000 |
A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 2000 |
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1999 |
[High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe français de pneumo-cancérologie (GFPC)].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Female; Humans; Ifos | 1999 |
Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy | 1999 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epi | 2000 |
Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic | 2000 |
A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopla | 2000 |
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free | 2000 |
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dos | 2000 |
A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoth | 2000 |
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro | 2000 |
Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Ci | 2000 |
Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung | 2000 |
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-S | 2000 |
Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma--results of three consecutive phase II programs.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide | 2000 |
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung; | 2000 |
Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell | 2001 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 2001 |
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Carboplatin; Carcinoma | 2001 |
Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
A phase II study of VP-16-fosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combi | 2000 |
[Use of etoposide, ifosfamide and cisplatin (EIP) for treatment of inoperable non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto | 2000 |
Radiation induced chemotherapy sensitization in trimodality therapy of stage III non small cell lung cancer. A preliminary report.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2000 |
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2001 |
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclo | 2001 |
Combination chemotherapy for extensive small cell lung cancer -- experience from India.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administrat | 2001 |
[The effect of small cell lung cancer extension on secretion of interleukin-2 (IL-2) and interferon gamma (IFM gamma) in whole blood culture stimulated with mitogens].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epiru | 2001 |
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carb | 2001 |
Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Blood Cell Count; B | 2001 |
Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 2001 |
Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2001 |
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Proto | 2001 |
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy | 2001 |
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2002 |
The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fem | 2001 |
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2002 |
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 2002 |
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Squ | 2002 |
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi | 2002 |
Protection against chemotherapy toxicity by IV hyperalimentation.
Topics: Bacterial Vaccines; Carcinoma, Squamous Cell; Doxorubicin; Evaluation Studies as Topic; Humans; Ifos | 1978 |
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1979 |
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin | 1979 |
Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Bacterial Vaccines; Body Weight; Carcinoma, Squamous Cell; Clinical Tri | 1978 |
Advances in cancer management--an essay on the application of basic science principles.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Clinical Trials as Topic; Cytological Tec | 1979 |
Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Child; Clinical Trials as Topic; Cyclopho | 1976 |
[Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru | 1992 |
Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; | 1992 |
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyc | 1992 |
Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Car | 1992 |
A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1992 |
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1992 |
Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1992 |
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1992 |
Carboplatin in small cell lung cancer: the Royal Marsden Hospital experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1992 |
[Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; F | 1991 |
Sequential chemotherapy in good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Thera | 1991 |
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide | 1991 |
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1991 |
Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell | 1991 |
A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1991 |
[Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
Topics: Adenocarcinoma; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No | 1990 |
High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Non-S | 1991 |
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders.
Topics: Adult; Aged; Double-Blind Method; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna | 1991 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1990 |
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide | 1990 |
Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Clinical Trials as | 1987 |
Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophospha | 1989 |
Treatment of small cell lung cancer with induction chemotherapy followed by late intensification.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyc | 1989 |
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clini | 1987 |
Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; | 1988 |
[Results of 2 multicenter therapy studies in inoperable non-small cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 1988 |
Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Topics: Acetylcysteine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1986 |
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; | 1987 |
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifos | 1986 |
Two randomized trials for alternating polychemotherapy of small cell lung cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clini | 1986 |
"Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carc | 1987 |
The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
Topics: Adult; Aged; Clinical Trials as Topic; Cystitis; Female; Hemorrhage; Humans; Ifosfamide; Lung Neopla | 1986 |
High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, | 1986 |
Ifosfamide--pharmacology, safety and therapeutic potential.
Topics: Animals; Biotransformation; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evalu | 1985 |
[Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
Topics: Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Humans; If | 1974 |
[Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
Topics: Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Female; Humans | 1974 |
330 other studies available for ifosfamide and Cancer of Lung
Article | Year |
---|---|
Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features.
Topics: Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Retrospective Studies; Sarcoma; Soft Tissue Neoplasm | 2022 |
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Lung Neoplasms; Mesna; Progressi | 2023 |
[Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxy | 2023 |
Complete remission of a case of high-grade myxofibrosarcoma with lung metastases after modified MAID regimen chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Fibrosarcoma; Human | 2020 |
[Lung Metastasis from High-grade Uterine Endometrial Stromal Sarcoma;Report of a Case].
Topics: Aged; Endometrial Neoplasms; Female; Heparin; Humans; Ifosfamide; Lung Neoplasms; Sarcoma, Endometri | 2020 |
Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma; Etoposide; Hu | 2020 |
Multimodality treatment including whole pleura radiation therapy for DICER1-associated pediatric pleuropulmonary blastoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Mo | 2021 |
Neurofibromatosis type 1 and disseminated malignant peripheral nerve sheath tumor.
Topics: Antineoplastic Agents; Cafe-au-Lait Spots; Disease Management; Doxorubicin; Humans; Ifosfamide; Lung | 2017 |
Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Endostatins; Etoposide; Human | 2017 |
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Doxoru | 2018 |
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.
Topics: Adult; Aged; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Midd | 2018 |
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etopo | 2018 |
The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Endostatins; Epirubicin; Hear | 2019 |
Complete remission of giant malignant phyllodes tumor with lung metastasis: A case report.
Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Doxorubicin; Female; Humans; Ifosfamide; Lung Neopl | 2019 |
MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report.
Topics: Adult; Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; | 2019 |
[A case of Ifosfamide-induced dysuria which could be avoided by changing the regimen of mesna].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysuria; Female; Humans; Ifosfamid | 2013 |
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neopla | 2013 |
Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Humans; Ifosfamide; Lung Neoplasms | 2013 |
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin | 2015 |
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carb | 2013 |
Targeted imaging of α(v)β(3) expressing sarcoma tumor cells in vivo in pre-operative setting using near infrared: a potential tool to reduce incomplete surgical resection.
Topics: Animals; Diagnostic Imaging; Humans; Ifosfamide; Integrin alphaVbeta3; Lung Neoplasms; Preoperative | 2014 |
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases.
Topics: Adult; Antineoplastic Agents; Axilla; Combined Modality Therapy; Dioxoles; Epirubicin; Fatal Outcome | 2014 |
Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2014 |
Topics: Adolescent; Adult; Animals; Antineoplastic Agents; Arachidonic Acids; Asbestos; Asbestosis; Attitude | 2014 |
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; | 2014 |
Extraskeletal myxoid chondrosarcoma of the thigh in a child: a case report.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chondrosar | 2014 |
Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; China; Dox | 2015 |
Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Fem | 2015 |
A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma.
Topics: Adolescent; Adult; Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chem | 2015 |
Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; C | 2015 |
Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 2015 |
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neopla | 2016 |
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; H | 2015 |
Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin | 2016 |
Primary proximal epithelioid sarcoma of the lung successfully treated with pneumonectomy and adjuvant chemotherapy.
Topics: Adult; Chemotherapy, Adjuvant; Doxorubicin; Hemoptysis; HIV Infections; Humans; Ifosfamide; Lung Neo | 2016 |
A Child with Rapid-onset Respiratory Distress after Chemotherapy, Lung Irriadiation, General Anaesthesia, and Blood Transfusion.
Topics: Abdominal Neoplasms; Acute Lung Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chil | 2015 |
A Pediatric Case of Metastatic Conventional Parosteal Osteosarcoma Treated With Multidrug Chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cispla | 2016 |
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2016 |
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothera | 2017 |
Pleomorphic malignant fibrous histiocytoma: response of bone, lung, and brain metastases to chemotherapy.
Topics: Acetabulum; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Brain; B | 2008 |
Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti | 2009 |
Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot | 2009 |
Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Choriocarcinoma | 2009 |
Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2009 |
Desmoplastic small round cell tumor in children: a new therapeutic approach.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Ca | 2009 |
Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etopo | 2010 |
Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Membe | 2010 |
[Lung metastases of epithelioid sarcoma revealed by bilateral spontaneous pneumothorax: a pathological diagnosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Doxorubicin; Drainage; Fatal Outc | 2010 |
[A rare tumour with a distinctive histological appearance].
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemo | 2010 |
Successful treatment of metastatic malignant fibrous histiocytoma of the kidney.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Dacarbazine; Doxorub | 2010 |
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral | 2010 |
Pulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Drug Administration Sch | 2011 |
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dacarbazine; Doxorub | 2011 |
[A case of recurrent high-grade endometrial stromal sarcoma controlled by a combination of Ifosfamide, adriamycin, and cisplatin].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endomet | 2010 |
Mestastatic gastric cancer from malignant fibrous histiocytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dio | 2011 |
A case of uterine cervical carcinosarcoma recurrence who obtained a clinically complete response by ifosfamide, doxorubicin and cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Doxorubicin; Female; Huma | 2011 |
[Nephropathy following administration of angiogenesis inhibitors].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2011 |
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modali | 2011 |
[Successful treatment of a case of advanced adult Wilms' tumor with pre-surgical chemotherapy, irradiation and radical nephrectomy].
Topics: Adult; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplasti | 2011 |
Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2011 |
Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Female; Humans; Ifosfamide; Lung Neopla | 2011 |
Dyspnoea and a lung mass in a young female 2 weeks after Caesarean delivery.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms | 2011 |
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Female; Humans; I | 2012 |
[A rare tumor of the chest wall: the synovial sarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chest Pain; Comb | 2011 |
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuro | 2012 |
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2012 |
[Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Transplantation; Ch | 2012 |
[Biphasic pulmonary blastoma with germ cell differentiation: a challenge in diagnosis and treatment].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; Huma | 2011 |
Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.
Topics: Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Neoadjuv | 2012 |
Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamo | 2012 |
Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2012 |
[Treatment and prognosis of stage IV alveolar soft part sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Dacarbazine; | 2012 |
Response to chemotherapy in a child with primary bronchopulmonary leiomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Child, Preschool; Dactinomycin; | 2002 |
Chemotherapy induced complete remission in malignant phyllodes tumor of the prostate metastasizing to the lung.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Lung Neoplas | 2002 |
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined | 2002 |
[Pulmonary carcinosarcoma with jejunal metastasis: complete response to chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Doxorubicin; Humans; Ifos | 2002 |
A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; C | 2002 |
Neo-adjuvant chemotherapy in early stages of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2002 |
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modal | 2002 |
Preoperative chemotherapy is essential for conservative surgery of Askin tumors.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplas | 2003 |
[Primary pulmonary synovial sarcoma: a report and diagnosis of 2 cases].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherap | 2003 |
Modified Ifosphamide/CarboPlatin/Etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Human | 2003 |
[Maintenance chemotherapy for small-cell lung cancer. A new publication].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administratio | 2003 |
Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug | 2003 |
Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2003 |
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma | 2004 |
A case of renal synovial sarcoma: complete remission was induced by chemotherapy with doxorubicin and ifosfamide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Ifosfamide; Kidn | 2004 |
Ifosfamide-induced psychosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Humans; Ifosfamide; Lung Ne | 2004 |
[Cellular changes in non-small cell lung cancer after neoadjuvant therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Ce | 2004 |
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; C | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carbopla | 2004 |
Tumor excision and reconstruction of the upper cervical spine: a multidisciplinary approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axis, Cervical Vertebra; Bone Transplantation | 2004 |
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child, Preschool; Cispl | 2005 |
Is the tolerance to MIP chemotherapy different between English and other European populations?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III a | 2005 |
Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Databases | 2005 |
[Evaluation of combined chemotherapy with vinorelbine, ifosfamide and cisplatin in the treatment of metastatic non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcin | 2005 |
Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; I | 2005 |
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Mod | 2005 |
Fas expression in lung metastasis from osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2005 |
The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysi
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined | 2006 |
Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.
Topics: Administration, Intranasal; Animals; Antineoplastic Agents, Alkylating; Bone Neoplasms; Combined Mod | 2006 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, P | 2007 |
Successful treatment via chemotherapy and surgical resection of a femoral hemangiopericytoma with pulmonary metastasis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modalit | 2006 |
[Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bi | 2006 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti | 2006 |
Pancreatoblastoma in a teenage patient.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2006 |
Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fat | 2006 |
Cardiac metastasis from uterine leiomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Deoxycytidin | 2006 |
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Ch | 2006 |
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide | 2006 |
Durable and complete remission of a metastatic bladder sarcomatoid carcinoma with chemotherapic and surgical treatments.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; | 2006 |
A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Drug A | 2006 |
[Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; F | 2006 |
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2006 |
[Efficacy of adriamycin, etoposide plus ifosfamide on small cell lung cancer--a retrospective analysis of 69 cases treated in Centre Hospitalo-Universitaire de Bordeaux].
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubi | 2006 |
[Role of radiotherapy of lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2006 |
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dactin | 2007 |
Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinica | 2006 |
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Etoposide; | 2007 |
Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined M | 2007 |
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality | 2007 |
[Three-year survival after treatment of a primary pulmonary angiosarcoma].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Diseas | 2007 |
Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Therapy, Co | 2007 |
Chemotherapy improves low performance status lung cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female | 2007 |
Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Topics: Abdominal Neoplasms; Aged; Antidotes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Che | 2007 |
Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Carcinoma, Non-Small- | 2007 |
[Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemothe | 2007 |
Salvage combination chemotherapy with docetaxel, ifosfamide and cisplatin (DIP): successful treatment of a case with metastatic testicular immature teratoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Ifosfamide; Lun | 2008 |
[A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic | 2008 |
Big question, small answer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Admi | 2008 |
Diseases desperate grown.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Sur | 2008 |
[A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide].
Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Humans; Ifosfamide; Lung Neoplasms; Male; Middle | 2008 |
[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; C | 1984 |
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Ca | 1984 |
Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
Topics: Acetylcysteine; Adenocarcinoma; Administration, Oral; Carcinoma; Carcinoma, Small Cell; Carcinoma, S | 1981 |
[Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Human | 1982 |
Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug | 1982 |
Small cell lung cancer. Serial bronchofiberscopy and photographic documentation--the bridge sign.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcino | 1983 |
Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Administrati | 1982 |
[Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin | 1983 |
[Ifosfamide in the treatment of small cell carcinoma of the lung].
Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Cystitis; Drug Administration Schedule; Drug T | 1983 |
Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Bronch | 1984 |
Pharmacokinetic studies in lung cancer patients.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Cyclophospha | 1984 |
Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubic | 1983 |
Electron-capture--gas chromatographic analysis of ifosfamide in human plasma and urine.
Topics: Cyclophosphamide; Fluorocarbons; Humans; Ifosfamide; Lung Neoplasms; Phosphoramide Mustards | 1983 |
Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Ifosfamide; | 1983 |
N-acetylcysteine: its bioavailability and interaction with ifosfamide metabolites.
Topics: Acetates; Acetylcysteine; Biological Availability; Carcinoma, Bronchogenic; Chemical Phenomena; Chem | 1983 |
Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.
Topics: Acetylcysteine; Acrolein; Adenocarcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Cystitis; Dose | 1983 |
[Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophos | 1983 |
[Pulmonary metastasis of renal cell carcinoma].
Topics: Adenocarcinoma; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; | 1983 |
The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy.
Topics: Adolescent; Adult; Alkylating Agents; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Humans | 1982 |
The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lung.
Topics: Acetylcysteine; Administration, Oral; Cyclophosphamide; Female; Hematuria; Humans; Ifosfamide; Lung | 1982 |
Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.
Topics: Alopecia; Brain; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Hematuria; Humans; | 1982 |
Serum zinc levels in lung cancer patients.
Topics: Adult; Aged; Bacterial Vaccines; Carcinoma, Squamous Cell; Copper; Doxorubicin; Humans; Ifosfamide; | 1981 |
The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
Topics: Administration, Oral; Adult; Biological Availability; Carcinoma, Bronchogenic; Cyclophosphamide; Fem | 1981 |
[Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
Topics: Adenocarcinoma; Bone Neoplasms; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney Neoplasms; Lung | 1980 |
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
Topics: Administration, Oral; Adolescent; Antidotes; Bone Neoplasms; Brain Diseases; Drug Overdose; Female; | 1994 |
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemothe | 1993 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dacti | 1994 |
A complicated case of metastatic teratoma. Growing teratoma syndrome and cerebral metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cispl | 1995 |
[Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etopos | 1995 |
Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate? West of Scotland Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Eto | 1995 |
[Combination effect of pirarubicin, ifosfamide, and vincristine sulfate in the treatment of advanced synovial sarcoma--report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buttocks; Cystitis; Doxorubicin; Female; Hemo | 1995 |
[Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastasis in non small cell lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-C | 1995 |
Reversible myocardial ischaemia following vincristine containing chemotherapy.
Topics: Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Myocardia | 1994 |
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; | 1994 |
[Epileptic seizures and treatment with ifosfamide-mesna].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Epilepsy; Fatal Outcome; H | 1994 |
[Peri-operative chemotherapy during resection of pulmonary metastases of sarcoma].
Topics: Adult; Combined Modality Therapy; Female; Humans; Ifosfamide; Infusions, Intravenous; Intraoperative | 1994 |
Acute pancreatitis after ifosfamide therapy.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; H | 1994 |
Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epiru | 1993 |
Teniposide for meningeal carcinomatosis of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyc | 1993 |
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1994 |
[A case of malignant fibrous histiocytoma of jejunal origin with marked response to cisplatin, ifosfamide and adriamycin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Doxorubicin; Histiocytom | 1993 |
Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophos | 1993 |
Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
Topics: Acetaldehyde; Adult; Aged; Carcinoma, Bronchogenic; Chromatography, Gas; Chromatography, High Pressu | 1993 |
[Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Do | 1993 |
Osteosarcoma with deeply eosinophilic rhabdomyoblast cells in a lung metastatic focus. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Femoral Neoplasms; | 1993 |
Ifosfamide neurotoxicity. A challenge for nurses, a potential nightmare for patients.
Topics: Brain Diseases; Carcinoma, Small Cell; Central Nervous System; Female; Humans; Ifosfamide; Lung Neop | 1993 |
Management of small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; | 1993 |
[Pathology and clinical aspects of peripheral neuroectodermal tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dexamethasone; Doxorubicin; Dru | 1993 |
Antitumor activity of treosulfan in human lung carcinomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti | 1996 |
Case report: pulmonary blastoma in children--response to chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Moda | 1996 |
Disease extent and response to chemotherapy in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 1996 |
Response of small cell carcinoma of pancreas to a small cell lung cancer regimen: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cy | 1996 |
Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Smal | 1995 |
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, | 1996 |
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Gene Ex | 1997 |
Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Di | 1997 |
Gemcitabine shows promise as combination agent in NSCLC.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcin | 1996 |
The carcinogenicity of environmental tobacco smoke.
Topics: Adenocarcinoma; Adenoma; Administration, Inhalation; Animals; Antineoplastic Agents; Biomarkers; But | 1997 |
Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
Topics: Acetaldehyde; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cells, Cultured; Dose-Response Relation | 1997 |
Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Fema | 1997 |
Miliary osteosarcomatosis with associated hypocalcemia.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
[Efficacy of systemic chemotherapy in adenocarcinoma of the lung with pleuritis carcinomatosa].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin | 1997 |
Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Cranial | 1997 |
Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Humans; Ifos | 1997 |
[The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas].
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Drug Administration Sch | 1997 |
Prolonged survival in a nasopharyngeal carcinoma patient with multiple metastases: a case report and review of the literature.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 1997 |
Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxo | 1997 |
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; | 1998 |
[Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Ci | 1998 |
Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Erythrop | 1997 |
[Peripheral neuroectodermal tumors of the chest wall. Description of a case].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; | 1998 |
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyc | 1998 |
Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dermatomy | 1998 |
[Chemotherapy for pulmonary metastases of soft tissue sarcoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administra | 1998 |
Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; | 1998 |
[Successful management for chemorefractory testicular cancer with brain and lung metastases. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinoma, Embryonal; | 1998 |
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1998 |
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; | 1999 |
The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Case-Control Studies | 1999 |
Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
Topics: Adult; Antineoplastic Agents, Alkylating; Breast Neoplasms; Child; Clinical Trials as Topic; Cycloph | 1998 |
Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow | 1999 |
Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-C | 1999 |
Treatment of primary pure angiosarcoma of ovary with multiple lung metastases: a case report.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fema | 1999 |
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Division; Cispl | 2000 |
[Combination chemotherapy consisting of ifosfamide and vindesine for non-small cell lung cancer in the elderly].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2000 |
Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinom | 2000 |
Induction chemotherapy for locoregional lung cancer using paclitaxel combination. A preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2000 |
Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Tri | 2001 |
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2001 |
[A case of primary malignant hemangiopericytoma of the lung with marked response to combination chemotherapy with cisplatin, ifosfamide and gemcitabine].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopl | 2001 |
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
Topics: Amino Acid Substitution; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP-Bin | 2001 |
A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deo | 2001 |
[Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2001 |
[Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2001 |
Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Carcinoma, Small Cell; Drug Resist | 2001 |
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2001 |
[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2001 |
Pleuropulmonary blastoma.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Child, Preschool; Dactinomycin; Disease-Free Survival | 2001 |
Three conventional-drug combination (ifosfamide, carboplatin, etoposide--ICE regimen) in advanced non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2001 |
Docetaxel and non small-cell lung cancer: new indication. One of several non curative chemotherapies.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical | 2001 |
Managing poor performance non-small-cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; I | 2001 |
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; | 2002 |
[Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)].
Topics: Adult; Antineoplastic Agents; Bleomycin; Cell Transformation, Neoplastic; Child; Child, Preschool; D | 1975 |
Chemotherapy in testicular tumors.
Topics: Bleomycin; Castration; Cell Division; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; D | 1977 |
Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophos | 1978 |
Advances in the chemotherapy and immunotherapy of lung cancer.
Topics: Humans; Ifosfamide; Immunotherapy; Lung Neoplasms | 1979 |
Cyclophosphamide and iphosphamide against Lewis lung carcinoma: evaluation of toxic and therapeutic effects.
Topics: Animals; Cyclophosphamide; Ifosfamide; Lethal Dose 50; Lung Neoplasms; Male; Mice; Mice, Inbred C57B | 1979 |
[Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
Topics: Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
Comparative effects of cyclophosphamide and isophosphamide on Lewis lung carcinoma.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Ifosfamide; Lung Neoplasms; Mice; Neopl | 1978 |
Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
Topics: Animals; Bromine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ifosfamide; Le | 1992 |
[Advances in the treatment of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined | 1992 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1992 |
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1992 |
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma | 1992 |
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcino | 1992 |
Oral ifosfamide-mesna: a clinical investigation in advanced non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dreams; Drug Administration Schedule; Female; Humans; Ifosfami | 1992 |
[Chemotherapy with cisplatin, adriamycin, etoposide and ifosfamide in microcytic lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxor | 1992 |
Primary treatment of pelvic osteosarcoma. Report of five cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemot | 1992 |
[A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; | 1992 |
[Elderly non-Hodgkin's lymphoma presenting with pulmonary squamous cell carcinoma as a complication of chemotherapy for malignant lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cyclophosphamide; Hu | 1992 |
A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, | 1991 |
Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 1991 |
A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Ifosfamide; Interferon | 1991 |
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1991 |
Ifosfamide, Fanconi's syndrome, and rickets.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Chronic Kidney Disease-Mineral an | 1991 |
Intercalated radio-chemotherapy in small cell lung cancer: toxicity and implications for future regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1991 |
Ifosfamide vs cyclophosphamide in cancer therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Female; Genital Neoplasms, | 1991 |
Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; D | 1991 |
Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1991 |
A pilot study of mitomycin, ifosfamide and cisplatin as outpatient combination chemotherapy for advanced non-small cell lung cancer.
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1991 |
Chemotherapy in recurrent and advanced cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplati | 1991 |
[Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1991 |
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxor | 1991 |
[Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Drug Admini | 1991 |
[Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Squamous Cell; Cisplatin; Dr | 1991 |
Ifosfamide extrapyramidal neurotoxicity.
Topics: Adenocarcinoma; Basal Ganglia Diseases; Humans; Ifosfamide; Lung Neoplasms; Lymphoma, Large B-Cell, | 1991 |
Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Ther | 1990 |
Interstitial pneumonitis associated with ifosfamide therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide | 1990 |
Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1990 |
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
Ifosfamide with mesna uroprotection in the management of lung cancer.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans | 1990 |
Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Female; Huma | 1990 |
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1990 |
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
[Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung | 1990 |
[Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1990 |
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administration | 1990 |
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1990 |
The effect of age on the pharmacokinetics of ifosfamide.
Topics: Adult; Aged; Aging; Body Water; Carcinoma, Non-Small-Cell Lung; Half-Life; Humans; Ifosfamide; Lung | 1990 |
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Eto | 1990 |
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sma | 1990 |
Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
[Successful treatment of several metachronous pulmonary metastases of a chondroblastic osteosarcoma].
Topics: Amputation, Surgical; Bleomycin; Child; Chondroblastoma; Cyclophosphamide; Dactinomycin; Female; Hum | 1985 |
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Colony-Stimulating Factors; D | 1988 |
[Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; D | 1989 |
[Desmoid fibroma of the scapula. Recurrence with pulmonary metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Female; Fibroma | 1989 |
Comparative evaluation of acute toxicity and antitumor activity of IF-XXV preparation and holoxan.
Topics: Animals; Female; Ifosfamide; Lethal Dose 50; Leukemia L1210; Lung Neoplasms; Male; Mice; Mice, Inbre | 1989 |
European experience with ifosfamide in non-small cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dr | 1989 |
Pilot study with adriamycin and ifosfamide in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Fem | 1989 |
Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1989 |
A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemo | 1989 |
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1989 |
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chromat | 1989 |
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Ma | 1989 |
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1987 |
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1987 |
[Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1988 |
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1988 |
[The role of radiotherapy in small cell lung cancer].
Topics: Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; | 1988 |
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Ev | 1988 |
Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1988 |
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1988 |
[Hepatotoxicity with etoposide-ifosfamide combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cel | 1988 |
Concurrent chemo-radiotherapy in small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; Female; Humans; Ifosfamid | 1988 |
Ifosfamide/mesa and encephalopathy.
Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms; | 1985 |
Ifosfamide as single-agent chemotherapy in inoperable non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma; Cyclophosphamide; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1985 |
Failure of response to ifosfamide in squamous cell bronchogenic carcinoma.
Topics: Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Drug Resistance; Humans; Ifosfamide; Lung Neoplas | 1989 |
A phase II study of high dose ifosfamide in metastatic colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Drug Evaluation; Female; Humans; Ifosfamide; Liver Neoplasms; Lun | 1989 |
[A case of retrocecal appendicitis occurrence during effective chemotherapy in lung cancer].
Topics: Abscess; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Appendicitis; Bone Marrow; | 1989 |
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1985 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug | 1985 |
Augmentation of cytotoxicity of chemotherapy by human alpha-interferons in human non-small cell lung cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; | 1986 |
[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule; | 1986 |
[Ifomide].
Topics: Animals; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Leukemia, Experimental; | 1987 |
Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcino | 1987 |
Ifosfamide by bolus as treatment for advanced non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Female; Humans; Ifosfamide; Inject | 1986 |
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1986 |
Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1987 |
False-positive ketonuria during ifosfamide and mesna therapy.
Topics: False Positive Reactions; Female; Humans; Ifosfamide; Ketone Bodies; Lung Neoplasms; Male; Mercaptoe | 1986 |
Phase II study of ifosfamide in cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Central Nervo | 1986 |
Prediction of ifosfamide/mesna associated encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Huma | 1986 |
Ifosfamide and Mesna in advanced malignancies.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Lymphom | 1988 |
Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Ifosfamide; | 1988 |
[Results of whole lung irradiation and chemotherapy in comparison with partial lung irradiation in metastasizing, undifferentiated soft tissue sarcomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 1988 |
Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
Topics: Animals; Cyclophosphamide; Ifosfamide; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mice; | 1986 |
Bioavailability of ifosfamide in patients with bronchial carcinoma.
Topics: Administration, Oral; Aged; Biological Availability; Carcinoma, Bronchogenic; Female; Humans; Ifosfa | 1986 |
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide; | 1986 |